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ABSTRACT 
Pathways involved in bi-directional communication within the cumulus-oocyte complex 
(COC) include gap junction (GJ) communication, oocyte growth factor production, and 
glucose metabolism and are essential for oocyte health. Perturbation of these pathways may 
result in reduced oocyte quality due to altered COC function. Using rats as a model, in vitro 
effects of exposure to bisphenol A (BPA), caffeine, nicotine, ethanol, 
methylenedioxymethamphetamine (MDMA), or Δ9-tetrahydrocannabinol (THC) on COC 
function were investigated. Furthermore, MDMA was administered to rats to compare in 
vitro with in vivo effects.  
The transfer of a fluorescent dye (calcein) from cumulus cells (CC) to the oocyte was used as 
a measure of GJ communication. Expression of CC-derived (Atr, Cx43, Cycs, Gfpt1, Pfkp) and 
oocyte-derived (Atr, Bmp15, Cx37, Gdf9) genes were measured using multiplex TaqMan 
quantitative PCR. Levels of CX43 and GDF9 proteins were quantified using Western blotting.  
Optimisation of the GJ bioassay included the addition of phosphodiesterase inhibitors 
(rolipram and dipyridamole), and a 1 hour post-calcein incubation period to allow dye 
transfer. Quantification of gene expression in calcein-treated CC and oocytes was validated, 
enabling direct comparisons between GJ communication and gene expression.  
To determine the in vitro effects, COC were incubated with test factors at high physiological 
concentrations over 25 hours. GJ communication decreased over time in control COC. This 
reduction was attenuated after exposure to BPA and nicotine, and partially by caffeine. 
Furthermore, exposure to ethanol maintained oocyte meiotic arrest, whereas MDMA and 
THC promoted meiotic resumption.  
Oocyte-derived gene expression was mostly unaffected by in vitro exposure to the lifestyle 
and environmental factors, although a treatment x time interaction for Cx37 levels following 
nicotine exposure was observed. Of the CC-derived genes, Cx43 was the most sensitive 
where BPA, MDMA, and THC increased, and caffeine and ethanol decreased, expression. In 
CC, exposure to MDMA and THC increased Gfpt1 levels and exposure to MDMA resulted in a 
treatment x time interaction in Cycs and Pfkp expression.  
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In COC, caffeine increased CX43 protein levels after 1 hour. Nicotine initially reduced, but 
with time increased CX43 levels. Furthermore, CX43 levels decreased and increased after 25 
hour exposures to ethanol and MDMA, respectively. GDF9 protein levels in COC exhibited 
wide within-treatment variation. Overall, BPA and caffeine reduced GDF9 levels after 1 hour 
whereas GDF9 levels were increased following exposure to BPA, caffeine, MDMA, and THC 
for 25 hours. 
To determine in vivo effects, female rats were administered saline or 5 mg/kg/day MDMA 
for 3 days. COC from MDMA-treated rats had higher levels of CX43 protein but gene 
expression and meiotic reactivation were unaffected.  
In conclusion, COC function was altered by in vitro exposure to BPA, caffeine, ethanol, 
nicotine, MDMA, and THC. Furthermore, in vivo exposure to MDMA elicits similar, albeit 
reduced, effects on COC function. A role for CC in protecting the oocyte from harmful 
contaminants is proposed. Perturbation of the bi-directional communication pathway is 
likely to influence oocyte quality due to alterations in nutrient availability and timing of 
follicular events, although these may not be associated with negative outcomes. This study 
provides evidence that exposure to lifestyle factors and environmental contaminants affect 
COC function.  
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1 INTRODUCTION 
1.1 Female Reproduction 
1.1.1 The ovary 
Female mammals have two ovaries located in the abdominal cavity on either side of the 
uterus. The ovary consists of a medulla and cortex enclosed by an epithelial layer called the 
ovarian surface epithelium. The cortical region contains the ovarian follicles, which are 
composed of an egg (oocyte) surrounded by a layer or layers of somatic cells and a basal 
lamina. The medulla region contains the main blood and lymphatic vessels.  
1.1.2 Ovarian follicular formation and growth 
Germ cells are first identified in the yolk sac during early embryonic life in mammals. They 
migrate from here to the gonadal ridge and differentiate into oogonia. These proliferating 
oogonia continue to migrate towards the ovarian cortex and, together with adjacent 
mesynchymal cells (pregranulosa cells), eventually coalesce into a convoluted array of 
ovigerous cords. Enclosed within these cords, the oogonia continue to proliferate but now 
are limited to recruiting pregranulosa cells from the proliferating ovarian surface epithelium.  
During this process, the oogonia enter meiosis and arrest at the diplotene stage of prophase 
I (see Sawyer et al., 2002). As the oogonia enter meiosis, many undergo apoptosis and their 
associated pregranulosa cells dissociate from these degenerating oogonia and re-attach to 
surviving oocytes. Prior to birth, individual meiotically-arrested oocytes surrounded by a 
single layer of squamous pregranulosa cells and enclosed by a basement membrane emerge 
from the base of the ovigerous cords as primordial follicles (Aerts and Bols, 2010). The 
assembly of primordial follicles is completed prior to birth in primates and domestic species, 
and during neonatal life in rodents (Rajah et al., 1992; Van den Hurk et al., 2000; Sawyer et 
al., 2002). It is generally accepted that this pool of non-growing primordial follicles is non-
renewable although this view has been contested (Johnson et al., 2004). 
Follicles initiate growth one at a time from the moment they are formed. Once growth has 
been initiated, the follicle grows without rest until it either becomes atretic and dies, or 
undergoes ovulation. Initiation of follicular growth takes place continuously regardless of the 
stage of reproductive life or time of the oestrous or menstrual cycle. This continuum is only 
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terminated at death or when the pool of follicles is depleted such as at menopause in 
humans. The mechanism by which individual primordial follicles are recruited into the 
growing pool is largely unknown. Activation of growth of primordial follicles is likely to occur 
as a result of both stimulating factors and removal of inhibitory factors. Several pathways 
have been identified to be involved in primordial follicle activation including KIT ligand 
signalling, NOBOX and SOHLH1 transcription factor activation, and anti-Mullerian hormone 
(Edson et al., 2009).  The transition from the primordial to primary follicle stage is 
characterised by a change in granulosa cell (GC) shape, from flattened to cuboidal (Figure 
1-1). All growing follicles that reach the developmental stage that requires support from 
pituitary hormones will undergo atresia if these hormone concentrations are inappropriate 
such as any time before puberty (McNatty, 2000), during anoestrus or during certain stages 
of the oestrous cycle (Hirshfield, 1991). 
Progression from the primary stage to the secondary stage involves enlargement of the 
oocyte and proliferation of the GC to form multiple concentric layers. Theca cells, derived 
from the interstitial stroma, surround the basal lamina sometime after the primary stage of 
growth (Edson et al., 2009). Two distinct layers, the theca interna and externa, become 
evident by the late preantral (i.e. secondary) stages of development: the theca externa is a 
less-well differentiated layer while the more differentiated and vascularised theca interna 
region is localised adjacent to the follicular basal lamina. The theca interna is the major 
source of follicular androgens, notably androstenedione. Androstenedione is a primary 
substrate for follicular oestradiol production. During antral follicular growth, 
androstenedione is metabolised to oestradiol by the P450 aromatase enzyme present in the 
GC (Magoffin, 2005). After initiation of growth, a glycoprotein matrix forms, termed the zona 
pellucida, separating the oocyte from the GC. The zona pellucida is essential for normal 
fertilization (Edson et al., 2009). Throughout follicular growth, the GC secrete fluid which 
gradually coalesces to form an antral cavity during the late secondary stage of growth 
(Edwards, 1974). This fluid-filled antrum leads to the differentiation of two distinct sub-
populations of GC: the cumulus cells (CC) and the mural GC (Figure 1-1 and Figure 1-2). 
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Figure 1-1: The structure of the ovarian follicle during different growth stages. Following initiation of follicle 
growth, the GC become cuboidal and proliferate to form multiple concentric layers. Secretions from the GC and 
exudates from the plasma coalesce to form a fluid filled antrum. Concurrently, the GC differentiate into two 
populations, the mural GC and the CC. The theca interna and theca externa form outside the basal lamina of 
the follicle. Modified from Johnston, L (VUW BBMedSci Honours thesis, 2010).  
 
The CC directly surround the oocyte, and serve to nurture it (Su et al., 2009). The mural GC 
line the outer regions of the follicle, perform steroidogenesis and express receptors for 
pituitary gland-derived gonadotrophins, follicle-stimulating hormone (FSH) and in later 
follicular stages, luteinising hormone (LH). The differentiation of the mural GC and CC is 
proposed to be mediated by opposing gradients of FSH from the blood, and factors secreted 
by the oocyte (Diaz et al., 2007). Following the formation of the antrum and differentiation 
of the GC, the follicle is termed an antral or tertiary follicle.  
During the primary and secondary phases, follicular growth is not reliant on gonadotrophin 
signalling; conversely tertiary follicles require a functional LH receptor signalling system in 
theca interna cells and a functional FSH receptor signalling system in GC for continued GC 
proliferation and synthesis of steroids such as oestradiol (Kumar et al., 1997). Those 
developing follicles that acquire functional LH receptors on GC are considered to be the 
‘dominant’ follicles which will go on to be ovulated. The number of follicles that are ovulated 
during each reproductive cycle depends on the species. Species such as primates (e.g. 
humans) and ruminants typically ovulate one oocyte per cycle whereas species such as 
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rodents and pigs will ovulate multiple oocytes per cycle. These few dominant follicles are the 
major source of oestrogens and inhibins, which rise cyclically during the mid- to late- 
follicular stage of the oestrous cycle. Oestrogens and inhibins secreted from the dominant 
follicle(s) suppress FSH, but not LH, release from the pituitary, thus preventing any follicles 
that do not have LH receptors expressed on GC from sustaining oestradiol production and 
further maturation. As FSH is an essential factor for antral follicular development, it is 
thought a key mechanism to reduce the number of dominant follicles is lowering the plasma 
concentrations of FSH while increasing the GC responsiveness to LH. This allows maturation 
of the dominant follicle(s) to continue in increasingly low concentrations of FSH but rising 
concentrations of LH (Edson et al., 2009).    
 
 
Figure 1-2: Sheep ovarian follicles at various stages of development. A pre-antral follicle with multiple 
concentric layers of GC may be seen at the bottom of the image. The follicle above this is beginning to form an 
antrum, while the next follicle has a more developed antrum. The top-most follicle has a large antral space, and 
the differentiated CC-oocyte complex (COC) is visible in the middle of the follicle. Image supplied by Ken 
McNatty. 
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The final stages of follicular growth involve the maturation of the oocyte nucleus and 
cytoplasm in preparation for ovulation (Eppig, 1996). Nuclear maturation includes the 
resumption of meiosis and will be discussed in Section 1.1.3. Cytoplasmic maturation 
prepares the oocyte for activation and preimplantation development and involves the 
storage of messenger ribonucleic acid (mRNA) transcripts and proteins for use after 
fertilisation. These mRNA stores are essential as the embryonic genome is not activated until 
a few days after fertilisation (Gosden and Lee, 2010). During cytoplasmic maturation, ultra-
structural changes also occur including redistribution of the mitochondria, endoplasmic 
reticulum, and cortical granules (Marteil et al., 2009).  
1.1.3 Oocyte meiotic arrest 
From the time of follicular formation until the pre-ovulatory LH surge, the oocyte is arrested 
at the diplotene stage of the first meiotic prophase. During this time the DNA is contained 
within the nuclear envelope, termed the germinal vesicle (GV). The oocyte gains the ability 
to progress through meiosis around the same time as the antrum forms, although meiotic 
arrest is maintained until the preovulatory LH surge (Mehlmann, 2005). Resumption of 
oocyte meiosis can be recognised morphologically by the breakdown of the GV (GVBD). 
Meiotic progression results in release of the first polar body, but arrests again at metaphase 
II and only resumes at fertilization. Meiosis is completed following fertilization and the 
release of the second polar body (Edson et al., 2009) 
Meiotic arrest has long been known to be regulated by high levels of cyclic adenosine 
monophosphate (cAMP) in the oocyte (Cho et al., 1974). Removal of the CC-oocyte complex 
(COC) from the follicle, or inhibition of gap junction (GJ) transfer, causes cAMP levels within 
the oocyte to decline, and the oocyte to resume meiosis (Pincus and Enzmann, 1935; 
Racowsky et al., 1989; Tornell et al., 1990). Within the oocyte, cAMP is synthesised by 
adenylyl cyclase which is stimulated by a constitutively activated G protein coupled receptor 
(Norris et al., 2009). Despite the presence of adenylyl cyclase (Conti et al., 2012), it has been 
shown that the oocyte receives much of its cAMP from the somatic cells via GJs (Thomas et 
al., 2002; Webb et al., 2002). Thus, it is understood that intra-oocyte cAMP levels are the net 
result of a supply of this second messenger from CC via GJ, synthesis within the oocyte itself 
and the rate of enzymatic degradation. The degradation (hydrolysis) of cAMP occurs mainly 
by phosphodiesterases (PDEs). The major PDE isoform reportedly expressed in mammalian 
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oocytes is PDE3A, and this has been shown to prevent oocyte nuclear maturation both in 
vitro and in vivo (Conti et al., 2002). While PDE3A preferentially and rapidly hydrolyses 
cAMP, it also hydrolyses another secondary messenger (cyclic guanosine monophosphate; 
cGMP), but at a much slower rate. Thus the presence of cGMP within the oocyte slows the 
hydrolysis of cAMP and is described as an inhibitor of cAMP degradation by PDE3A (Beavo, 
1995). During meiotic arrest, cGMP is transferred to the oocyte from the CC via GJs, resulting 
in a reduction of cAMP hydrolysis by PDE3A (Norris et al., 2009). 
One way through which FSH contributes to the maintenance of meiotic arrest is stimulation 
of the cGMP pathway. Studies in the rat using equine chorionic gonadotrophin reveal that 
activation of the FSH receptor stimulates mRNA expression of GC-derived natriuretic peptide 
precursor type C (Nppc), and its receptor on CC (Npr2). The action of NPPC on NPR2 results 
in an increase in cGMP production by the GC and CC (Zhang et al., 2010). In addition, 
oestradiol increases the levels of Npr2 mRNA and maintains the ability of NPPC to stimulate 
cGMP production in vitro (Zhang et al., 2011). Conversely, treatment of mouse follicles with 
LH caused a rapid reduction in NPR2 guanylyl cyclase activity, without reducing NPR2 protein 
levels (Robinson et al., 2012). The preovulatory LH surge also triggers closure of the GJs as a 
result of mitogen activated kinase (MAPK)-dependent phosphorylation of the GJ protein 
connexin 43 (CX43) (Norris et al., 2008). The net result of NPR2 inhibition and closure of the 
GJs is that both cAMP and cGMP concentrations within the oocyte decrease and meiosis 
resumes.  
As discussed earlier, oocyte maturation in response to the preovulatory LH surge is a cAMP-
mediated process. However, cAMP has paradoxical actions in the CC and oocyte. Following 
the LH surge, a transient rise in cAMP levels occurs in the GC. In the rat, elevated levels of 
cAMP levels in the follicular cells as a result of inhibition of PDE4 promotes oocyte 
maturation in the absence of LH (Tsafriri et al., 1996). PDE4D is the major PDE isoform 
expressed in the CC and GC in rat follicles and is cAMP specific (Tsafriri et al., 1996). PDE4D 
regulation of LH receptor signalling is essential, as demonstrated by a PDE4D knockout (KO) 
mouse model. Following human chorionic gonadotrophin (hCG) stimulation, follicles from 
KO mice showed an abnormal pattern of cAMP accumulation and failed to rupture, resulting 
in a decreased ovulation rate (Park et al., 2003).   
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In addition to PDE3 and 4, PDE1, 5, 7, 8, 10, and 11 have also been detected in follicles from 
various species (Sasseville et al., 2009a; Conti, 2011). However, the role of these PDE families 
in oocyte maturation is less well known and is thought to be secondary to the actions of 
PDE3/PDE4 in most species. The exception to this is PDE8, which accounts for around 20 % 
and 60 % of PDE activity in the bovine oocyte and CC, respectively (Sasseville et al., 2009a). 
Detection of DNA damage and replication errors during meiosis is critical for maintaining 
genetic integrity. Two protein kinases that detect DNA damage and regulate progression of 
meiosis have been identified. The ataxia telangiectasia mutated (Atm) gene is activated by 
ionizing radiation and double-strand breaks. The ataxia telangiectasia and Rad3-related (Atr) 
gene is primarily activated by UV light, hydroxyurea, stalled replication forks and single-
stranded DNA, but may also be activated by ATM in response to double-strand breaks 
(Rhind, 2009). Activation of the ATR protein causes the phosphorylation of multiple proteins 
including CHK1, BRCA1, and NBS1 and results in the formation of check point complexes and 
G2/M arrest (Abraham, 2001; Miles et al., 2010). ATR is localised at unsynapsed 
chromosomes during the pachytene stage of prophase in human oocytes (Garcia-Cruz et al., 
2009). Pachytene is a stage of prophase during which crossing over between homologous 
chromosomes occurs. The pachytene checkpoint monitors DNA damage, repair of 
recombination intermediates, and chromosomal synapsis prior to chiasma formation (Kogo 
et al., 2012). In addition, phosphorylation of ATR/ATM substrates has been detected in 
bovine oocytes during the second stage of meiosis (MII)  (Siemer et al., 2009). Moreover, 
Chk1 mRNA expression is present in germ cells of female mice at 14.5 days post conception 
(Hasthorpe et al., 2007) and is essential for maintaining meiotic arrest in Xenopus laevis 
oocytes (Nakajo et al., 1999).  
1.1.4 The pre-ovulatory LH surge and ovulation 
As follicles grow and synthesise inhibin subunits and oestradiol, levels of inhibins and 
oestradiol within both the follicular fluid and circulation increase. The high levels of inhibins 
act on the pituitary gland to inhibit FSH production. Oestradiol production in dominant 
follicles is driven by the increasing release of LH acting on LH receptors expressed in mural 
GC of dominant follicles (Edson et al., 2009). The positive feedback effect of oestradiol leads 
to a preovulatory LH surge. As discussed previously (Section 1.1.3) the LH surge triggers 
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oocyte nuclear maturation and resumption of meiosis. In addition, the LH surge initiates 
morphological changes of the follicle, which are required for ovulation.  
The rise in LH levels stimulates the CC to secrete a specialised extracellular matrix, composed 
of a backbone of hyaluronan in a process termed CC expansion. CC expansion is mediated by 
MAPK signalling (Su et al., 2002) and oocyte paracrine factors (Buccione et al., 1990b) and 
results in the CC transforming from a tightly packed mass to an expanded mucified complex. 
CC expansion is essential for extrusion of the oocyte from the follicle (Kidder and 
Vanderhyden, 2010). The follicle wall is also remodelled through capillary haemorrhage, 
proteolytic degradation and cell death at the apical site and luteinisation of the GC. These 
events culminate in follicular rupture thereby allowing the expanded COC to be released 
from the follicle for entry into the reproductive tract (Russell and Robker, 2007).  
The preovulatory LH surge also stimulates luteinisation of the mural GC. Following ovulation 
and release of the expanded COC, the luteinised GC and, in some species, the theca cells 
differentiate from the remnants of the haemorrhagic follicle to form the corpus luteum (CL). 
The CL is a specialised structure that in all species produces progesterone (and in some 
species oestradiol and inhibin) to stimulate the uterus to prepare for pregnancy (Edson et 
al., 2009).  
1.2 The Role of GJs in Folliculogenesis 
1.2.1 General GJ structure and function 
GJs are intercellular channels that allow direct passage of small molecules (<1 kDa) between 
the cytoplasm of two adjacent cells. Cells share ions, small metabolites, and second 
messengers through GJs as a means of intercellular signalling (Bruzzone et al., 1996). GJs are 
composed of integral membrane proteins (connexins; CX), which form hexameric pore 
structures termed hemichannels or connexons (Figure 1-3). The docking of two 
hemichannels results in formation of a GJ channel. 
There are around 20 different connexin proteins encoded in the mammalian genome. Most 
cells express multiple connexin isoforms, and each connexin isoform has a characteristic 
tissue expression pattern (Goodenough and Paul, 2009). Connexins are named according to 
their size; the smallest connexin is CX26 (26 kDa) while the largest connexin is CX57 (57 kDa).  
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Figure 1-3: Basic structure of GJ channels. CX proteins are transmembrane proteins that form hexameric pore 
structures (hemichannels). The docking of two hemichannels from adjacent cells forms a GJ channel through 
which small molecules can pass between the cells. 
 
All connexins have the same structure consisting of a cytoplasmic C terminus, four 
membrane spanning domains, two extracellular loops, an intracellular loop, and a 
cytoplasmic N terminus (Figure 1-4). 
Oligomerization of six connexins to form a hemichannel occurs in the endoplasmic reticulum 
and Golgi body (Musil and Goodenough, 1993). The hemichannels are transported in vesicles 
which move along microtubules to the plasma membrane. The vesicles fuse with the plasma 
membrane, thus delivering the hemichannels to the cell surface (Gaietta et al., 2002; 
Segretain and Falk, 2004). Analysis of the crystal structure of human CX26 GJs has shown 
that the hemichannels possess a positively charged cytoplasmic opening, a narrow funnel, a 
negatively charged transmembrane region and an extracellular exit (Maeda et al., 2009). A 
large amount of variation in GJs occurs through the different composition of hemichannels. 
Hemichannels may contain only one connexin isoform or multiple connexin isoforms; these  
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Figure 1-4: Structure of connexin proteins. Connexins are transmembrane proteins which have four 
transmembrane domains, two extracellular loops, one cytoplasmic loop, and cytoplasmic C- and N-termini. 
Figure adapted from Kidder and Mhawi, 2002; Maeda et al., 2009.  
 
are termed homomeric and heteromeric hemichannels respectively. It is thought homomeric 
and heteromeric hemichannels have different permeability to small molecules. Although 
unpaired hemichannels were previously thought to be non-functional, they have recently 
been found to play a role in extracellular release of adenosine triphosphate (ATP), 
Nicotinamide adenine dinucleotide (NAD+), prostaglandins, and glutamate, and transduction 
of Ca2+ waves (Tong et al., 2007). 
Two hemichannels from adjacent cells dock through interactions between cysteine residues 
in the extracellular loops (Dahl et al., 1991). The two hemichannels that make up a GJ 
channel may be identical or non-identical, forming homotypic or heterotypic GJs respectively 
(Goodenough and Paul, 2009). The permeability of homotypic GJ channels to small 
molecules varies greatly. For example, ethidium bromide does not pass through GJs 
composed of CX31 or CX32, but will pass through GJs composed of CX26, CX37, CX40, CX43, 
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or CX45. Moreover, total conductance of GJ channels in cells transfected with CX31 or CX45 
is only around 50 % of that observed in cells transfected with other isoforms (Elfgang et al., 
1995). Less information is available about the permeability of heterotypic GJ channels due to 
their complexity, but it is likely that different combinations of connexins give rise to GJ 
channels with different physiological properties, in a similar manner as that described for 
homotypic channels (Goodenough and Paul, 2009). 
GJs are further assembled into large GJ plaques, which may contain several to thousands of 
GJ channels. Formation of GJ plaques may be essential for GJ function, as CX43 
hemichannels that are not part of a plaque are unlikely to form GJs, and those GJs that are 
formed are not functional. However, within a GJ plaque composed of CX43 GJs only 2-20 % 
of the GJs are functional, depending on the size of the plaque (Bukauskas et al., 2000).  
GJ permeability is also modified in response to cytoplasm acidification and changes in Ca2+ 
concentration however these modifications are slower than voltage gating. Increases in H+ 
and Ca2+ ion concentrations have been demonstrated to reduce the permeability of almost 
all GJs (Peracchia, 2004). A number of other compounds that specifically inhibit GJs have 
been identified. These compounds are termed GJ uncouplers and include glyccerrhetinic acid 
derivatives, long-chain alkanols, and acidifiers (Bukauskas and Verselis, 2004). Inhibition of 
GJs by GJ uncouplers is reversible and is thought to reduce conductance to the residual state 
in a similar manner to voltage gating.  
GJs are regulated by phosphorylation. All connexins, with the exception of CX26, are 
phosphoproteins (Ahmad and Evans, 2002; Moreno, 2005). Multiple phosphorylation steps 
regulate GJ assembly. Connexins are phosphorylated on specific residues during transport 
through the Golgi, and these phosphorylation sites appear to be essential for trafficking 
(Solan and Lampe, 2007). Phosphorylation can also inhibit or stimulate connexin degradation 
(Goodenough and Paul, 2009). Phosphorylation of CX43 at serine (S)368 is thought to 
prevent CX43 from being assembled into GJs, and results in a 50 % decrease in unitary 
conductance (Lampe et al., 2000). CX43, the best studied of the connexin isoforms, contains 
two serines within its N-terminal region and 21 serines within the C-terminal cytoplasmic 
region (Lampe and Lau, 2000).  
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GJs are regulated by rapid turnover: the half-life of CX43 in most cell types is <3 hours. 
Indeed, most connexin isoforms have a half-life of less than 10 hours  (Hervé et al., 2007). 
Turnover of GJs occurs by removal of the channels at the centre of a plaque, and additionally 
at the edges (Gaietta et al., 2002). Moreover, GJs may be removed from the cell surface by 
internalisation of the entire GJ plaque (Jordan et al., 2001).  
1.2.2 The Role of GJs in Folliculogenesis 
The follicle functions as a syncytium through folliculogenesis, with the oocyte coupled to the 
surrounding somatic cells by GJ channels. In a tertiary follicle, the oocyte is coupled to the 
CC, that are then coupled to the mural GC by GJ channels (Gilula et al., 1978). GJs allow 
intercellular signalling between the oocyte and somatic cells and provide a pathway for the 
CC to supply the oocyte with essential nutrients. Glucose metabolites, amino acids, cyclic 
nucleotides, ions, choline, and inositol are all passed to the oocyte through GJ channels 
(Kidder and Vanderhyden, 2010). In addition, the GC regulate the pH of the growing oocyte 
by transferring ions to the oocyte via GJs (FitzHarris et al., 2007). The GJ channels between 
the oocyte and CC occur at the end of CC trans-zonal projections (Kidder and Mhawi, 2002).  
The major connexin isoforms expressed in rat ovarian follicles are CX37 (expressed in the 
oocyte) and CX43 (expressed in CC and GC) (Teilmann, 2005). In addition, CX30.3, CX32 and 
CX45 are expressed in lower proportions in rat GC. Whilst CX57 has been detected in mouse 
CC, it has not been measured in rat CC (Kidder and Mhawi, 2002).  
The essential role of CX37 in follicular growth has been demonstrated by targeted gene KO 
studies. As CX37 is the major connexin expressed in the oocyte, oocyte-GC coupling is 
abolished in mice that have a KO of the Cx37 (alternatively named Gja4) gene that encodes 
CX37. Growth of follicles initially appears to proceed normally in Cx37-KO mice however 
halts at the preantral stage (Simon et al., 1997). The size of oocytes from these mice reached 
only 74 % of that of fully grown oocytes from wild-type mice  and did not gain meiotic 
competence (Carabatsos et al., 2000). The ovaries of Cx37-KO mice eventually become filled 
with CL-like structures, indicating premature differentiation of the GC into luteal cells (Simon 
et al., 1997). Expression of Cx37 mRNA in oocytes, but not GC, is essential for follicle growth 
as demonstrated by the use of chimeric ovaries containing wild-type or Cx37-KO oocytes and 
wild-type or Cx37-KO GC in all combinations (Gittens and Kidder, 2005). Chimeric ovaries 
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were created in vitro and implanted in the kidney capsule of ovariectomized female wild-
type mice. Ovaries containing wild-type oocytes and Cx37-KO GC showed similar proportions 
of follicles at each stage of development compared to ovaries containing wild-type oocytes 
and wild-type GC. However, ovaries containing Cx37-KO oocytes and wild-type GC had 
significantly reduced proportions of late secondary and tertiary follicles compared to 
completely wild-type ovaries. 
Due to the expression of CX43 in many tissues, mice which have a targeted KO of Cx43 
(alternatively named Gja1) gene are aborted in utero. In order to study the role of CX43 in 
follicular growth, Cx43-KO ovaries from neonatal mice were cultured in vitro before being 
grafted into the kidney capsule of ovariectomized wild-type adult mice (Ackert et al., 2001). 
GC from Cx43-KO mice were unable to proliferate causing follicular growth to arrest at the 
primary stage. Oocytes from Cx43-KO ovaries were morphologically abnormal, did not gain 
meiotic competence and could not be fertilised. Dye transfer experiments indicated that 
some GJ channels were retained between the GC, consistent with expression of other 
connexin isoforms. The essential role of GC, but not oocyte, expression of CX43 was 
demonstrated using chimeric ovaries containing wild-type or Cx43-KO oocytes, and wild-type 
or Cx43-KO GC in all combinations (Gittens and Kidder, 2005). Ovaries with Cx43-KO oocytes 
and wild-type GC contained follicles at all developmental stages in similar proportions to 
those seen in ovaries containing wild-type oocytes and wild-type GC. Ovaries with wild-type 
oocytes and Cx43-KO GC had significantly reduced proportions of early secondary, late 
secondary and tertiary follicles compared with the wild-type comparison, consistent with a 
block at the primary stage of follicular development. 
As Cx37 mRNA is expressed solely by the oocyte and Cx43 mRNA is expressed in the CC and 
GC, the GJs that form between the oocyte and CC must be heterotypic. Conductance studies 
of cell lines transfected with rat Cx43 and/or human Cx37 genes showed that homotypic, 
heterotypic, and heteromeric GJs are able to be formed in vitro  (Brink et al., 1997). 
However, to my knowledge this has not been demonstrated in vivo.  
Within the follicle, Cx43 mRNA and protein levels are dynamically regulated throughout the 
oestrus cycle by gonadotrophins. In antral follicles of rats that express FSH receptors, rising 
levels of FSH stimulate an increase in Cx43 mRNA and protein levels (Granot and Dekel, 
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1997). As discussed previously (Section 1.1.3), cAMP and cGMP pass through the GJ to the 
oocyte to maintain the threshold concentration of cAMP that inhibits meiotic resumption. 
The FSH-mediated increase in oocyte cAMP is blocked by treatment with the GJ uncoupler 
carbenoxolone (Webb et al., 2002) confirming that cAMP is transferred to the oocyte from 
the CC via GJ. Following the LH surge in mice, the decrease in GJ permeability between the 
oocyte and CC is mediated by the phosphorylation of CX43 at S255, S262, and S279/S282 
(Norris et al., 2008). Subsequently, Cx43 mRNA expression is abolished (Granot and Dekel, 
1997). To my knowledge, Cx37 gene expression has not been reported to be regulated by 
gonadotrophins.  
The CC transfer a range of nutrients to the oocyte via GJs. Compared with denuded oocytes 
(DO), CC-enclosed mouse oocytes had a significantly higher uptake of [3H]glycine and 
[3H]choline, however this was abolished following treatment with the GJ uncoupler 18-α-
glycyrrhetinic acid (Haghighat and Van Winkle, 1990). Glucose and glucose metabolites are 
transferred into the oocyte from the CC via GJs. The amount of a fluorescently-labelled 
glucose derivative in the mouse oocyte was significantly reduced when the GJs were blocked 
with the GJ uncoupler carbenoxolone (Wang et al., 2012). CC-enclosed mouse oocytes also 
contain higher amounts of amino acids glycine, alanine, proline, serine, tyrosine, glutamic 
acid, and lysine compared with DO (Colonna and Mangia, 1983). Moreover, Ca2+ and Na+ 
ionic currents between mouse CC and oocytes were abolished following treatment with the 
GJ uncoupler octanol (Arellano et al., 2002).  
In addition to fully-formed GJ channels, undocked hemichannels may play a role in ovarian 
folliculogenesis. Dye uptake and ATP release, indicative of hemichannel opening, was 
observed in mouse GC following application of stimuli known to cause hemichannel opening 
(Tong et al., 2007). However hemichannel function in the absence of GJs is not sufficient for 
follicle growth. Reaggregated ovaries containing GC with a mutant Cx43 gene that lacked the 
conserved cysteines in the extracellular loops required for docking were created. Follicle 
growth was arrested at the primary stage, similar to Cx43-KO mutants.  
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Figure 1-5: Schematic of a GJ bioassay utilising calcein to measure GJ communication between the CC and 
oocyte. Calcein-AM enters the CC by permeating the cell membrane (1). Inside the CC, the AM group is cleaved 
by non-specific esterases (2). The resultant calcein molecule is lipid insoluble and fluorescent (3). Calcein is 
transferred to the oocyte through GJ channels (4).  
 
A technique developed to determine GJ activity between the CC and oocyte utilised the 
transfer of a fluorescent dye, calcein (Thomas et al., 2004). Intact COC were exposed to the 
acetoxymethyl (AM) derivative of the calcein. Calcein-AM is a non-fluorescent, lipophilic 
molecule that readily crosses the cell membrane. The AM group is cleaved by non-specific 
esterases inside the cell. As a consequence of removing the AM moiety, the resultant calcein 
is now lipid insoluble and hydrophilic. Thus being unable to permeate the cell membrane, 
calcein can now only be transferred between cells through GJ channels (Figure 1-5). 
1.3 Oocyte-secreted factors  
1.3.1 Oocyte-secreted factors and follicular development 
During follicular growth, co-ordination between the follicular somatic cells and the oocyte is 
essential. As discussed in the previous section, the CC transfer nutrients to the oocyte via 
GJs. The oocyte regulates CC function through secretion of growth factors, thus creating a bi-
directional communication loop. Aspiration of the COC causes the remaining GC to undergo 
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premature luteinisation (el-Fouly et al., 1970). Soon after it was found that rat GC co-
cultured in close proximity to the oocyte retained their GC phenotype whereas GC further 
away from the oocyte underwent luteinisation (Nekola and Nalbandov, 1971). Further 
investigation revealed that oocyte-secreted factors form a concentration gradient in the 
follicle, and this influences the differentiation of GC into either the CC or the mural GC. 
Compared to mural GC, CC have a higher proliferation rate and lower steroidogenic activity 
and expression levels of LH receptor. The CC also possess the ability to secrete hyaluronic 
acid and undergo expansion, unlike the mural GC (Gilchrist et al., 2004a). The best 
characterised of the oocyte-secreted factor candidates are growth differentiation factor 9 
(GDF9) and bone morphogenetic protein 15 (BMP15). In most species studied to date, GDF9 
and BMP15 are co-expressed in a species-specific manner and the two secreted proteins 
function synergistically (McNatty et al., 2005a; Crawford and McNatty, 2012). Although the 
addition of GDF9 and BMP15 to cultured GC in part mimics the addition of oocytes, they are 
not sufficient to produce the range of GC responses caused by oocytes (Gilchrist et al., 
2004a). This indicates that other oocyte-secreted factors exist that may play a role in 
somatic cell function. Alternatively, the recombinant forms of GDF9 and/or BMP15 tested in 
vitro may have been at inappropriate concentrations or ratios, or different biopotencies to 
that of native GDF9 and BMP15. Currently, other candidates for oocyte-secreted factors are 
also members of the TGFβ family, including BMP6 and the activins.  
Bioassays are commonly used to determine the effects of oocyte-secreted factors on GC 
function. One common method involves removal of the oocyte from the COC to produce 
oocytectomised (OOX) CC. The basis of this bioassay is to determine the functions of CC that 
are regulated by oocyte-secreted factors, on the assumption that OOX CC will be significantly 
altered compared to CC from intact COC. These OOX CC may then be co-cultured with DO 
which would rescue the CC function (Gilchrist et al., 2008).  
The importance of the oocyte on follicular development was demonstrated by transferring 
mouse oocytes from secondary follicles into primordial follicles. The rate of follicular growth 
in the re-aggregated follicles was doubled, producing antral follicles within 9 days as 
opposed to 20 days in control follicles (Eppig et al., 2002). This indicates that the oocyte 
strongly regulates follicular growth and development, including GC proliferation. Studies 
involving the culturing of DO with GC revealed oocyte-secreted factors stimulated the 
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proliferation rate of GC in many mammalian species including cows (Li et al., 2000; Glister et 
al., 2003), mice (Vanderhyden, 1992; Gilchrist et al., 2004b) and rats and sheep (McNatty et 
al., 2005a, 2005b; Lin et al., 2012). In mice, co-culture of mural GC with DO caused an up-
regulation of the gene encoding cyclin D2 in the GC (Gilchrist et al., 2006). These actions of 
DO on GC proliferation are due, at least in part, to both GDF9 and BMP15 as is observed in 
studies in rodents (Otsuka et al., 2000; Vitt et al., 2000, Lin et al., 2012). 
Immunoneutralization of GDF9 in an in vitro bioassay abolished around half of the mitogenic 
activity of mouse oocytes, indicating that other oocyte-secreted factors are also involved in 
stimulation of GC proliferation (Gilchrist et al., 2004b). Importantly, GDF9 and BMP15 act in 
synergy with one another to stimulate proliferation in rat and ovine GC (McNatty et al., 
2006). Addition of recombinant murine GDF9 in combination with ovine BMP15 to rat GC 
enhanced 3H-thymidine uptake by greater than 3-fold compared to either oocyte-secreted 
factor alone (McNatty et al., 2005a). Addition of recombinant ovine GDF9 in combination 
with ovine BMP15 to ovine GC enhanced 3H-thymidine uptake by 1.6-fold compared to GC 
cultured in the absence of oocyte-secreted factors (McNatty et al., 2005b). It should be 
noted that there are significant species differences in the potency of oocyte-secreted factor 
action on GC proliferation that are outside the scope of this literature review. Additionally, 
whilst some oocyte-secreted factors (e.g. murine) strongly stimulate GC proliferation in vitro 
(Gilchrist et al., 2001), oocyte-secreted factors from other species (e.g. bovine and porcine) 
require the addition of insulin-like growth factor 1 (Li et al., 2000; Hickey et al., 2005).  
In addition to the effects of oocyte-secreted factors on GC proliferation, oocyte-secreted 
factors have also been reported to reduce luteinisation of CC. Relatively high expression 
levels of the LH receptor and high steroidogenic activity are observed in mural GC from 
intact human and bovine follicles compared to CC (Amsterdam et al., 1975; Li et al., 2000). 
Evidence for the involvement of oocyte-secreted factors in regulating somatic cell 
luteinisation is further strengthened by the observation that progesterone production and 
LH receptor expression are increased in mouse OOX CC compared to either intact COC or 
OOX CC cultured with DO (Eppig et al., 1997). Both BMP15 and GDF9 are inhibitors of CC 
luteinisation in rats. The action of BMP15 alone does not affect steroidogenesis, but inhibits 
FSH action thereby abolishing FSH-mediated progesterone production and upregulation of 
the LH receptor and other key receptors involved in luteinisation (Otsuka et al., 2001). GDF9 
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inhibits the stimulatory effect of FSH on oestradiol and progesterone production, LH 
receptor activity, and cAMP production by GC (Vitt et al., 2000). Both GDF9 and BMP15 
cooperate to inhibit luteinisation of rat and bovine GC (McNatty et al., 2006). In both of 
these studies, the combined addition of recombinant ovine GDF9 and BMP15 resulted in 
reduced progesterone production compared to either GDF9 or BMP15 alone.  
As discussed in Section 1.1.4, CC expansion occurs just prior to ovulation in response to 
unidentified oocyte paracrine factors (termed the CC expansion enabling factor; CEEF) and 
the preovulatory LH surge. In mice, expansion of CC can be prevented by removal of the 
oocyte or inhibition of oocyte signalling, and can subsequently be restored by co-culturing 
CC with DO (Buccione et al., 1990a). Though the identity of the CEEF is currently unknown, 
GDF9 has long been suspected as the primary candidate. This is supported by the findings 
that GDF9 stimulates CC expansion in vitro (Elvin et al., 1999) and that DO from GDF9 KO 
mice were unable to stimulate CC expansion in wild-type CC. However, there is evidence 
negating that GDF9 alone is sufficient to induce CC expansion. For example, 
immunoneutralization of GDF9 did not inhibit oocyte stimulated CC expansion (Dragovic et 
al., 2005). Moreover, meiotically incompetent oocytes from small growing follicles express 
GDF9 (Juengel and McNatty, 2005) but are not able to stimulate CC expansion (Vanderhyden 
et al., 1990). OOX CC isolated from BMP15-/- GDF9+/- double mouse mutants had a reduced 
ability to undergo expansion compared to either the single mutants (i.e. BMP15-/- GDF9+/+ or 
BMP15+/+ GDF9+/-) (Su et al., 2004). Taken together, these results suggest that while GDF9 
may partially account for the ability of the oocyte to promote CC expansion, BMP15 and 
other oocyte factors may also play a role. 
In vitro studies have also revealed that in a similar manner to DO, GDF9 and BMP15 
significantly prevent CC apoptosis in bovine OOX CC (Hussein et al., 2005). Interestingly 
however, culturing OOX CC with GDF9 alone had no effect on CC apoptosis. The action of 
GDF9 has also been reported on follicular constituents additional to CC. The addition of 
GDF9 to cultured rat GC stimulates the production of inhibin A and inhibin B (Roh et al., 
2003). It has also been reported to regulate theca cell function, as recombinant GDF9 
strongly stimulated basal and forskolin-stimulated androstenedione production in theca cells 
in vitro (Solovyeva et al., 2000). 
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The regulation of GC function by the oocyte varies during folliculogenesis. The ability of 
oocytes to stimulate GC proliferation decreases as the oocyte matures. Thymidine uptake in 
murine GC was greatest when the GC were co-cultured with oocytes that had a visible GV. 
Although maturing and ovulated oocytes (i.e. those that had initiated GVBD) were also able 
to stimulate thymidine uptake in GC, the effect was attenuated (Gilchrist et al., 2001). 
Conversely, the ability of the oocyte to inhibit progesterone production in GC increases 
throughout maturation. Progesterone production was maximally inhibited when murine 
OOX CC were co-cultured with fully-grown oocytes rather than growing oocytes. However, 
CC from ovulated COC produced large amounts of progesterone due to a reduced ability to 
respond to the oocyte-secreted factors (Vanderhyden and Macdonald, 1998). Both LH 
receptor mRNA expression and CC-responsiveness to FSH and CEEF are developmentally 
regulated by oocyte-secreted factors in mice in a similar manner to progesterone production 
(Vanderhyden et al., 1990; Eppig et al., 1997).  
1.3.2 Oocyte-secreted factors and follicular metabolic functions 
Fully-grown bovine and rat oocytes have a poor capacity for glucose metabolism, yet are 
completely reliant on oxidative phosphorylation for ATP production (Zeilmaker and 
Verhamme, 1974; Cetica et al., 2002). In large antral follicles, CC readily import and 
metabolise glucose, and transfer glucose metabolites to the oocyte for ATP production 
(Brower and Shultz, 1982; Cetica et al., 2002). The expression levels of enzymes involved in 
glucose breakdown, including phosphofructokinase (Pfkp), aldolase A (Aldoa), 
triosephosphate isomerise (Tpi), α-enolase (Eno1), pyruvate kinase (Pkm2), and lactate 
dehydrogenase (Ldh1), showed a morphogenic gradient across the mouse follicle with 
highest levels being measured in the CC and lowest levels in the outer mural GC (Sugiura et 
al., 2005). Gene expression levels of Eno1, Pkm2, Ldh1, and Pfkp were significantly 
downregulated in OOX CC compared with intact COC in mice. However, expression levels 
were restored to those seen in intact COC when OOX CC were cultured with fully grown 
oocytes. Similarly, glycolytic activity and tricarboxylic acid (TCA) cycle activity in mice were 
equivalent in intact COC and OOX CC cultured with fully grown oocytes but were 
downregulated in OOX CC. 
These results demonstrate the potent effect that oocyte-secreted factors have on CC glucose 
metabolism. Importantly however, there are significant species differences in the ability of 
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oocyte-secreted factors to regulate CC glycolytic activity. For example, bovine COC, OOX, and 
OOX co-cultured with DO showed similar glucose consumption in vitro(Sutton et al., 2003). 
Conversely, mouse OOX have a 10-fold decrease in glycolytic activity and reduced expression 
of Pfkp, and Ldh1 compared to COC and OOX co-cultured with DO (Sugiura et al., 2005). 
Oocyte-secreted factors are also implicated in the regulation of cholesterol biosynthesis in 
CC in mice. The expression of enzymes involved in cholesterol biosynthesis, including 
mevalonate kinase (Mvk), phosphomevalonate kinase (Pmvk), farnesyl disphosphate 
synthase (Fdps), squalene epoxidase (Sqle), cytochrome p450 51 (Cyp51), sterol-C4-methyl 
oxidase-like (Sc4mol), and 3β-hydroxysteroid-Δ8,Δ7-isomerase (Ebp) were elevated in CC of 
COC, compared to OOX CC (Su et al., 2008). Similar to the glycolytic pathway, GDF9 and 
BMP15 also regulate cholesterol biosynthesis. In Bmp15 and Gdf9 double KO mutants, lower 
levels of enzymes involved in cholesterol biosynthesis, (Mvk, Pmvk, Fdps, Sqle, Cyp51, 
Sc4mol, and Ebp) as well as glycolytic enzymes (Pfkp and Ldh1), were measured in CC. In 
addition, reduced cholesterol biosynthesis and glycolytic activity was observed in CC from 
the double mutants (Su et al., 2008). Treatment of double mutant CC with recombinant 
BMP15 in combination with fibroblast growth factor 8B (FGF8B) promoted expression of 
Pfkp and Ldh1. As GDF9 did not promote expression of Pfkp and Ldh1, it appears that BMP15 
but not GDF9 regulates CC glycolytic activity (Sugiura et al., 2008).  
Oocyte-secreted factors have been reported to regulate the uptake of amino acids in CC via 
the sodium-coupled neutral amino acid transporter Slc38a3 (Eppig et al., 2005). In mice, the 
Slc38a3 gene is expressed in mural GC and CC of early tertiary follicles, but mural GC 
expression is abolished in late tertiary follicles. Expression levels of Slc38a3 mRNA and 
uptake of alanine, histidine, and leucine were similar in intact COC and OOX CC cultured with 
fully grown oocytes, but were downregulated in OOX CC. Fully-grown, but not growing, 
oocytes were able to restore Slc38a3 mRNA levels and uptake of alanine and leucine to 
those observed in intact COC. Interestingly, Slc38a3 mRNA was not affected in Bmp15 or 
Bmp15/Gdf9 KO CC, indicating that other oocyte-secreted factors are responsible for 
regulating amino acid uptake (Su et al., 2009).  
1.3.3 GDF9 and BMP15 expression and signalling in the ovary 
Both GDF9 and BMP15 are members of the transforming growth factor β (TGFβ) superfamily 
of proteins and are thought to be exclusively expressed in the oocyte of most mammalian 
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species (Crawford and McNatty, 2012). GDF9 and BMP15 have been reported to be 
expressed by the somatic cells in pig, goat, and primates (Duffy, 2003; Silva et al., 2005; 
Paradis et al., 2009) however it is possible that these samples were contaminated with 
oocyte mRNA. There are significant species differences in the timing and levels of 
expression. For example, GDF9 is expressed in oocytes from the primordial stage onwards in 
cows, sheep, and brushtail possums (Bodensteiner et al., 1999; Eckery et al., 2002). BMP15 is 
also expressed from the primordial stage in the brushtail possum (Eckery et al., 2002), 
however is expressed from primary stage in sheep (Galloway et al., 2000). GDF9 and BMP15 
are expressed only in growing follicles in mice, rats, and humans (Laitinen et al., 1998; 
Aaltonen et al., 1999; Jaatinen et al., 1999). Recent work indicates that rats and mice 
produce very little BMP15, compared to GDF9. The ratio of Gdf9:Bmp15 mRNA was 3.65 and 
5.19 in the rat and mouse, respectively (Crawford and McNatty, 2012). Moreover, mature 
GDF9 protein was detected by Western blotting in rat oocyte lysate and in the oocyte 
culture medium, indicating secretion of GDF9 (Lin et al., 2012). However, mature BMP15 
protein was not detected in rat oocyte lysate or in the culture medium. The promature form 
of BMP15 was detected in rat oocyte lysate however the biological activity is unknown. 
Furthermore, immunoneutralization of BMP15 in rat oocytes did not affect the ability of 
those oocytes to stimulate GC 3H-thymidine uptake indicating BMP15 by rat oocytes does 
not play a role in regulating GC proliferation. 
Unlike most other TGFβ proteins, GDF9 and BMP15 lack the conserved cysteine residues that 
are required for covalent dimer formation. It has been reported that GDF9 and BMP15 may 
form non-covalent homo- and hetero-dimers in vitro (Peng et al., 2013) however the 
existence of these forms in vivo remains a matter of debate (Mottershead et al., 2013). What 
is known is that GDF9 and BMP15 act synergistically both in vivo and in vitro to influence 
somatic cell function (Hanrahan et al., 2004; McNatty et al., 2005a; Mottershead et al., 
2012). GDF9 and BMP15 regulate GC function by activating two serine/threonine kinase 
receptors located on the plasma membrane of GC. Binding of the ligand causes activation of 
type II receptor kinase activity and phosphorylation of the type I receptor (Figure 1-6). The 
type I receptor then phosphorylates specific regulatory similar to mothers against 
decapentaplegic (SMAD) proteins (rSMADs) resulting in the phosphorylated rSMAD binding 
to the common SMAD4. The rSMAD/SMAD4 complex translocates to the nucleus and 
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modulates gene expression through interactions with transcription factors, co-activators, 
and co-repressors (Knight and Glister, 2006). GDF9 signals through the activin-like receptor 
kinase (ALK) 5 receptor and BMP receptor type II (BMPRII) and activates the SMAD2/3 
pathway (Mazerbourg et al., 2004). BMP15 signals through ALK6 and BMPRII and activates 
the SMAD1/5/8 pathway (Juengel and McNatty, 2005). The synergistic actions of GDF9 and 
BMP15 act through the SMAD2/3, but not SMAD1/5/8, pathway (Reader et al., 2011). 
 
 
Figure 1-6: Schematic overview of the TGFβ family signalling pathway. The ligand dimer binds to the Type II 
receptor (1) which recruits and phosphorylates the Type I receptor (2). The Type I receptor phosphorylates an 
rSMAD (3), which binds to the common SMAD (4), and this complex translocates to the nucleus where it 
modulates gene expression (5).  
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Whilst GDF9 is required for follicular growth in both sheep and mouse, BMP15 is required 
for follicular growth in sheep but not mouse. This supports evidence that BMP15 does not 
play a large role in follicular function of rodents. Follicles from sheep with a naturally-
occurring homozygous Bmp15-/- or Gdf9-/- mutation arrest growth at the primary stage, 
causing sterility (Hanrahan et al., 2004). Interestingly, sheep heterozygous for mutations in 
either Gdf9-/+ or Bmp15-/+ have a higher ovulation rate than wildtype animals (Galloway et 
al., 2000; Hanrahan et al., 2004). Conversely, whilst follicular development arrests after the 
primary follicle stage in Gdf9 KO mice, mice with a Bmp15 KO are fertile, although produce 
smaller litters (Yan et al., 2001). Mice heterozygous for the Gdf9 KO showed normal fertility 
(Dong et al., 1996).  
1.4 The Role of Glucose Metabolism  
1.4.1 Overview of glucose metabolic pathways 
Glucose may be metabolised by several different pathways, each playing a different function 
within the cell. The primary pathways described herein are those concerned with glycolysis 
and hexosamine biosynthesis, with brief descriptions of the pentose phosphate and the 
polyol pathways.  
Glycolysis functions primarily to generate energy for the cell and involves the conversion of 
glucose to pyruvate through multiple steps (Figure 1-7). The conversion of fructose 6-
phosphate to fructose 1,6-bisphosphate by PFKP is considered to be the rate limiting step 
(Krisher, 2004). Pyruvate may be converted into lactate by the enzyme LDH1 or into acetyl 
coenzyme A (CoA) by the enzyme pyruvate dehydrogenase. Lactate can also be recycled 
back to glucose by gluconeogenesis, or to pyruvate. Acetyl CoA enters into TCA cycle, which 
produces ATP and nicotinamide adenine dinucleotide (NADH) which, together with ribose, is 
important for the reduction of the antioxidant glutathione. The NADH produced in the TCA 
cycle is utilised for oxidative phosphorylation by the mitochondrial electron transport chain. 
In addition, glycolysis intermediates are used for a number of other cellular pathways 
including the pentose phosphate pathway (glucose 6-phosphate) and lipid metabolism 
(dihydroxyacetone phosphate) (Voet and Voet, 2004). During times of rest, or in response to 
high glucose levels, glucose 6-phosphate may alternatively be converted into the stored 
form of glucose, glycogen, by the glycogenesis pathway.  
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Oxidative phosphorylation refers to the coupled processes of ATP synthesis and the electron 
transport chain within the mitochondria. The electron transport chain removes electrons 
from NADH and succinate, resulting in conversion of oxygen to water concurrent with the 
transfer of H+ across the mitochondrial membrane. This proton-motive force drives ATP 
synthase resulting in the transfer of adenosine disphosphate (ADP) to ATP. The stepwise 
removal of electrons from NADH and succinate involves several electron acceptors, including 
NADH dehydrogenase, succinate dehydrogenase, ubiquinone, cytochrome bc1 complex, 
cytochrome c, and cytochrome c oxidase. Cytochrome c is localised in the intermembrane 
space, and is responsible for transferring one electron to cytochrome c oxidase (Voet and 
Voet, 2004). Cytochrome c is a common mitochondrial marker, that correlates well to other 
mitochondrial markers including citrate synthase and respiratory capacity (Fitts et al., 1975). 
In addition to its role in the electron transport chain, cytochrome c plays an essential role in 
activation of apoptosis. Mitochondrial activation of the intrinsic apoptotic pathway results in 
release of cytochrome c into the cytoplasm, where it binds to apoptotic protease activating 
factor 1 (APAF1) and pro-caspase-9 resulting in activation of effector caspases and initiation 
of apoptotic processes (Chandra et al., 2002) 
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Figure 1-7: The glycolysis metabolic pathway. The blue boxes contain the pathway intermediates/products, 
while the enzymes that catalyse each reaction are beside the arrows. Those enzymes that are outlined in 
orange are thought to be regulated by oocyte-secreted factors. 
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The hexosamine biosynthetic pathway converts glucose-6-phosphate to uridine 
disphosphate (UDP)-N-acetyl glucosamine (Figure 1-8). The rate limiting enzyme is 
glutamine-fructose-6-phosphate transaminase 1 (GFPT1). The hexosamine biosynthesis 
pathway acts as a fuel sensing pathway. Typically, only a small amount of glucose 6-
phosphate (1-3 %) is metabolised through this pathway. Increased flux through the 
hexosamine pathway causes decreased uptake of glucose, and increased glycogen 
accumulation (Rossetti, 2000). The UDP-N-acetyl glucosamine produced by the hexosamine 
pathway is used for O-linked glycosylation (Sutton-McDowall et al., 2010). The hexosamine 
pathway plays an additional role in pre-ovulatory follicles, as UDP-N-acetyl glucosamine is a 
precursor for hyaluronic acid. Hyaluronic acid makes up the backbone of the specialised 
extracellular matrix secreted as a part of CC expansion.  
Two other main pathways are involved in glucose metabolism in the COC. The pentose 
phosphate pathway (PPP) results in production of nicotinamide adenine dinucleotide 
phosphate (NADPH; involved in cytoplasmic integrity and redox state through glutathione) 
and phosphoribosylpyrophosphate (a substrate for purine synthesis). The polyol pathway 
involves the oxidation of glucose to produce sorbitol and fructose. The polyol pathway is 
utilised in hyperglycaemic conditions, for example it is thought to be involved in the diabetic 
pathology of many tissues (Gabbay, 1975).  
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Figure 1-8: The hexosamine biosynthetic pathway. Pathway intermediates/products are contained within the 
blue boxes. Glc = glucosamine.  
 
1.4.2 Glucose metabolism in the ovarian follicle 
The mechanism through which glucose uptake by the COC is regulated is species-specific and 
occurs primarily via facilitative glucose transporters but may also occur via sodium-coupled 
glucose transporters (Purcell and Moley, 2009; Wang et al., 2012). For example, bovine and 
ovine GC express mRNA for the facilitative glucose transporter genes Glut1, Glut3, and Glut8 
(Nishimoto et al., 2006; Pisani et al., 2008) and mouse and ovine GC additionally express the 
Glut4 gene (Williams et al., 2001; Roberts et al., 2004). Furthermore, bovine and ovine 
oocytes express the genes Glut1 and Glut3, with the bovine oocyte additionally expressing 
the Glut8 gene (Augustin et al., 2001; Pisani et al., 2008). Mouse oocytes express the Glut1, 
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and Glut4 genes (Zhou et al., 2000; Roberts et al., 2004). In addition to glucose transporters 
in mice, oocytes also express monocarboxylate transporters 1, 2, and 4 indicating that 
murine oocytes are able to take up lactate and pyruvate directly (Hérubel et al., 2002). 
Oocytes at both the GV and MII stages of meiosis have been reported to consume pyruvate 
(Harris et al., 2009). In murine oocytes, the concentration of a glucose analogue, 2-
deoxyglucose, was significantly higher in COC than in DO, indicating that the CC facilitate 
glucose uptake in oocytes. In vitro studies of bovine COC revealed that glucose is primarily 
taken up by the outer CC and gradually moves into the inner CC and oocyte (Sutton-
McDowall et al., 2010).  In addition, treatment of COC with hCG, which abolishes GJ coupling 
in a similar manner to LH, reduced the concentration of 2-deoxyglucose in the oocyte to 
levels similar to those seen in DO (Saito et al., 1994).  
It is generally accepted that oocytes metabolise very little glucose compared to CC. Bovine 
CC consume 23-fold more glucose in comparison to oocytes when assessed per millimetre 
volume of tissue (Sutton-McDowall et al., 2010). However, both mouse and human oocytes 
express the enzymes essential for glycolysis (Hardy et al., 1989; Harris et al., 2009) as well as 
for importing both pyruvate and glucose. Murine oocytes may also metabolise glucose by 
other pathways as evidenced by expression of hexokinase, glucose-6-phosphate 
dehydrogenase, GLUTs, and enzymes involved in the PPP (Wang et al., 2012).  
The growing oocyte fully depends upon oxidative phosphorylation for ATP production, 
however has a poor capacity for glucose metabolism (Biggers et al., 1967). The murine 
oocyte has low PFKP activity, and thus low glycolytic activity. Conversely, murine CC have 
high activity of enzymes involved in glycolysis such as PFKP and hexokinase (Downs et al., 
1996). Thus, the CC produce a significant amount of pyruvate which is able to be transferred 
to the oocyte (Purcell and Moley, 2009). It is thought that the flux of glucose through the 
glycolytic pathway in bovine COC remains stable during a 24 hour in vitro maturation (IVM) 
step despite increased glucose consumption, indicating that glucose may be metabolised by 
other pathways (Sutton et al., 2003). Increased glycolytic activity in bovine oocytes is 
associated with increased developmental competence, however this may also lead to 
increased reactive oxygen species, resulting in oxidative damage (Krisher and Bavister, 
1999). Oxidative damage leads to impaired mitochondrial function which, in turn, is 
associated with decreased developmental competence (Krisher, 2004). 
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Activity through the hexosamine biosynthetic pathway is increased towards the end of 
oocyte maturation in cows due to the requirement for hyaluronic acid (Gutnisky et al., 
2007). However, increased activity through this pathway can also lead to increased O-linked 
glycosylation, leading to activation or inactivation of target proteins. This can have negative 
effects, and has been reported to be a factor in the pathology of diabetes in somatic cells 
(Brownlee, 2001). Supplementation of IVM media with glucosamine, a substrate which is 
exclusively metabolised by the hexosamine pathway, inhibited blastocyst development in 
bovine embryos. This effect was mediated by increased O-linked glycosylation (Sutton-
McDowall et al., 2006).  
Regulation of the PPP pathway is the primary mechanism by which changes in glucose 
concentration affect nuclear maturation (Downs, 1996). The PPP is more active within the 
oocyte than the CC, and influences meiotic resumption and developmental competence in 
both cattle and mice (Downs et al., 1998; Cetica et al., 2002; Wang et al., 2012). Treatment 
of murine oocytes with a PPP stimulator caused increased numbers of oocyte to undergo 
GVBD and stimulated intra-oocyte glucose consumption (Wang et al., 2012). Glucose flux 
through the PPP is increased in response to FSH in diabetic mice, indicating that this 
pathway is important for metabolising glucose in hyperglycaemic conditions (Colton et al., 
2003). Under normal conditions very little glucose is metabolised via the polyol pathway, 
with other pathways such as glycolysis or hexosamine biosynthesis being preferred 
(Brownlee, 2001).  
The use of a type I diabetes mouse model has demonstrated the importance of correct 
glucose levels on oocyte maturation and health (Chang et al., 2005). Pre-ovulatory oocytes 
from diabetic mice were 30 % smaller than those from control mice. Moreover, oocytes from 
these mice underwent precocious nuclear maturation. However the proportion of MII 
oocytes observed was reduced, suggesting a decrease in oocyte competence (Kim et al., 
2007). Despite these COC being exposed to hyperglycaemic conditions, the flux through the 
glycolytic pathway was unaffected as the excess glucose was metabolised through the polyol 
pathway (Colton et al., 2003; Colton and Downs, 2004). In GC of the type I diabetic mice, GJ 
communication between the GC and oocyte was decreased by 60 %. In addition, Cx37 gene 
and protein expression was decreased by 36 % (Ratchford et al., 2008). Increased O-linked 
glycosylation and decreased concentrations of FSH are thought to primarily modulate the 
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reduction in oocyte competence caused by high glucose concentrations (Hashimoto et al., 
2000). Conversely, it is thought that the major pathways involved in reduced oocyte 
competence as a result of low glucose concentrations are the glycolytic and PPP pathways 
(Downs et al., 1998).  
1.5 The Influence of Exogenous Factors on Oocyte Quality 
Oocyte quality is likely influenced by a mixture of genetic, endocrine and paracrine signals as 
well as exogenous factors from the environment. The quality of the ovulated oocyte is 
particularly important for two reasons. First, the embryonic genome, consisting of paternal 
and maternal genetic information, is only activated after several cell divisions. Thus, the 
early development of the embryo in the first few days after fertilisation is largely directed by 
the oocyte (Kidder and Vanderhyden, 2010). Second, most, if not all, of the oocytes that a 
female will ever have are contained within the ovary by birth. Thus, oocytes that are 
ovulated later in life may have been formed 1-1.5 (rodents) or 50 years (humans) earlier 
(McGee and Hsueh, 2000). Not surprisingly, oocyte quality is reported to decrease over time 
(Navot et al., 1991).  
Poor oocyte quality is a major cause of female infertility. For example, the age-related 
decline in female fertility is attributed to a concurrent decline in both oocyte quality and 
numbers (Navot et al., 1991). In humans, infertility is defined as the inability to conceive 
after one year of unprotected intercourse, with one in six couples experiencing this at some 
stage of their reproductive life (Anderson, 2010). In 2010, there were ~62,000 assisted 
reproductive technology (ART) cycles performed in Australia and New Zealand. Of these 
cycles, 3.5 % used donor oocytes (Macaldowie et al., 2012). The large cost of ART, and 
frequency of adverse effects, means identification of modifiable factors is important for 
fertility preservation (Chavarro et al., 2007). A person’s lifestyle choices may cause an 
increase in time to pregnancy, and decrease the chance of a healthy, live birth . However, 
the current data on the effects of lifestyle on fertility are scarce, contradictory or poorly 
designed (Anderson, 2010). Thus, further research into the effects of lifestyle on fertility may 
remove myth-based, unnecessary lifestyle restrictions for couples trying to have a baby 
(Anderson, 2010).  
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Exogenous factors may affect fertility at a number of levels of the reproductive system 
(Figure 1-9). The coordination of follicular growth is complex, incorporating signals from the 
pituitary gland (FSH and LH), along with feedback signals from the ovary (oestrogen and 
progesterone). In addition, feedback from other organs regulates both ovarian and 
hypothalamic-pituitary function.  
Perturbation of the hypothalamic-pituitary-gonadal axis has been observed following 
exposure to exogenous factors. For example, both acute and chronic exposure of male rats 
to methylenedioxymethamphetamine (MDMA; ecstasy) leads to reduced mRNA levels of 
gonadotrophin releasing hormone (GnRH) in the hypothalamus (Dickerson et al., 2008). 
MDMA is known to target both serotoninergic and dopaminergic pathways, and these also 
regulate the neurons that produce GnRH. Similarly, GnRH protein levels are reduced as a 
result of exposure to Δ9tetrahydrocannabinol (THC), a compound present in cannabis smoke 
(Smith et al., 1979). As a result of THC exposure in female rhesus monkeys, inhibition of 
GnRH signalling causes a reduction in blood gonadotrophin levels (Armstrong, 1986; Park et 
al., 2004). Additionally, moderate to heavy alcohol consumption in women has been 
associated with increased plasma oestradiol concentrations (Mendelson et al., 1988). Other 
known disruptors of the hypothalamic-pituitary-gonadal axis are stress, strenuous exercise, 
and compounds with oestrogen mimicking properties (Armstrong, 1986). 
Exogenous factors may also directly influence the ovary and/or oocytes to reduce fertility. 
Ovarian follicles, particularly non-growing primordial follicles are sensitive to toxic agents. 
For example, radiation therapy damages primordial follicles in mice, pigs, monkeys, and 
humans (Armstrong, 1986). Chemotherapeutic agents also target primordial follicles. 
Examination of the ovaries of prepubertal girls that had been treated with chemotherapeutic 
agents found a significantly lower number of oocytes present compared to that in 
prepubertal girls not exposed to chemotherapy (Himelstein-Braw et al., 1978). Similarly, 
polycyclic aromatic hydrocarbons, a constituent in automobile exhaust fumes and cigarette 
smoke, has been shown to destroy primordial follicles in mice (Mattison and Thorgeirsson, 
1979). This may also be the case in women, as smokers are reported to undergo menopause 
significantly earlier than non-smokers (Kaufman et al., 1980). 
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Figure 1-9: Potential sites of action for disruption of female fertility by exogenous factors. As indicated by the 
orange arrows. Black arrows indicate interactions between the organs.  
 
A number of exogenous factors decrease oocyte quality without causing toxicity. Bisphenol A 
(BPA), a compound found in plastics, causes spindle abnormalities including distribution of 
the centriolar material and chromosome alignment in mouse oocytes (Eichenlaub-Ritter et 
al., 2008). Mouse follicles treated with BPA in vitro had decreased numbers of GC, and a 
higher proportion of oocytes were unable to resume meiosis (Lenie et al., 2008). BPA 
exhibits oestrogenic activity, as it binds with both oestrogen receptor α and β (Fujimoto et 
al., 2010). BPA concentrations in the serum of Asian women were correlated with a decrease 
in MII oocytes (Fujimoto et al., 2010). Caffeine also directly affects the oocyte through its 
PDE-inhibitory properties. Superovulation in mice was inhibited by treatment with caffeine, 
with most of the oocytes collected still in the GV stage (Jagiello et al., 1972). Cigarette 
smoking and compounds found in cigarette smoke have been reported to affect the quality 
of oocytes in a range of species. Cigarette smoking (either active or passive) causes an 
increase in the thickness of the zona pellucida in women undergoing in vitro fertilisation 
(IVF) (Shiloh et al., 2004). Treatment of bovine oocytes with nicotine, the primary addictive 
agent in cigarettes, inhibited CC expansion, oocyte maturation, and caused meiotic 
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abnormalities (Liu et al., 2008). When mice were treated with nicotine, the oocytes 
displayed premature anaphase, and the proportion of oocytes ovulated was halved 
compared to controls (Mailhes et al., 2000). 
Finally, factors may affect other organs causing an indirect reduction in fertility (Armstrong, 
1986). In particular, the liver is a target for such actions as steroid hormone metabolism 
occurs there. For example, rats that were fed fish that had been exposed to high levels of 
polychlorinated biphenyls (PCBs) showed increases in hepatic expression of cytochrome 
P450, an enzyme involved in steroid hormone metabolism. Additionally, the rise in 
oestradiol levels due to moderate to heavy drinking in women as mentioned above is 
thought to be due to the breakdown of alcohol in the liver, causing inhibition of oestradiol 
breakdown (Gill, 2000).  
1.5.1 Lifestyle factors chosen for this study 
Six exogenous lifestyle factors were selected for investigation in this study. These factors 
were chosen because of their prevalence in our everyday lives (see Table 1-1).  
BPA is an endocrine disrupting chemical used in the synthesis of polycarbonate plastics and 
epoxy resins. BPA accounts for most of the oestrogenic activity that leaches from landfills 
(Coors et al., 2003) and has been detected in follicular fluid, foetal serum, and amniotic fluid 
(Ikezuki et al., 2002). Increased BPA concentrations in follicular fluid have been correlated to 
decreased fertilization rates in both conventional insemination and intracytoplasmic sperm 
injection (Fujimoto et al., 2010). In Asian women, increased BPA serum concentrations were 
also linked to reduced oocyte maturation. Urinary BPA concentrations are associated with a 
reduction in peak plasma oestradiol levels in women during IVF (Mok-Lin et al., 2010), 
however no relationship was found between urinary BPA and aromatase gene expression 
levels (Ehrlich et al., 2013). In vitro culture of human oocytes that had been discarded during 
IVF with BPA resulted in reduced proportions of MII oocytes, and increased proportions of 
oocytes that had degenerated or spontaneously activated (Machtinger et al., 2013). 
During IVF, urinary BPA concentrations are associated with reduced oocyte numbers, 
reduced fertilisation, and reduced oestradiol concentrations (Ehrlich et al., 2012). 
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Caffeine is the most widely used psychoactive compound and is found in many ingested food 
products including coffee, tea, and chocolate. In a study of women undergoing IVF, 76% had 
drunk at least one caffeinated beverage each day in the month prior (Domar et al., 2012). 
Caffeine has been detected in follicular fluid (Al-Saleh et al., 2010), however the link 
between caffeine and infertility is contentious (Anderson, 2010). Some studies have found 
that increased caffeine consumption is associated with a longer time to conception (Hatch 
and Bracken, 1993; Bolumar et al., 1997) however these failed to adequately take other 
variables into account, such as smoking. A prospective study showed a significant correlation 
between not achieving a live birth and consumption of caffeine during IVF (Klonoff-Cohen et 
al., 2002). A meta-analysis of studies looking at the effect of caffeine and time to conception 
found that there was no convincing evidence that caffeine increased time to conception 
(Leviton and Cowan, 2002).  
Alcohol (ethanol) is consumed in large amounts throughout most of the world. 
Approximately 73% of women undergoing IVF reported drinking at least one serving of 
alcohol in the month prior (Domar et al., 2012). Mild to moderate consumption of alcohol 
has a significant negative effect on female fertility (Emanuele et al., 2002). For example, 
alcoholic women are known to have irregular menstruation or even cessation of menses. 
Alcohol consumption is correlated with increased plasma oestradiol levels (Van Thiel et al., 
1978; Mendelson et al., 1988), and has been associated with anovulation (Mendelson and 
Mello, 1988). Furthermore, alcohol consumption at levels below those that would cause liver 
damage can cause temporary anovulation and infertility.  
Nicotine is the primary addictive agent found in cigarette smoke. Only 2.5% of women 
undergoing IVF reported that they had smoked at least one cigarette in the previous month 
(Domar et al., 2012). Cigarette smoke is well documented to adversely affect female fertility 
(Waylen et al., 2009; Anderson, 2010). In vitro or in vivo exposure to nicotine in animal 
models causes disruption to normal oocyte maturation and ovulation (Liu et al., 2008). 
Nicotine is metabolised to produce nicotine-N-oxide and cotinine. Cotinine has been 
detected in follicular fluid (Weiss and Eckert, 1989; Zenzes et al., 1996). Nicotine has been 
reported to inhibit CC expansion and oocyte GVBD, and cause chromosomal abnormalities in 
bovine COC (Liu et al., 2008). Smokers are 1.6 times more likely to experience infertility than 
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non-smokers (Augood et al., 1998), and need approximately twice as many IVF cycles to 
achieve pregnancy compared with non-smokers (Feichtinger et al., 1997).  
The primary psychoactive compound found in cannabis is THC. Cannabis is the most widely-
used illicit drug (U.S. Department of Health and Human Services, 2010) and is reported to 
suppress LH production in women (Mendelson et al., 1986). Acute exposure to THC causes 
disruption to the menstrual cycle of rhesus monkeys, however tolerance develops during 
long-term exposure (Smith et al., 1979). In vitro exposure to THC of rat follicles inhibited 
progesterone, testosterone, and oestradiol production by the follicular cells. In addition, THC 
stimulated meiotic resumption in rat oocytes (Reich et al., 1982). In a study of couples 
undergoing IVF, THC was detected in hair samples of 3.7% of the participants (Pichini et al., 
2012) A prospective study showed that women who had smoked marijuana within the past 
year had 25% fewer oocytes collected during IVF (Klonoff-Cohen et al., 2006) 
MDMA is a recreational drug that is primarily consumed by young people of reproductive 
age (U.S. Department of Health and Human Services, 2006). Animal studies have found that 
MDMA suppresses the production of GnRH and testosterone (Dickerson et al., 2008), delays 
puberty, and affects sperm quality in male rats (Barenys et al., 2010). There are currently no 
data on the effects of MDMA on IVF outcome, to the best of my knowledge. 
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Table 1-1: Measured concentrations of lifestyle factors in biological fluids. 
Compound Species Concentration Biological 
Fluid 
Population details Reference 
BPA Human 2.53 ng/mL (range 
0.0-67.4) 
Serum Women undergoing 
IVF 
(Fujimoto et 
al., 2010) 
 Human 2.08 ± 0.8 ng/mL   Serum Healthy women (Ikezuki et al., 
2002) 
 Human 2.4 ± 0.8 ng/mL     Follicular 
fluid 
Women undergoing 
IVF 
(Ikezuki et al., 
2002) 
 Human 2.2 ± 1.8 ng/mL     Foetal 
serum 
Umbilical cord blood 
from healthy women 
(Ikezuki et al., 
2002) 
Caffeine Human 0.913 μg/mL 
(range 0.0-64.04) 
Serum Women undergoing 
IVF 
(Al-Saleh et al., 
2010) 
 Human 0.701 μg/mL  
(range 0.0-6.48) 
Follicular 
fluid 
Women undergoing 
IVF 
(Al-Saleh et al., 
2010) 
 Human 10 μg/mL Plasma Males given an oral 
dose of 7 mg/kg 
caffeine 
(Axelrod and 
Reichenthal, 
1953) 
Ethanol Human 800 μg/mL Blood Legal driving limit for 
blood alcohol content 
New Zealand 
Transport 
Agency1 
Nicotine Human 30-50 ng/mL Plasma Active smokers (Moyer et al., 
2002) 
 Rat 40-120 ng/mL Plasma Self-administration 
model of nicotine 
dependency 
(Shoaib and 
Stolerman, 
1999) 
 Human 33 ng/mL (range 
4-72) 
Plasma Active smokers (Russell et al., 
1980) 
MDMA Human 0.715 μg/mL 
(range 0.13-2.4) 
Serum Patients who 
consumed ecstasy at 
one nightclub and 
were later treated at 
two London hospitals 
(Greene et al., 
2003) 
 Human 130.9 ± 38.6 
ng/mL 
Plasma Male subjects given 75 
mg MDMA 
(de la Torre et 
al., 2000) 
THC Human 67-98 ng/mL Plasma Peak plasma THC levels 
in light and heavy 
marijuana users 
respectively who had 
smoked one marijuana 
cigarette 
(Lindgren et 
al., 1981) 
1 New Zealand Transport Agency. (Published 26 November 2012). About limits. In The Official New Zealand 
Road Code. Retrieved 30 April 2013. From http://www.nzta.govt.nz/resources/roadcode/about-limits/alcohol-
and-drugs-limits.html 
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1.6 Aims 
The overall aim of this study was to determine whether the health of mammalian oocytes is 
directly affected by exposure to exogenous lifestyle and environmental factors. To 
determine the effects of exogenous factors, a rat COC model was used as the test system. 
Rats are a commonly used test species for pharmacologically active compounds, enabling 
investigation into both the in vitro and in vivo effects of lifestyle and environmental factors 
on COC function. In addition, the large number of antral follicles present in the prepubescent 
rat ovary facilitated experiments in which large amounts of biological material was required. 
The presence of a rat breeding colony at VUW meant that female rats were readily available 
for this study. 
A GJ bioassay was optimised to assess the extent of transfer of a fluorescent dye (calcein) 
from CC to the oocyte following exposure to targeted reagents. In addition, a multiplex 
quantitative PCR (qPCR) technique was used to measure gene expression levels in individual 
rat oocytes and CC masses. Subsequently, both the dye transfer assay and multiplex qPCR 
were tested in combination and validated, to allow for direct comparison of GJ 
communication and mRNA levels of candidate genes in the same samples. A Western blot 
protocol was also optimised to detect CX43 and GDF9 proteins in rat COC.  
The effect of in vitro exposure to lifestyle factors on rat COC was the major focus of this 
study utilising the aforementioned assays. The lifestyle factors tested in this study were BPA, 
caffeine, ethanol, nicotine, MDMA, and THC. Moreover, the effect of in vivo exposure to 
ecstasy (MDMA) on COC health was also determined. MDMA was administered to 
adolescent female rats and thereafter the COC were extracted, and mRNA and protein 
expression levels were measured.  
The key endpoints of this study were: measurement of GJ communication between the CC 
and oocyte using an optimised bioassay; qPCR quantification of Cx43, Gfpt1, Pfkp, Atr, Cycs, 
and Glut1 in CC and Cx37, Gdf9, Bmp15, Atr, Cycs, and Glut1 in oocytes; and quantification of 
CX43 and GDF9 protein levels using Western blotting. 
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2 GENERAL METHODS 
2.1 Effect of in vitro exposure to lifestyle factors 
For in vitro studies, ovaries were collected from pre-pubescent Sprague-Dawley female rats 
as part of routine culling of a breeding colony in the vivarium at the School of Psychology, 
Victoria University of Wellington (VUW). Euthanasia for tissue collection was included under 
a general animal ethics approval for rodent research issued by the VUW Animal Ethics 
Committee (VUW application number 10695).  
2.1.1 Recovery of ovaries  
Prepubescent (21-25 days old) female Sprague-Dawley rats were euthanized by carbon 
dioxide (CO2) asphyxiation. The ovaries were recovered into dissection media (see Appendix 
2) supplemented with PDE inhibitors for transportation back to the laboratory. The 
concentration and type(s) of PDE inhibitors was dependent upon the experiment performed. 
In the laboratory, the ovaries were transferred into a 35 mm Petri dish containing dissection 
media supplemented with PDE inhibitors. Subsequently, the surrounding fatty tissue was 
trimmed whilst viewing under a Zeiss stereo-zoom dissection microscope (Leica 
Microsystems; Auckland, NZ).  
2.1.2 Collection of COC for culture 
All of the visible antral follicles (0.5 – 1.0 mM in diameter) were punctured using a 20 gauge 
needle fitted onto a 1 mL syringe to release the COC into the dissection media supplemented 
with PDE inhibitors. The COC that had at least two intact layers of CC were transferred into 
wells of a non-treated, flat bottomed 48-well polystyrene tissue culture plate (Interlab; 
Wellington, NZ) and washed twice in 200 μL of wash media (see Appendix 2) supplemented 
with PDE inhibitors. The dimethyl sulfoxide (DMSO) concentration was maintained ~1 %. 
Typically 15-20 COC were added to each well. 
2.1.3 GJ Assay 
An acetoxymethyl (AM) ester derivative of the fluorescent dye calcein (Invitrogen; Auckland, 
NZ) was used to measure GJ transfer from the CC to the oocyte. Calcein fluoresces with 
excitation and emission wavelengths of 495 and 515 nm, respectively. 
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Two distinct GJ assay protocols were used in this study. The first was used to optimise the 
amount of calcein transfer to the oocyte to allow enhanced assay sensitivity (Figure 2-2). The 
second protocol was used for all subsequent experiments, including those where the COC 
were exposed to lifestyle factors (Figure 2-4). 
In experiments where the aim was to optimise calcein transfer to the oocyte, COC were 
exposed to 2 μM calcein-AM (see Appendix 2) in 200 μL incubation media supplemented 
with PDE inhibitors, in the presence or absence of treatments, for 10 minutes in incubator 
conditions of 37 °C, 5 % CO2 and  96 % humidity. The COC were then transferred into 200 μL 
calcein-AM free incubation media with PDE inhibitors, in the presence or absence of 
treatments, and cultured at 37 °C either transiently or for up to 24 hours. After being 
washed in 200 μL of incubation media free of PDE inhibitors and treatment, the CC were 
removed from the oocyte. This was accomplished by vigorous and repeated pipetting of 200 
μL of incubation media containing the 15-20 COC. The DO were photographed to allow 
future analysis of the presence or absence of a GV (Figure 2-1). Oocytes were either 
categorised as containing (see Figure 2-3A) or not containing a visible GV (see Figure 2-3B). 
In cases where the GV was not clearly identifiable, the oocyte was categorised as not 
containing a GV for analysis purposes. The degree of fluorescence emitted by the DO was 
measured using a Leica inverted microscope (CTR4000) with a CRAIC fluorescence detection 
system (model QDI302; Leica Microsystems; Wetzlar, Germany). The settings for these 
measurements were 50 milliseconds over the wavelength range of 300 to 700 nm. A dark 
scan was performed to determine the amount of electronic noise when the excitation light is 
turned off. Fluorescence was measured near the centre of each oocyte.  
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Figure 2-1: Photographs depicting rat COC (A, C) and denuded oocytes (B, D) before and after exposure to 
calcein-AM. Indicated on the photographs are the cumulus cells (CC), oocyte (O), germinal vesicle (GV), and 
zona pellucida (ZP).  
 
 
 
Figure 2-2: Schematic overview of the protocol used to optimise dye transfer in the GJ assay. 
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Figure 2-3: Photographs depicting an oocyte with a visible germinal vesicle (A) and without a germinal vesicle 
(B).  
 
 
Figure 2-4: Schematic overview of the optimised GJ assay protocol. 
 
For all other experiments, COC were cultured at 37 °C in 200 μL incubation media with PDE 
inhibitors in the presence or absence of treatment for up to 48 hours. Following the 
incubation period, the COC were exposed to 2 μM calcein-AM for 10 minutes at 37 °C. The 
COC were then transferred into calcein-AM free media with PDE inhibitors and with or 
without treatment and incubated at 37 °C for a further 1 hour to allow dye transfer. In those 
experiments where the COC were not collected for RNA extraction, the COC were washed 
twice in 200 μL incubation media free of PDE inhibitors and treatment and the 15-20 oocytes 
within each well were denuded from their CC as described above. The DO were 
photographed for GV analyses and the fluorescence was measured using the Leica inverted 
microscope as described previously.  
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In those experiments where the COC were collected for RNA extraction, individual COC were 
transferred into wells of a 96-well plate (Thermo Fisher Scientific; Auckland, NZ) where they 
were washed twice in 100 μL phosphate buffered saline (PBS). The COC were transferred 
into 10 μL PBS and photographed. Thereafter, the oocytes were separated from the CC and 
the DO were transferred into 100 μL incubation media free of PDE inhibitors and treatment. 
The DO were photographed and fluorescence was measured within the oocyte as described 
previously. Thereafter the DO were washed twice more in 100 μL PBS before being 
transferred into 10 μL fresh PBS. The 96-well plates containing the separated CC masses and 
DO each in 10 μL PBS were stored at -80 °C. 
2.1.3.1 GJ assay data analysis 
Each oocyte was considered to be a discrete variable, so that the number of samples was 
considered to be the total number of readings across all replicates. For each replicate 
experiment, the geometric mean value was calculated for the raw fluorescence 
measurements of the control group (usually the untreated group at 1 hour). Relative 
fluorescence values were then calculated by dividing the raw fluorescence measurement for 
each individual oocyte by the geometric mean of the control group. The geometric mean 
and 95 % confidence interval of the relative fluorescence values were calculated for each 
experimental group. All statistical analyses of the data were performed using the GraphPad 
Prism 5 statistics program.  
Experiments were analysed using the appropriate statistical test, namely either the Mann-
Whitney test (one-way analysis), the Kruskal-Wallis test with Dunn’s multiple comparison 
post-hoc test (one-way analysis), or the two-way analysis of variance (ANOVA; two-way 
analysis). Where a two-way ANOVA was utilised, the data were first tested for normality 
using the D'Agostino & Pearson normality test. Data that was not normally-distributed was 
transformed using an appropriate transformation and tested for normality again. If no 
transformation method yielded normally-distributed data, the data points were ranked and 
a two-way ANOVA was performed on the ranks.  
2.1.4 COC culture for Western blotting 
For the Western blotting experiments, the dissection, wash and incubation media contained 
the PDE inhibitors, dipyridamole (50 μM) and rolipram (50 μM). Following extraction, COC 
43 
 
were transferred into a 48-well plate and washed twice in 200 μL wash media. Subsequently, 
the COC were transferred into 200 μL incubation media containing PDE inhibitors in the 
absence or presence of treatment. The COC were then incubated at 37 °C with 5 % CO2 and 
96 % humidity for up to 25 hours.  
After the culture period, the COC were washed twice in 200 μL PBS. A known number of COC 
(100 COC/group) were transferred into a microcentrifuge tube, and the total volume was 
made up to 500 μL with PBS. The microcentrifuge tubes were centrifuged at 800 x g for 10 
min, and the supernatant was removed and dispensed into a culture dish. The supernatant 
was checked under the dissection microscope to ascertain whether any COC were 
accidentally removed from the pellet. The COC pellet was then resuspended in PBS 
supplemented with protease inhibitors and stored at -20 °C.  
Due to the time taken to extract the COC, only 100 COC per treatment group were collected 
in each experiment and these were later pooled if necessary.   
2.1.5 CC serial dilution 
Rat ovaries were collected in PBS, and the COC were extracted into fresh PBS as described 
previously. The CC were stripped from the oocyte by vigorous and repeated pipetting and 
the oocytes were removed from the resulting cell suspension and discarded. A 50 μL aliquot 
of the CC suspension was mixed with 5 μL 0.4 % Trypan blue stain, and the cells were 
counted using a haemocytometer under an inverted microscope at 400x magnification. The 
total cell count was determined and the CC were serially diluted in triplicate with PBS to 
produce samples containing between 280 and 18,000 CC. The samples were stored at -80 °C 
prior to RNA extraction.  
2.2 Effect of in vivo exposure to methylenedioxymethamphetamine 
(MDMA) 
2.2.1 Treatment regimen 
All experiments involving administering MDMA to rats were approved by the VUW Animal 
Ethics Committee (VUW application number 2011R16). 
Pre-pubescent (21-25 day old) female Sprague-Dawley rats were weaned and housed in 
groups of 4 in a temperature controlled room at 22 °C and 55 % humidity, with a 12 hour 
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light/dark cycle. Food and water was available ad libitum. At the beginning of each 
experimental week, MDMA (kindly donated by Mr Richard Moore and Prof Susan Schenk, 
School of Psychology, VUW), was diluted in sterile saline to a concentration of 2.5 mg/mL 
and stored at 4 °C. The rats were administered either the vehicle (sterile saline; N=12) or 5 
mg/kg/ MDMA (N=12) via intraperitoneal (ip) injection. Each rat was administered one 
injection every 24 hours for 3 days (total of 3 injections). Due to logistics, three replicate 
experiments were undertaken (i.e. 4 rats/group/replicate experiment) over three 
consecutive weeks. 
To check the efficacy of the MDMA, locomotor activity of all rats following each injection 
was measured using Activity Monitor Version 5 software (Med Associates Inc.; St Albans, VT, 
USA). This test was performed by placing each rat in a locomotor activity box (40 x 40 cm) 
containing 16 infrared beams and corresponding sensors. When the subject stops a beam 
from reaching the sensor, this event is recorded. As a subject moves, a ‘box’ is established 
which is 3 infrared beams in width and length. The subject is considered ambulatory when it 
breaks more than 3 beams outside the ‘box’ within 1000 milliseconds. If the subject fails to 
meet these criteria, it is considered to be in a resting phase until such time as it meets the 
ambulatory criteria. The software measures ambulatory counts, which are defined as the 
total number of beams broken while the subject is in an ambulatory episode.  
The rats were habitualised in the locomotor activity boxes for 30 minutes, with the Activity 
Monitor software running to measure their activity. The activity boxes were located inside 
cupboards to create a darkened environment, and a white noise generator was used 
throughout the measurement of locomotor activity to minimise environmental disturbances. 
After habitualisation, the rats were administered their daily injection of either 5 mg/kg 
MDMA or saline (N=4/treatment group/week) via ip injection. The rats were returned to the 
locomotor activity boxes where their activity was monitored for a further 60 minutes. The 
rats were then returned to the temperature-controlled room. Measurement of locomotor 
activity was repeated following every injection. 
Approximately 18 hours after the final injection, the rats were sacrificed by CO2 
asphyxiation. The ovaries were collected into sterile PBS.  
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2.2.2 Collection of COC 
The ovaries from control and MDMA-treated rats were kept separate at all times. The 
ovaries were transferred into a 35 mm Petri dish containing sterile PBS and the surrounding 
fatty tissue was trimmed. The follicles were punctured using a 20 gauge needle, releasing 
the COC into the PBS. The COC were then transferred into a fresh dish containing sterile PBS 
for either gene or protein expression studies. 
The COC that were collected for gene expression were transferred singly into 10 μL of PBS in 
a 96-well plate and thereafter DO and CC were isolated separately as previously described. 
The DO were photographed before being transferred into 10 μL PBS. The 96-well plates 
containing the isolated DO and CC were then stored at -80 °C until gene expression studies 
were performed. 
For protein analysis, 200 COC/group were transferred into a microcentrifuge tube. 
Additional PBS was added to make the volume up to 500 μL. The microcentrifuge tubes were 
centrifuged at 800 x g for 10 min. The supernatant was transferred into a culture dish to 
check for the accidental removal of any COC. The COC pellet was then resuspended in 15 μL 
PBS containing protease inhibitors. The samples were stored at -20 °C until required.  
2.3 Quantitative PCR (qPCR) 
For the optimisation steps for each qPCR gene set, cDNA from pools of 50 COC were used as 
the template. All subsequent qPCR experiments were performed on individual DO and 
associated CC masses. 
2.3.1 RNA extraction and cDNA synthesis 
Total RNA was extracted using the ArrayPure Nanoscale RNA purification kit (Epicentre 
Biotechnologies; Madison, WI, USA) following the manufacturer’s instructions. In detail, 30 
µL of Nanoscale Lysis solution containing 5 μg of Proteinase K was added to each sample, 
and mixed thoroughly by pipetting. If the sample was in a 96-well plate, this solution was 
transferred to a microcentrifuge tube before proceeding. The contents of the 
microcentrifuge tubes were vortexed for 1 minute before being incubated at 65 °C for 15 
minutes. The samples were then placed on ice for 5 minutes, followed by the addition of 18 
µL of MPC Protein Precipitation Reagent and mixing by vortex for 10 seconds. The 
precipitated protein was pelleted by centrifugation at 12,000 x g at 4 °C for 7 minutes, and 
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the supernatant was transferred into a fresh microcentrifuge tube. In order to precipitate 
the RNA, 50 µL of isopropanol was added to the supernatant and vortexed for 30 seconds 
before being pelleted by centrifugation at 12,000 x g at 4 °C for 5 minutes. The isopropanol 
was discarded, and the RNA pellet was air dried for 5 minutes. The pellet was resuspended 
in 20 µL of DNase buffer containing 0.5 U DNase I enzyme by vortexing for 1 minute. To 
remove any contaminating genomic DNA, this solution was incubated at 37 °C for 30 
minutes. Following the incubation, 20 µL of 2x Nanoscale Lysis solution was added and the 
tubes were vortexed for five seconds. Subsequently 20 µL of MPC protein precipitation 
reagent was added, and the tubes were vortexed for a further 10 seconds. To precipitate any 
remaining protein, samples were then placed on ice for 5 minutes before being centrifuged 
at 12,000 x g at 4 °C for 5 minutes. The supernatant was transferred to a fresh 
microcentrifuge tube and RNA was precipitated with the addition of 50µL of isopropanol. 
The tubes were vortexed for 30 seconds and then centrifuged at 12,000 x g at 4 °C for 5 
minutes. The isopropanol was discarded, and the RNA pellet was washed with 50 µL of 70 % 
ethanol. The samples were centrifuged at 12,000 x g at 4 °C for a further 3 minutes and the 
ethanol was discarded. The RNA pellet was allowed to air dry for 5 minutes before being 
resuspended in 10 µL Ultrapure distilled H2O (Invitrogen) by vortexing for 2 minutes. To 
ensure full resuspension of the RNA pellet, the samples were incubated at 55 °C for 2 
minutes before being either stored at -80 °C until required or added directly to the 
complementary DNA (cDNA) synthesis reaction as described below.  
The synthesis of cDNA from total RNA was performed using the SuperScript® Vilo™ cDNA 
Synthesis Kit (Invitrogen) following manufacturer’s instructions. In detail, the entire total 
RNA sample (10 µL) was added to 4 µL of 5x VILO reaction mix, 2 µL of 10x SuperScript® 
Vilo™ enzyme and made up to a total volume of 20 µL with distilled H2O (dH2O; 4 µL). 
Following mixing by vortex, the samples were incubated in the Corbett Rotor-Gene 6000 
machine (model no. 11754-050; Corbett Life Science; Sydney, Australia) under the following 
conditions: 25 °C for 10 minutes, 42 °C for 120 minutes, 85 °C for 5 minutes. The samples 
were removed immediately following cDNA synthesis and stored at -20 °C until required.  
2.3.2 Multiplex qPCR 
Gene expression was quantified using multiplex TaqMan qPCR. TaqMan probes contain a 
fluorophore (FAM, HEX, ROX, or Cy5) at the 3’ end that differ in excitation and emission 
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wavelengths, an oligonucleotide sequence specific to the query gene, and a quencher at the 
5’ end. The fluorophore does not emit fluorescence due to the close proximity of the 
quencher. During the annealing steps of the amplification cycle, the primers and TaqMan 
probe bind to the template sequence. As the DNA polymerase moves along the sequence 
during the extension step, it displaces the fluorophore from the probe containing the 
quencher, allowing the emission of fluorescence.  
Each reaction contained optimised concentrations of the appropriate forward and reverse 
primers (Invitrogen) and TaqMan probes (Sigma; Auckland, NZ) a pre-made master mix 
(Agilent Technologies; Santa Clara, USA), cDNA template, and was made up to a total volume 
of 52 μL with UltraPure dH2O. This reaction was mixed by vortex before being pipetted in 
duplicate 25 μL aliquots into 0.1 mL strip tubes. Each reaction run contained a calibrator 
control and a no template control. The calibrator control contained pooled cDNA that had 
been isolated from a pool of rat COC, and was included in every reaction to enable 
normalisation against differences in reaction.  
The Brilliant II SYBR® Green QPCR Master Mix (Agilent Technologies) was used to optimise 
the primer concentrations. The Brilliant® Multiplex QPCR Master Mix (Agilent Technologies) 
was used for all other experiments. 
The samples were placed in the Corbett Rotor-Gene 6000 machine for thermal cycling and 
measurement of fluorescence. The thermal cycle conditions were as follows: 10 minutes at 
95 °C, then 40 repeats of 15 seconds at 95 °C and 60 seconds at 60 °C. To check primer 
specificity, a final melt step was added when SYBR green technology was used, involving 
heating the samples from 60 °C to 95 °C, with 5 seconds incubation for each 0.5 °C rise in 
temperature. The qPCR results were analysed using the Corbett Rotor-Gene 600 Series 
Software 1.7. 
2.3.3 Primers and probes 
To determine gene expression levels, quadriplex reactions containing three query genes and 
the reference gene 60S ribosomal protein L19 (Rpl19) were prepared and measured using 
qPCR. Three different quadriplex reactions were included in this study. The first quadriplex 
reaction contained the oocyte-specific query genes growth differentiation factor 9 (Gdf9), 
bone morphogenetic protein 15 (Bmp15), and connexin 37 (Cx37). The second multiplex 
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reaction contained the query genes connexin 43 (Cx43), glutamine-fructose-6-phosphate 
aminotransferase (Gfpt1), and phosphofructokinase, platelet (Pfkp). The third multiplex 
reaction contained the query genes ataxia telangiectasia and Rad3 related (Atr), cytochrome 
c (Cycs), and glucose transporter 1 (Glut1).  
For each query gene, a forward oligonucleotide primer, reverse oligonucleotide primer, and 
TaqMan probe were designed using the Beacon Designer software package (Premier Biosoft 
International, USA). The same Rpl19 forward and reverse primers and TaqMan probe were 
used in each multiplex reaction. The sequences of each forward and reverse primer set and 
each TaqMan probe are listed in Table 2-1 and Table 2-2, respectively.  
 
Table 2-1: Nucleotide sequences for forward and reverse primers for qPCR, including NCBI accession 
numbers, for each gene investigated. 
Gene NCBI Accession No Forward (F) and reverse (R) primers 
Gdf9 NM_021672 
F- GGAACACTTACTCAAATCGGTCTTG 
R- GCCTTGCTGGAAGACATGGG 
Bmp15 NM_021670 F- AACGAGGTAGCATACCAACTAATCAG 
R- GTTCGACATTTAGGGACCCAAGG 
Cx37 NM_021654 F- GACGGTCGTCTTCGCATTCG
R- ACGCCACTGGCCATAGAGG 
Cx43 NM_012567 F- CAGCCATTAGCCATCGTG
R- CGGTTTAAATCTCCAGGTCATC 
Gfpt1 NM_001005879 
F- AGCAGCCAGAATCTGTTG
R- GTGGTAACTTGTGCCACA 
Pfkp NM_206847 F- GGGCATAACCAACCTGTG
R- CGATCTCACCATTCTTAGCC 
Atr XM_003754445 F- GGTAGAATCTCTCCACTCCAGTCA 
R- AAGCCATTTCTCTGTGATGAGCAA 
Cycs NM_012839 
F- CCCGTGCTTCAGTGTGTGTAAA 
R- CAGTGGTGAAAGGCAGCATCA 
Glut1 NM_138827 
F- CCTTGCCTGAGACCAGTTGAA 
R- ACAGCAGGGCAGGAGTGTC 
Rpl19 NM_031103 
F- CCCAATGAAACCAACGAAA
R- GGGAATGGACAGTCACAG 
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Table 2-2: Nucleotide sequences for TaqMan probe sequences for qPCR for each gene investigated.  
Gene Probe Sequence 
Gdf9 [6-FAM]CACTCTGAACAACTCCGCTGCTTCCTCCT[BHQ1]
Bmp15 [HEX]CACTGTGGTCTACCGCCATCAACTTCATCTAGT[BHQ1]
Cx37 [ROX]CCTCCAGCACACTCTTACACAGCACACTC[BHQ2]
Cx43 [6-FAM]CTTCCAGCAGAGCCAGCAGC[BHQ1]
Gfpt1 [HEX]CAGAATCAACCGCCGACACCG[BHQ1]
Pfkp [ROX]TCCAGAAGACCGCTCCACTCC[BHQ2]
Atr [6-FAM]ACTCCTTGCCAGACTGCTGAGATGCGAA[BHQ1]
Cycs [ROX]TGCTAAACACCAGGACGGAACTATTCTTGACA[BHQ2]
Glut1 [HEX]TGTCTTCAGCAGTAAGTTCTCAGCCTCCGA[BHQ1]
Rpl19 [Cy5]CCAATGCCAACTCTCGTCAACAGATCAGGAAG[BHQ3]
 
 
Table 2-3: Optimal final concentrations (nM) of forward and reverse primers and TaqMan probes in qPCR 
reactions. 
Gene Forward Primer Reverse Primer Probe 
Gdf9 200 100 100 
Bmp15 300 200 100 
Cx37 300 100 50 
Cx43 50 300 50 
Gfpt1 100 200 100 
Pfkp 300 300 100 
Atr 200 200 50 
Cycs 100 100 100 
Glut1 100 200 100 
Rpl19 300 200 100 
 
 
2.3.4 Multiplex optimisation 
The optimal concentration of the forward and reverse primers for each gene was 
determined by titration of the primer concentrations between 50 nM and 300 nM. This was 
performed for each gene individually using SYBR green technology. The combination of 
primer concentrations that gave the lowest cycle threshold (CT) value without compromising 
on endpoint fluorescence was selected. The optimal probe concentration was determined 
for each gene individually by titration of the probe concentration between 50 nM and 300 
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nM. As each probe was labelled with a fluorophore, the TaqMan technology was used. The 
optimal primer and probe concentrations for each gene are shown in Table 2-3.  
The reaction efficiency of each gene in each quadriplex reaction was determined after the 
optimised conditions were determined for each gene. A cDNA dilution series was prepared, 
with each successive dilution containing half the concentration of cDNA. If the reaction had 
100 % efficiency, the CT value for each successive dilution would differ by 1.0, as CT values 
are on a logarithmic scale. The reaction efficiencies for each of the genes are shown in Table 
2-4.  
 
Table 2-4: The amplification efficiency for each gene in three different qPCR quadriplex reaction sets. 
Gene Threshold Efficiency (%)
Quadriplex 1 0.03 (slope correct)
Bmp15  92
Gdf9  93
Cx37  98
Rpl19  92
Quadriplex 2 0.03 (slope correct)
Cx43  90
Gfpt1  91
Pfkp  95
Rpl19  98
Quadriplex 3 0.07
Atr  101
Cycs  96
Glut1  98
Rpl19  99
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2.3.5 qPCR Analysis 
Each oocyte was considered to be a discrete variable, so that the number of samples was 
considered to be the total number of readings across all replicates. Relative gene expression, 
compared to the control group, was calculated as described previously (Livak and 
Schmittgen, 2001). The CC samples were further corrected for the reference gene Rpl19, to 
give gene expression relative to RNA input. The oocyte samples were corrected for inter-
assay reaction differences (i.e. internal calibrator control), to give total gene expression per 
single oocyte.  
For each CC sample, the CT value for Rpl19 was subtracted from the CT value of the query 
gene, to give the ΔCT value. For the oocyte samples, the CT value of the calibrator control for 
each query gene was subtracted from the CT value for each oocyte sample for the same 
query gene. The average ΔCT of the control group was calculated, and this was subtracted 
from the ΔCT values for each sample to give the ΔΔCT. The ΔΔCT values were converted to 
linear values by applying the formula 2-(ΔΔCT). This formula gives a positive change in linear 
values as mRNA levels increase. Any sample that had a CT value for Rpl19 of ≥30 was 
excluded from analysis due to insufficient template. Samples that had a CT value for the 
query genes that was out of the detection range (>34) were given a CT value of 40 for 
analysis purposes.  
In order to plot the data, the formula 2-(AverageΔΔCT) was applied to the average ΔΔCT for each 
group, to give the mean relative change in gene expression. The upper and lower errors 
were calculated using the formula 2-(AverageΔΔCT ± SEM), where SEM is the standard error of the 
mean.  
Statistical analysis was performed using the GraphPad Prism 5 software program. In general, 
either a Kruskal-Wallis test or a two-way ANOVA was employed to analyse the data. Where a 
two-way ANOVA was used, the data were first tested for a normal distribution using the 
D'Agostino & Pearson normality test. Where the data were not normally-distributed, the 
appropriate transformation method was used and the data were tested for a normal 
distribution again. If no transformation method made the data normally-distributed, the 
data were ranked and a two-way ANOVA was performed on the ranked data.  
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2.4 Western Blotting 
2.4.1 Protein quantification 
For Western blots, the total amount of protein loaded was determined using a bicinchoninic 
(BCA) based assay (Thermo Scientific; Auckland, NZ). This assay relies on the reduction of Cu+2 
ions to Cu+1 by protein in an alkaline environment. Each Cu+1 ion is chelated by two BCA 
molecules, and this complex has strong absorbance at 592 nm.  
The microplate procedure was used as described below. Bovine serum albumin was 
dissolved in PBS at concentrations of 0, 5, 10, 20, 30, 40, 50, 75, and 100 μg/mL. An aliquot 
(~67 COC; usually in 10 μL) of the crude COC lysate collected for Western blotting was 
diluted with 80 μL PBS buffer. Each COC sample was serially diluted to produce two sample 
dilutions, each containing half the amount of protein as the previous sample solution. The 
assay was performed in a 96-well plate. The assay plate was prepared by dispensing 25 μL of 
each standard and sample solution into the appropriate wells. The standards were assayed 
in triplicate and the samples were assayed in duplicate as described below.  
The BCA working reagent was prepared by mixing 50 parts of BCA Reagent A with 1 part of 
BCA Reagent B. This working reagent (200 μL) was added to each well, and the plate was 
mixed for 30 seconds using an Eppendorf MixMate plate shaker (Eppendorf; Hamburg, 
Germany). The plate was sealed and incubated at 37 °C (standard protocol) or 60 °C 
(optimised protocol) for 2 hours. The plate was removed from the incubator and allowed to 
cool to room temperature. The absorbance of the wells at 490 nm was measured using a 
VICTOR3 multilabel plate reader (Perkin Elmer, Waltham, MA, USA).  
The data were analysed by subtracting the absorbance of the blank from the standard and 
sample absorbance values. A standard curve was created using a best-fit linear regression of 
the absorbance values of the standards from which the protein concentrations of the 
samples were calculated. The amount of protein in each of the serial dilutions was corrected 
for the dilution factor, and an average protein concentration over the two serial dilutions 
was calculated.  
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2.4.2 SDS-PAGE 
Proteins were separated by molecular weight by sodium dodecyl sulphate polyacrylamide 
gel electrophoresis (SDS-PAGE). Polyacrylamide gels, with a 13.5 % separating gel and 4 % 
stacking gel (Appendix 2), were prepared one day in advance and stored overnight at 4 °C in 
paper towels soaked in dH2O.  
Sample buffer was added to each crude COC lysate to a final concentration of 2x (Appendix 
2). Each blot also contained a pre-stained SDS-PAGE Low-Range standard (BioRad; Auckland, 
NZ). All the samples were denatured at 95 °C for 10 minutes before being briefly centrifuged. 
An SDS-PAGE running cassette was set up using the polyacrylamide gel and 1x SDS-PAGE 
running buffer (Appendix 2). The entire crude COC lysate (minus the aliquot utilised for the 
BCA assay) was added into the appropriate well. Therefore, each COC sample lane contained 
protein from ~133 COC and this was kept constant between treatment groups and 
experimental replicates. If the entire volume of sample would not fit in one well, the gel was 
electrophoresed at 150 volts for 5 minutes to allow some of the sample to migrate into the 
stacking gel. Subsequently, the remainder of the sample was loaded into the appropriate 
well. Electrophoresis of the gel was then continued at 150 volts for a further 90 minutes, or 
until the blue marker dye had reached the bottom of the gel.  
2.4.3 Western Blotting 
A transfer sandwich was assembled to transfer the protein contained within the 
polyacrylamide gel onto a nitrocellulose membrane. All components, except the gel, were 
pre-soaked in transfer buffer (Appendix 2). The transfer sandwich components, in order 
from bottom to top, were: black face (negative charge), scotch pad, blotting paper, gel, 
nitrocellulose membrane, blotting paper, scotch pad, red face (positive charge). A roller was 
used to gently remove any air bubbles between each layer. The transfer sandwich was 
placed in the transfer stand along with a magnetic stirrer bar and ice pack, and transfer 
buffer was added to cover the transfer sandwich components. The transfer was performed 
at 100 volts for 70 minutes at 4 °C. To check that the transfer was successful, the 
nitrocellulose membrane was incubated with Ponceau S stain (Appendix 2) for 1 minute at 
60 rpm on a Labnet Orbit LS low speed platform shaker (Total Lab Systems Ltd.; Auckland, 
NZ). The membrane was de-stained with dH2O, and the position of the lanes was marked. 
The membrane was washed three times in Tris buffered saline (TBS; Appendix 2) before 
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being blocked in 5 % low-fat milk powder solution (Appendix 2) for 1 hour on the rotating 
platform shaker. The membrane was then incubated overnight in the appropriate primary 
antibody diluted in 5 % low-fat milk powder solution on the rotating platform shaker. The 
primary antibodies are detailed in Section 2.4.5. The membrane was washed three times in 
TBS, before being incubated with a secondary antibody conjugated to horseradish peroxidise 
(HRP) in 5 % low-fat milk powder solution. The secondary antibodies are detailed in Section 
2.4.5. The membrane was washed three times in TBS, before being incubated for 1 minute in 
electrochemiluminescence (ECL) reagents (Appendix 2). The membrane was wrapped in cling 
film and adhered to an exposure cassette. The x-ray films were exposed to the membrane 
for between 1 and 10 minutes, depending on the amount of protein signal. Following the 
development and fixture of the x-ray film, the ladder and lane positions were marked by 
comparison with the membrane.  
2.4.4 Western blot stripping 
The Western blots were stripped to remove the bound primary and secondary antibodies, 
allowing the membrane to be re-probed with different primary and/or secondary antibodies. 
The membrane was incubated in stripping buffer (Appendix 2) for 30 minutes at 50 °C. The 
membrane was washed vigorously in TBS, before undergoing 3 further wash steps in TBS on 
a rotating platform shaker. Thereafter, the Western blot protocol was carried out from the 1 
hour incubation step in low-fat milk powder solution.  
2.4.5 Antibodies 
A commercial anti-CX43 monoclonal antibody, MAB3067, was purchased from Millipore 
(Auckland, NZ). The MAB3067 antibody was raised in mice against the peptide sequence 
RSDPYHATTGPLSPSKDC, which corresponds to residues 252-270 of mouse CX43. This 
sequence is identical in rat CX43 and contains one potentially modified residue, a 
phosphoserine at residue 255. The MAB3067 antibody was used at a final concentration of 1 
μg/mL in 5 % low-fat milk powder solution. For ECL detection, blots that had been incubated 
with the MAB3067 antibody were subsequently incubated for 3 hours in 0.33 μg/mL rabbit 
anti-mouse secondary antibody conjugated to HRP (Jackson ImmunoResearch; Westgrove, 
PA, USA) in 5 % low-fat milk powder solution. For blocking experiments, MAB3067 was pre-
absorbed overnight at 4 °C on a rotating wheel with 5X (w/w) the corresponding control 
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peptide (Millipore). The blocked antibody was centrifuged at 13,000 x g for 10 minutes, and 
the supernatant was added to 5 % low-fat milk powder solution.   
The monoclonal antibody used to detect GDF9 (MAB47B) was produced by Oxford Brookes 
University for AgResearch. The MAB47B antibody was raised in mice against the peptide 
sequence SEYFKQFLFPQNEC, which corresponds to residues 122-135 (C-terminal region) of 
ovine GDF9. This sequence differs by one residue (bolded) in rat GDF9 (SEYFRQFLFPQNEC). 
Although the rat and sheep sequences are only 93 % homologous, MAB47B has previously 
been shown to recognise rat GDF9 (Lin et al., 2012) and in this study was used at a 
concentration of 1 μg/mL. For ECL detection, blots that had been incubated with MAB47B 
were subsequently incubated for 3 hours in 0.33 μg/mL rabbit anti-mouse secondary 
antibody conjugated to HRP. For blocking experiments, MAB47B was pre-absorbed overnight 
at 4 °C on a rotating wheel with 5X (w/w) E. coli produced recombinant ovine GDF9. The 
blocked antibody was centrifuged at 13,000 x g for 10 minutes, and the supernatant was 
added to 5 % low-fat milk powder solution.   
2.4.6 Western blot analysis 
Quantitative analyses of the western blots were performed using ImageJ 1.45s software. 
After scanning the x-ray film at high resolution, the scanned image was viewed in the ImageJ 
software package. The migration of the molecular standard was measured and used to 
estimate the size of the bands in the sample lanes. To measure the density of the bands, the 
image type was changed to 8-bit (grey-scale), and the subtract background process was 
used. The rectangular tool was used to select a band, and the measure function was used. 
The area of the rectangle was kept identical in all the corresponding bands of the same size. 
The integrated density (IntDen) value corresponds to the area and the mean grey value of 
the selection. For each band, the IntDen value was divided by the IntDen value of the time 
zero control. This value was subsequently divided by the relative amount of protein in each 
sample, as determined in the BCA assay.  
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3 VALIDATION OF A GJ BIOASSAY TO DETERMINE GJ ACTIVITY IN 
COC 
3.1 Introduction 
GJ communication between the CC and oocyte is essential for the transfer of essential 
nutrients and maintenance of meiotic arrest. A novel bioassay utilising the properties of a 
fluorescent dye (calcein) for measuring GJ communication between CC and oocytes was first 
reported in cultured bovine COC in vitro (Thomas et al., 2004). This bioassay involves the 
passive entry of the acetoxymethyl derivate (calcein-AM) into cells via permeation of the 
cellular membrane. Once inside the cell, the acetoxymethyl group is cleaved by non-specific 
esterases rendering calcein as a membrane impermeable fluorescent compound. Thus, when 
calcein-AM is incubated with CC-enclosed oocytes, the majority (~80 %) of the fluorescent 
calcein measured within the oocyte has been transferred from the CC through GJ (Thomas et 
al., 2004). Indeed, treatment of bovine COC with carbenoxolone, a GJ blocking agent that 
disassembles GJ plaques and dephosphorylates GJ proteins (Guan et al., 1996; Cruciani and 
Mikalsen, 2002), inhibited calcein transfer to the oocyte in a dose dependent manner 
(Thomas et al., 2004). 
Rat COC that have been isolated from their follicular environment resume meiosis within 1-2 
hours under in vitro conditions (Wert and Larsen, 1989). Meiotic arrest in oocytes is 
maintained by high levels of cAMP and evidence suggests that COC extraction from follicles 
results in the breakage of GJ (Wert and Larsen, 1989) and a subsequent decline in intra-
oocyte cAMP concentrations. Studies in bovine COC indicate that the primary mechanisms 
that regulate cAMP levels in the oocyte are the production of cAMP by adenylyl cyclase in 
the CC followed by transfer to the oocyte, and the degradation of cAMP by PDE expressed in 
the oocyte (Thomas et al., 2002). Additionally, the degree of intracellular communication 
facilitated through GJ has been reported to be regulated by cAMP via protein kinase A (PKA)-
mediated phosphorylation (Cruciani and Mikalsen, 2002). Thus, maintenance of cAMP levels 
in the oocyte by the addition of adenylyl cyclase stimulators or PDE inhibitors during in vitro 
culture of COC is critical for maintaining GJ communication and meiotic arrest in oocytes. It 
has long been thought that the major PDE isoform expressed in the rodent oocyte is PDE3, 
while the major isoform expressed in rodent CC is PDE4D (Tsafriri et al., 1996; Richard et al., 
2001). However, recent research has shown that inhibiting PDE8 activity in bovine COC 
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increased cAMP levels and delayed oocyte nuclear maturation (Sasseville et al., 2009a). This 
suggests that species differences in the forms of PDE may exist. 
Whilst the GJ bioassay had been modified for measuring GJ communication in rat COC (Patel, 
2009; Yadav, 2010), the specificity of the assay and the effectiveness of a range of 
compounds involved in maintaining meiotic arrest and GJ communication has not been fully 
elucidated. Therefore, the aims of this chapter were to (1) determine the optimal in vitro 
conditions for maximising the rate of fluorescent dye transfer in rat COC and (2) 
demonstrate that fluorescent dye transfer from the CC to the oocyte is specific to GJ transfer 
and can be blocked using the GJ uncoupler carbenoxolone.    
3.2 Methodology 
3.2.1 Tissue collection 
For experiments in sections 3.2.2-3.2.5 described below, ovaries were extracted and follicles 
were punctured in dissection media supplemented with 100 μM milrinone. The COC were 
transferred into 48-well plates containing wash media with 100 μM milrinone. Due to the 
results obtained in these aforementioned sections, subsequent experiments utilised a 
modified collection methodology. Namely for experiments in sections 3.2.6-3.2.8, ovaries 
were extracted, follicles were punctured and COC were transferred into 48-well plates 
containing dissection media supplemented with 50 μM dipyridamole and 50 μM rolipram 
(see Sections 2.1.1 and 2.1.2 for detailed tissue collection methodology). 
3.2.2 Dose-response effects of DMSO concentrations 
To determine the effects of the solvent (DMSO) used to facilitate solubilisation of PDE 
inhibitors and/or treatments, milrinone was dissolved in differing volumes of DMSO to 
achieve a final milrinone concentration of 100 µM and DMSO concentrations of 0.2 %, 0.5 %, 
1.0 %, and 2.0 % in media. The COC were washed twice in wash media containing 100 μM 
milrinone and the appropriate concentration of DMSO. The COC were then incubated with 2 
μM calcein-AM in incubation media containing 100 μM milrinone and the appropriate 
concentration of DMSO for 10 minutes. All incubations were carried out in an incubator at 
37 °C under 5 % CO2 in air with 96 % humidity. Subsequently, the COC were transferred into 
incubation media containing 100 μM milrinone and the appropriate concentration of DMSO 
without calcein-AM and incubated for either 0 or 4 hours. At the end of the incubation 
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times, each COC was transferred into fresh incubation media (without milrinone or DMSO) 
where the oocyte was denuded and fluorescence was measured as described previously.  
3.2.3 Dose-response effects of forskolin 
Following collection, the COC were washed twice in wash media containing 100 μM 
milrinone and incubated with 2 μM calcein-AM in incubation media with 100 μM milrinone 
for 10 minutes. To determine the effects of forskolin, the COC were then transferred to 
incubation media containing 100 μM milrinone and 0, 10, 20, or 50 μM forskolin. After 0 or 4 
hours incubation, the COC were transferred to fresh incubation media (no milrinone or 
forskolin) and the oocyte was denuded and fluorescence was measured as described 
previously (Section 2.1.3).  
3.2.4 Dose-response effects of single PDE inhibitors 
Three different PDE inhibitors were tested at the concentrations listed in Table 3-1. 
Milrinone is a specific inhibitor of PDE3 (Tsafriri et al., 1996), rolipram is a specific inhibitor 
of PDE4 (Sasseville et al., 2009a) and dipyridamole is reported to inhibit several PDE isoforms 
including PDE7, 8, 10, and 11 (Sasseville et al., 2009a). All concentrations of PDE inhibitors 
were dissolved in DMSO and the control media was supplemented with DMSO so that 
regardless of treatment, the final concentration of DMSO in media was 1 %. 
Following collections, COC were washed twice in wash media without (control) or with the 
appropriate PDE inhibitor at the concentrations described above. The COC were incubated in 
2 μM calcein-AM without or with the appropriate PDE inhibitor for 10 minutes and then 
transferred into fresh incubation media (no calcein-AM) containing the appropriate PDE 
inhibitors or media alone (control). Following 0 or 4 hours incubation, the COC were 
transferred into incubation media alone (no PDE inhibitors) and the oocytes were denuded 
and fluorescence was measured as described previously (Section 2.1.3).  
 
Table 3-1: Concentrations of PDE inhibitors used for the GJ dose-response experiments 
PDE inhibitor PDE isoforms inhibited Concentrations tested (μM) 
Milrinone PDE3 100, 300, 500 
Dipyridamole PDE5, 6, 7, ,8 , 10, 11 10, 50, 100 
Rolipram PDE4 10, 50, 100 
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3.2.5 Effects of combined PDE inhibitors 
Each PDE inhibitor was tested in combination with each other at the optimised 
concentration (as determined in section 3.2.4) as follows: 300 μM milrinone alone, 50 μM 
dipyridamole alone, 50 μM rolipram alone, 300 μM milrinone + 50 μM dipyridamole, 300 μM 
milrinone + 50 μM rolipram, 50 μM dipyridamole + 50 μM rolipram, and 300 μM milrinone + 
50 μM dipyridamole + 50 μM rolipram. The final concentration of the DMSO used to 
solubilise the PDE inhibitors in the media was ~1 %. Following collection, COC were washed 
twice in wash media without (control) or with the various PDE inhibitors as listed above. The 
COC were incubated for 10 minutes in 2 μM calcein-AM in media alone (control) or with the 
appropriate PDE inhibitor(s). Thereafter, the COC were transferred to fresh incubation media 
(without calcein-AM) in the absence (control) or presence of PDE inhibitors. Following 0 or 4 
hours incubation, COC were transferred into fresh media (free of PDE inhibitors) and the 
oocytes were denuded and the fluorescence intensity measured as described previously 
(Section 2.1.3).  
3.2.6 Effects of time on dye transfer to the oocyte 
Following collection, the COC were washed twice in wash media containing 50 μM 
dipyridamole and 50 μM rolipram. The COC were incubated in 2 μM calcein-AM in 
incubation media containing 50 μM dipyridamole and 50 μM rolipram for 10 minutes. To 
determine the effect of incubation time on oocyte fluorescence, COC were transferred into 
fresh media (without calcein-AM) containing 50 μM dipyridamole and 50 μM rolipram and 
incubated for 0, 1, 2, 3, 4, 12, or 24 hours. Following incubation, COC were transferred into 
fresh incubation media containing no PDE inhibitors and the oocytes were denuded and the 
fluorescence intensity measured as described previously (Section 2.1.3).  
3.2.7  Testing the specificity of the GJ bioassay 
To determine the specificity of fluorescent dye transfer from the CC to the oocyte by GJs, 
COC were incubated with varying concentrations of the GJ uncoupler carbenoxolone. 
Following collection, COC were washed twice in wash media containing 50 μM dipyridamole 
and 50 μM rolipram. The COC were incubated for 10 minutes in 2 μM calcein-AM in media 
containing 50 μM dipyridamole and 50 μM rolipram. COC were then transferred into fresh 
incubation media containing 50 μM dipyridamole and 50 μM rolipram and either 0, 100, 200, 
300, 500, or 1000 μM carbenoxolone. Following 0 or 4 hours incubation, COC were 
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transferred into incubation media free of PDE inhibitors and carbenoxolone and the oocytes 
were denuded and the fluorescence intensity measured as described previously (Section 
2.1.3).  
3.2.8 Testing the robustness of the GJ bioassay  
To determine the robustness of the in vitro GJ bioassay over time, the proportion of 
fluorescence that entered the oocyte via a non-GJ pathway over time was assessed. 
Following collection, COC were washed twice in wash media containing 50 μM dipyridamole 
and 50 μM rolipram. The COC were transferred into incubation media containing 50 μM 
dipyridamole and 50 μM rolipram and incubated for 0, 2, 10, or 22 hours. Those COC that 
were incubated for 2, 10, or 22 hours were then transferred to incubation media containing 
1 mM carbenoxolone, 50 μM dipyridamole and 50 μM rolipram and incubated for a further 2 
hours, so the total culture times were 4, 12, or 24 hours, respectively. Following incubations, 
COC were exposed for 10 minutes to 2 μM calcein-AM in incubation media containing 1 mM 
carbenoxolone, 50 μM dipyridamole and 50 μM rolipram. The COC were incubated for 1 
hour in calcein-AM free incubation media containing 1 mM carbenoxolone, 50 μM 
dipyridamole and 50 μM rolipram. The COC were then transferred into incubation media 
without carbenoxolone or PDE inhibitors, the oocytes were denuded and fluorescence 
intensity measured as described previously (Section 2.1.3). 
3.2.9 Data Analysis 
The data were analysed as previously described in Section 2.1.3.1. Briefly, the oocyte 
fluorescence in each individual sample was corrected for the geometric mean of the control 
group (usually the untreated group at 0 hours). The data were analysed using the Mann-
Whitney test, Kruskal-Wallis test with Dunn’s multiple comparison post-hoc test, or a two-
way ANOVA. Where a two-way ANOVA was used, the data were first tested for normality 
using the D'Agostino & Pearson normality test. Data that was not normally-distributed was 
transformed using a natural log transformation, tested for normality again, and a two-way 
ANOVA was performed on the transformed data.  
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3.3 Results 
3.3.1 Dose-response effects of DMSO concentrations 
The dose-response effects of DMSO in media on GJ communication in rat COC is depicted in 
Figure 3-1 where the fluorescent intensity values plotted are those at 4 hours normalised 
against the mean control value at 0 hours. There were no significant differences in relative 
oocyte fluorescent intensity at any of the DMSO concentrations tested (P=0.055). 
Nonetheless whilst not significant, there appeared to be a reduction in intra-oocyte 
fluorescent intensity at the highest dose (2 %) of DMSO, thus the DMSO concentration of 1 
% was used in all subsequent assays. 
 
 
Figure 3-1: Effect of differing concentrations of DMSO on fluorescence transfer from adjacent CC to oocytes 
after a 4 hour incubation of rat COC. Values are shown as geometric means ± 95 % confidence intervals of 
fluorescent ratios normalised against the geometric mean of the T0 control group (not shown, relative 
geometric mean=1.0). The data represent an N of 22-25 readings from individual oocytes in each group 
generated from 2 replicate experiments. The data were analysed using the Kruskal-Wallis test. No significant 
effect of DMSO concentration on relative fluorescent intensity was noted. The mean ± SEM fluorescent reading 
in the control group at T0 was 104 ± 36. 
 
3.3.2 Dose-response effects of forskolin 
The dose-response effects of forskolin (an adenylyl cyclase stimulator) on GJ communication 
in rat COC is shown in Figure 3-2, where the fluorescent intensity values plotted are those at 
4 hours normalised against the mean control value at 0 hours. Incubation of COC for 4 hours 
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with the two lowest doses of forskolin (10 μM or 20 μM) did not affect oocyte fluorescence. 
In comparison, incubation of COC for 4 hours with the highest dose of forskolin tested (50 
μM) resulted in a significant reduction (P<0.001) in oocyte fluorescence. The incubation time 
of 4 hours resulted in significantly increased (P<0.0001; Mann-Whitney test) fluorescent 
intensity in the control oocytes (no forskolin), compared to that at 0 hours (i.e. note the ~4-6 
fold higher values; Figure 3-2A, B, & C). The proportion of oocytes with a visible GV was 
similar between experimental treatment groups after 4 hours of incubation (Fisher’s exact 
test; data not shown). 
 
 
Figure 3-2: Effect of forskolin on fluorescent dye transfer from adjacent CC to oocytes after a 4 hour 
incubation of rat COC. Values are shown as geometric means ± 95 % confidence intervals of fluorescent ratios 
normalised against the geometric mean of the T0 control group (not shown, relative geometric mean=1.0). The 
data represent an N of (A) 46-64 readings from individual oocytes in each group generated from 5 replicate 
experiments, (B) 30-41 readings from individual oocytes in each group generated from 3 replicate experiments, 
(C) 8-19 readings from individual oocytes in each group generated from 1 replicate experiment. The data were 
analysed using the Mann Whitney test. No significant changes in relative fluorescent intensity were noted for A 
or B. For C, groups that do not share a letter are statistically different (P<0.05). The mean ± SEM raw 
fluorescent reading in the control group at T0 was (A) 56 ± 18, (B) 46 ± 16, and (C) 140 ± 46.  
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3.3.3 Dose-response effects of single PDE inhibitors 
The dose-response effects of milrinone (a PDE3 inhibitor) on GJ communication in rat COC is 
shown in Figure 3-3, where the fluorescent intensity values plotted are those at 4 hours 
normalised against the mean control value at 0 hours. There were no significant differences 
in oocyte fluorescent intensity following a 4 hour incubation of rat COC with 100 and 300 μM 
of milrinone. In contrast, the highest dose of milrinone (500 μM) resulted in a significant 
reduction (P<0.01) in fluorescence compared to the other two dosages. The incubation time 
of 4 hours resulted in significantly increased (P<0.05; Mann-Whitney test) fluorescent 
intensity in the control oocytes (no milrinone), compared to that at 0 hours (i.e. note the ~2 
fold higher value; Figure 3-3). The proportion of oocytes with a visible GV, indicating 
arrested meiosis, was similar between all experimental treatment groups after 4 hours of 
incubation (Table 3-2).  
 
 
Figure 3-3: Effect of differing concentrations of milrinone on fluorescent dye transfer from adjacent CC to 
oocytes after a 4 hour incubation of rat COC. Values are shown as geometric means ± 95 % confidence 
intervals of fluorescent ratios normalised against the geometric mean of the T0 control group (not shown, 
relative geometric mean=1.0). The data represent 31-35 readings from individual oocytes in each group 
generated from 3 replicate experiments. The data were analysed by a Kruskal-Wallis test and where significant 
differences were observed, a Dunn’s multiple comparison post-hoc test was performed. Groups that do not 
share a letter are statistically different (P<0.05). The mean ± SEM raw fluorescent reading in the control group 
at T0 was 206 ± 28. 
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Table 3-2: Effect of differing concentrations of milrinone on the proportion of oocytes in which a GV was 
observed. The table shows the proportion (%) of oocytes with a visible GV, with the actual number of oocytes 
with a GV observed in brackets. The data from 3 replicate experiments (N=31-35) were analysed by a Fisher’s 
exact test. No significant effect of milrinone concentration on the presence of a GV was noted.  
Milrinone concentration (μM) GV oocytes (%) 
0 78 (25) 
100 94 (33) 
300 79 (26) 
500 74 (23) 
 
 
The dose-response effects of dipyridamole (a PDE7, 8, 10, and 11 inhibitor) on GJ 
communication in rat COC is depicted in Figure 3-4, where the fluorescent intensity values 
plotted are those at 4 hours normalised against the mean control value at 0 hours. The 
incubation of COC with 50 μM dipyridamole for 4 hours caused a significant increase in 
oocyte fluorescence relative to the appropriate control (4 hour incubation with the vehicle 
alone). No other concentration of dipyridamole tested resulted in a significant change in 
oocyte fluorescence relative to the control. The incubation time of 4 hours resulted in 
significantly increased (P<0.01; Mann-Whitney test) fluorescent intensity in the control 
oocytes (no dipyridamole), compared to that at 0 hours (i.e. note the ~2 fold higher value; 
Figure 3-4). The proportion of oocytes with a visible GV was similar between experimental 
treatment groups after 4 hours of incubation (Table 3-3). 
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Figure 3-4: Effect of differing concentrations of dipyridamole on fluorescent dye transfer from adjacent CC to 
oocytes after a 4 hour incubation of rat COC. Values are shown as geometric means ± 95 % confidence 
intervals of fluorescent ratios normalised against the geometric mean of the T0 control group (not shown, 
relative geometric mean=1.0). The data represent 34-38 readings from individual oocytes in each group 
generated from 4 replicate experiments. The data were analysed by a Kruskal-Wallis test and where significant 
differences were observed, a Dunn’s multiple comparison post-hoc test was performed. Groups that do not 
share a letter are statistically different (P<0.05). The mean ± SEM raw fluorescent reading in the control group 
at T0 was 207 ± 24. 
 
Table 3-3: Effect of differing concentrations of dipyridamole on the proportion of oocytes in which a GV was 
observed. The table shows the proportion (%) of oocytes with a visible GV, with the actual number of oocytes 
with a GV observed in brackets. The data from 3 replicate experiments (N=34-38) was analysed by a Fisher’s 
exact test. No significant effect of dipyridamole concentration on the presence of a GV was noted.  
Dipyridamole concentration (μM) GV oocytes (%) 
0 59 (22) 
10 66 (25) 
50 81 (29) 
100 59 (20) 
 
 
The effect of incubating rat COC for 4 hours with differing concentrations of rolipram (a 
PDE4 inhibitor) on GJ communication is shown in Figure 3-5, where the fluorescent intensity 
values plotted are those at 4 hours normalised against the mean control value at 0 hours. No 
differences were observed in oocyte fluorescence between any experimental groups. The 
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incubation time of 4 hours resulted in significantly increased (P<0.005; Mann-Whitney test) 
fluorescent intensity in the control oocytes (no rolipram), compared to that at 0 hours (i.e. 
note the ~2 fold higher value; Figure 3-5). The proportion of oocytes with a visible GV was 
similar between experimental treatment groups after 4 hours of incubation (Table 3-4).  
 
 
Figure 3-5: Effect of differing concentrations of rolipram on fluorescent dye transfer from adjacent CC to 
oocytes after a 4 hour incubation of rat COC. Values are shown as geometric means ± 95 % confidence 
intervals of fluorescent ratios normalised against the geometric mean of the T0 control group (not shown, 
relative geometric mean=1.0). The data represent 26-29 readings from individual oocytes in each group 
generated from 3 replicate experiments. The data were analysed by a Kruskal-Wallis test and where significant 
differences were observed, a Dunn’s multiple comparison post-hoc test was performed. No significant changes 
in relative fluorescent intensity were noted. The mean ± SEM raw fluorescent reading in the control group at T0 
was 212 ± 23. 
 
Table 3-4: Effect of differing concentrations of rolipram on the proportion of oocytes in which a GV was 
observed. The table shows the proportion (%) of oocytes with a visible GV, with the actual number of oocytes 
with a GV observed in brackets. The data from 3 replicate experiments (N=26-29) was analysed by a Fisher’s 
exact test. No significant effect of rolipram concentration on the presence of a GV was noted.  
Rolipram concentration (μM) GV oocytes (%) 
0 32 (12) 
10 53 (18) 
50 43 (17) 
100 50 (18) 
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3.3.4 Effects of combined PDE inhibitors 
The effects of incubating rat COC for 4 hours with combinations of the aforementioned PDE 
inhibitors on GJ communication is shown in Figure 3-6, where the fluorescent intensity 
values plotted are those at 4 hours normalised against the mean control value at 0 hours. A 
combination of dipyridamole and rolipram resulted in a significantly higher (P<0.05) 
fluorescence intensity in oocytes compared to that in the untreated control group. All other 
treatment groups (PDE inhibitors alone and in combination) had oocyte fluorescent 
intensities similar to that of the control. The incubation time of 4 hours resulted in 
significantly increased (P<0.05; Mann-Whitney test) fluorescent intensity in the control 
oocytes (no PDE inhibitors), compared to that at 0 hours (i.e. note the ~2 fold higher value; 
Figure 3-6). The proportion of oocytes with a visible GV was similar between all experimental 
treatment groups after 4 hours of incubation (Table 3-5).  
 
 
Figure 3-6: Effect of single or combinations of PDE inhibitors on fluorescent dye transfer from adjacent CC to 
oocytes after a 4 hour incubation of rat COC. Values are shown as geometric means ± 95 % confidence 
intervals of fluorescent ratios normalised against the geometric mean of the T0 control group (not shown, 
relative geometric mean=1.0). The data represent 22-30 readings from individual oocytes in each group 
generated from 3 replicate experiments. The data were analysed by a Kruskal-Wallis test and where significant 
differences were observed, a Dunn’s multiple comparison post-hoc test was performed. Groups that do not 
share a letter are statistically different (P<0.05). The mean ± SEM raw fluorescent reading in the control group 
at T0 was 232 ± 46. 
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Table 3-5: Effect of single or combinations of PDE inhibitors on the proportion of oocytes in which a GV was 
observed. The table shows the proportion (%) of oocytes with a visible GV, with the actual number of oocytes 
with a GV observed in brackets. The data from 3 replicate experiments (N=22-30) was analysed by a Fisher’s 
exact test. No significant effect of PDE inhibitor concentration on the presence of a GV was noted.  
PDE inhibitor combination % GV oocytes 
No PDE inhibitors 64 (18) 
Milrinone 86 (25) 
Dipyridamole 70 (16) 
Rolipram 73 (19) 
Milrinone + Dipyridamole 83 (25) 
Milrinone + Rolipram 81 (22) 
Dipyridamole + Rolipram 71 (20) 
Milrinone + Dipyridamole + Rolipram 59 (13) 
 
 
3.3.5 Effects of time on dye transfer to the oocyte 
The effect of varying the incubation time following exposure to calcein-AM on the 
fluorescent intensity of the oocyte is depicted in Figure 3-7. Initially, oocyte fluorescence 
increased with time to reach maximum levels after 2-3 hours of incubation. As a result of 
these experiments and to remain within a responsive fluorescent intensity range, COC were 
incubated for 1 hour after the 10 minute exposure to calcein-AM for all subsequent assays.  
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Figure 3-7: Effect of time on fluorescent dye transfer from adjacent CC to oocytes. Values are shown as 
geometric means ± 95 % confidence intervals of fluorescent ratios normalised against the geometric mean of 
the T0 control group. The data represent 23-27 readings from individual oocytes at each time generated from 3 
replicate experiments. The data were analysed by a Kruskal-Wallis test and where significant differences were 
observed, a Dunn’s multiple comparison post-hoc test was performed. Groups that do not share a letter are 
significantly different (P<0.05). The mean ± SEM raw fluorescent reading at T0 was 297 ± 38. 
 
3.3.6 Testing the specificity of the GJ bioassay 
To determine the proportion of calcein transfer to the oocyte that is facilitated through GJ, 
rat COC were exposed to increasing concentrations of the GJ blocking agent carbenoxolone. 
These results are depicted in Figure 3-8, in which the fluorescent intensity values plotted are 
those at 4 hours normalised against the mean control value at 0 hours. Carbenoxolone 
inhibited calcein transfer to the oocyte in a dose-dependent manner. The lowest 
concentration of carbenoxolone to cause a significant reduction (~60 %; P<0.05) in oocyte 
fluorescence, compared to the control group, was 200 μM. The lowest dose that caused the 
maximum inhibition (>88 %; P<0.0001) of GJ communication within COC was 500 μM 
carbenoxolone. The incubation time of 4 hours resulted in significantly increased (P<0.0001; 
Mann-Whitney test) fluorescent intensity in the control oocytes (no carbenoxolone), 
compared to that at 0 hours (i.e. note the ~4-fold higher value; Figure 3-8). 
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Figure 3-8: Effect of increasing concentrations of carbenoxolone on fluorescent dye transfer from adjacent CC 
to oocytes after a 4 hour incubation of rat COC. Values are shown as geometric means ± 95 % confidence 
intervals of fluorescent ratios normalised against the geometric mean of the T0 control group (not shown, 
relative geometric mean = 1.0). The data represent 25-37 readings from individual oocytes in each group 
generated from 4 replicate experiments. The data were analysed by a Kruskal-Wallis test and where significant 
differences were observed, a Dunn’s multiple comparison post-hoc test was performed. Groups that do not 
share a letter are significantly different (P<0.05). The mean ± SEM raw fluorescent reading in the control group 
at T0 was 195 ± 35. 
 
3.3.7 Testing the robustness of the GJ bioassay  
The robustness of the in vitro GJ bioassay over time was assessed by determining the 
proportion of fluorescent dye that enters the oocyte via a means other than GJs over time. 
These results are depicted in Figure 3-9, in which the fluorescent intensity values plotted are 
normalised against the mean control value at 0 hours. As carbenoxolone takes at least 2 
hours to effectively block GJ (see Appendix 1), the specificity of calcein transfer to the oocyte 
in the COC incubated for 1 hour was not able to be determined. A 2 hour incubation of COC 
with carbenoxolone, regardless of a prior 2, 10, or 22 hour incubation without 
carbenoxolone, caused a marked decrease (91 %, 85 %, and 92 %, respectively) in dye 
transfer to the oocyte by the end of the total incubation period. All of the incubation times 
tested resulted in significantly increased (P<0.0001; Mann-Whitney test) fluorescent 
intensities in the control oocytes, compared to those at 1 hours (i.e. note the ~3.5-fold 
higher values, Figure 3-9). 
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Figure 3-9: Effect of 1 mM carbenoxolone on fluorescent dye transfer from adjacent CC to oocytes after 5, 13, 
and 25 hours incubation in rat COC. The incubation time indicates the pre-calcein incubation + the 1 hour post-
calcein incubation. The control (i.e. untreated) group is represented by the unfilled bars ( ), while the 
carbenoxolone-treated group is represented by the filled bars ( ). Values are shown as geometric means ± 
95 % confidence intervals of fluorescent ratios normalised against the geometric mean of the control group at 
1 hour (not shown, relative geometric mean = 1.0). The data represents 23-44 readings from individual oocytes 
in each group generated from 3 replicate experiments. The natural log-transformed data were analysed by a 
two-way ANOVA. The mean ± SEM raw fluorescent reading in the control group at 1 hour was 112 ± 14.  
 
3.4 Discussion 
These validation studies reveal for the first time in the rat that, of all the cAMP-modulating 
compounds tested the combination of dipyridamole and rolipram was arguably the most 
effective in maintaining GJ communication between the CC and oocyte. Interestingly, the 
inhibitors milrinone and rolipram that block the PDE isoforms reported to be primarily 
expressed in rat oocytes (i.e. PDE3; Richard et al., 2001) and CC (i.e. PDE4; (Tsafriri et al., 
1996), respectively had no effect on GJ communication in this study either singly or in 
combination with one another. Dipyridamole is reported to inhibit the actions of PDE7, 8, 10, 
and 11 (Sasseville et al., 2009a). Whilst the expression of PDE8 has previously been detected 
in the rat ovary (Kobayashi et al., 2003), PDE8 activity on regulating cAMP concentrations or 
oocyte meiotic resumption in this species has not been reported. Additionally, to the best of 
my knowledge, the expression of PDE7, 10, and 11 in the rat COC has not been previously 
detected. Therefore, these data indicate for the first time that the levels of PDE7, 8, 10, 
and/or 11 are active in rat COC. In the cow, PDE8 has been reported to account for up to 20 
% and 60 % of PDE activity in oocytes and CC, respectively. If a similar relationship exists in 
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the rat COC, these results suggest that inhibition of PDE activity in the CC, rather than the 
oocyte, is more important for maintaining GJ communication in this species. These results 
also suggest that prevention of cAMP breakdown (tested by the addition of PDE inhibitors), 
rather than stimulation of cAMP production (tested by the addition of forskolin) is more 
important for maintaining GJ communication in the rat.  
The ability of the GJ inhibitor carbenoxolone to inhibit calcein transfer to the oocyte up to 25 
hours in culture indicates that these culturing conditions allow the COC to retain its 
structural integrity in vitro. Furthermore, calcein transfer from the CC to the oocyte was 
reduced in a dose-dependent manner with increasing concentrations of carbenoxolone. 
Maximum inhibition (~90 %) of fluorescence transfer from the CC to the oocyte was 
achieved at a dose of 500 μM carbenoxolone. Thus, approximately 10 % of fluorescence 
measured within DO using the bioassay was the result of transfer facilitated by a means 
other than GJ. Indeed, other transfer channels exist in oocytes including aquaporins and 
calcium channels (Ford et al., 2000; Tosti et al., 2000). Aquaporins are involved in the 
transfer of water and neutral solutes such as polyols, purines, pyrimidines, and carbamides, 
and are thought to mediate oocyte volume control  (Tsukaguchi et al., 1998; Ford et al., 
2000). Calcium channels are thought to play a role in oocyte meiotic resumption (Tosti, 
2006).  
The optimal parameters for measuring GJ communication in rat COC using the bioassay 
herein include the addition of 50 μM dipyridamole and 50 μM rolipram in media. The 
inclusion of these PDE inhibitors in media should be used for ovary collections and 
dissections, throughout all in vitro incubation periods and the 1 hour incubation time 
following calcein-AM exposure to allow for appropriate dye transfer. Furthermore, the final 
concentration of the solvent DMSO should remain at <1 %.  
In summary, we report a successful bioassay for measuring GJ communication in rat COC 
that utilises a novel combination of PDE inhibitors (dipyridamole and rolipram). This study 
infers that PDE7, 8, 10 and 11 are active in the rat COC, and may play an important role in 
the maintenance of meiotic arrest in the oocyte in this species. Moreover this study verifies 
that GJ communication within the rat COC is a dynamic process that the bioassay described 
herein can accurately and repeatedly measure.  
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4 VALIDATING THE USE OF COC PREVIOUSLY UTILISED IN GJ ASSAYS 
FOR GENE EXPRESSION ANALYSES 
4.1 Introduction 
Ovarian follicles are activated to grow one at a time such that each one is at a different stage 
of development at any one time. Even when a large number of pre-ovulatory follicles are 
produced in sheep through hormonal superovulation protocols, it has been shown that GC 
isolated from these similarly-sized follicles showed significant differences in their responses 
to FSH, and hCG (McNatty et al., 2010). Thus, superovulation protocols are unable to 
overcome the hierarchical growth of ovarian follicles. Moreover, large differences in oocyte 
quality have also been reported following superovulation in humans (Krisher, 2004; Lasien et 
al., 2009) confirming that similar-sized follicles are unlikely to be at an identical stage of 
development, or to respond identically to external stimuli. These observations highlight the 
importance of assessing both the degree of GJ communication and the expression levels of 
candidate genes in individual COC. Moreover, the ability to directly correlate the degree of 
GJ communication and candidate gene expression levels would be invaluable for assessing 
the regulatory pathway(s) that are involved in CC-oocyte interactions. 
In order to directly correlate CC and oocyte gene expression with GJ activity, the aim of this 
study was to determine whether (1) the fluorescent properties of the dye (calcein) used in 
the GJ assays interfered with the fluorescence of the TaqMan probes used in the qPCR 
technique and (2) the exposure of COC to calcein affected mRNA levels of the candidate 
genes.  
4.2 Methods 
For all experiments described below, the fluorescence was measured in a Corbett Rotor-
Gene 6000 machine following a thermal cycle programme of: 95 °C for 10 minutes; and then 
40 cycles of 95 °C for 15 seconds and 60 °C for 60 seconds. The Corbett was set to acquire 
florescence on the green, orange, red, and yellow channels. The excitation and emission 
wavelengths for these channels (Table 4-1) determine the four florescence dyes chosen for 
the tags on the TaqMan probes, namely FAM, ROX, CY5 and HEX, respectively. Calcein has 
excitation and emission wavelength of 495 and 515 nm, respectively.  
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Table 4-1: Excitation and emission wavelengths for the green, orange, red, and yellow channels of the 
Corbett Rotor Gene 6000 
Channel Excitation (nm) Emission (nm) 
Green (FAM) 470 510 
Orange (ROX) 585 610 
Red (CY5) 625 660 
Yellow (HEX) 530 555 
 
 
4.2.1 Detection of calcein fluorescence in qPCR reactions  
To determine whether the fluorescence emitted by calcein in a diluted solution was 
detected by the Corbett apparatus, a 1 mM calcein-AM stock was diluted to a concentration 
of 40 μM in dH2O. Fluorescence was subsequently measured using the Corbett under the 
thermal conditions described above.  
To determine whether fluorescence in DO subjected to a GJ assay (i.e. exposed to calcein-
AM) was detectable by the Corbett apparatus, COC were extracted and included in a routine 
GJ assay. In brief, COC were incubated with incubation media supplemented with 50 μM 
dipyridamole and 50 μM rolipram and in the absence (control) or presence (treated) of 2 μM 
calcein-AM for 10 minutes. The COC were then transferred into calcein-AM free incubation 
media containing 50 μM dipyridamole and 50 μM rolipram and incubated for a further 4 
hours. The CC were removed from the oocyte and fluorescence was measured within each 
individual oocyte as described previously (see Section 2.1.3). The oocytes were stored at -80 
°C until further use. To determine whether fluorescence from the calcein is detected in cDNA 
of oocytes that were previously subjected to the GJ assay procedure, RNA was extracted 
from some of the oocytes collected in the previous experiment and cDNA synthesised. 
Fluorescence was detected using the Corbett under the thermal conditions described 
previously.  
4.2.2 Correlation of Rpl19 CT value to CC number and oocyte diameter 
To test the relationship between CC number and Rpl19 expression levels, COC were 
extracted from ovaries into PBS as described previously. The oocytes were stripped of the CC 
by vigorous pipetting and the oocytes were discarded from the resulting cell suspension. The 
number of CC/mL was determined by counting the CC under an inverted microscope using a 
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haemocytometer and Trypan blue stain (Section 2.1.5). The CC were serially diluted in 
triplicate, and stored at -80 °C prior to extraction of total RNA and synthesis into cDNA. The 
level of Rpl19 mRNA was ascertained in each sample in duplicate using TaqMan qPCR.  
To test the relationship between oocyte diameter and Rpl19 expression levels, oocytes with 
no CC contamination were selected from the experiment in Section 4.2.3. The diameter of 
each oocyte was measured, and this was compared to the level of Rpl19 mRNA measured 
using multiplex TaqMan qPCR. 
4.2.3 Effect of calcein/calcein-AM on expression of candidate genes 
To test whether exposure to calcein-AM during the GJ assay affects the expression levels of 
the candidate genes, a GJ assay was performed in which the COC were, or were not, exposed 
to calcein-AM. The COC were extracted from ovaries as described previously, and incubated 
either for 0, 4, 12, or 24 hours in incubation media containing 50 μM dipyridamole and 50 
μM rolipram. The COC were further incubated for 10 minutes in the aforementioned 
incubation media in the absence (control) or presence (treated) of 2 μM calcein-AM. The 
COC were transferred into fresh incubation media (same as above) but without calcein-AM 
and incubated for a further 1 hour. The oocyte was denuded of CC, and oocyte fluorescence 
was measured as described previously. Individual CC masses and DO were collected 
separately in PBS and stored at -80 °C until further use. 
Total RNA was extracted from the thawed CC and oocyte samples, and cDNA was 
synthesised as previously described (see Section 2.3.1). Multiplex TaqMan qPCR was 
performed to determine the mRNA levels of the following sets of genes: Atr, Cycs, Glut1 and 
Rpl19 in DO and CC separately; Cx43, Gfpt1, Pfkp and Rpl19 in CC; and Gdf9, Bmp15, Cx37 
and Rpl19 in DO. The data were analysed using the 2-(ΔΔCT) method (Section 2.3.5; Livak and 
Schmittgen, 2001). As discussed herein, CC-derived genes were corrected for the reference 
gene Rpl19 to give gene expression relative to input, while oocyte-derived genes were 
corrected to an internal calibrator control to give total gene expression in a single oocyte. 
The relative linear mRNA levels were analysed for normality using the D'Agostino & Pearson 
normality test. Data that were not normally-distributed were transformed (natural log, 
1(y+1), or square root(y+0.5) transformations) and reanalysed using the D'Agostino & 
Pearson normality test to confirm a normal distribution. Normally-distributed data were 
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analysed by a two-way ANOVA. In cases where data were not normally-distributed after all 
transformation options were exhausted, the data were ranked and a two-way ANOVA was 
performed on the ranked values.  
4.3 Results 
4.3.1 Detection of calcein fluorescence  
The fluorescence levels detected in a 40 μM calcein-AM solution is shown in Figure 4-1. 
Fluorescence was detected at very high levels on the green channel but was not detected 
above baseline levels on the orange, red, or yellow channels.  
 
Green 
Orange   Red Yellow 
 
Figure 4-1: Detection of fluorescence in a 40 μM calcein-AM solution over 40 cycles. The red lines show, in 
duplicate, the fluorescence measured on each channel in the calcein-AM solution.   
 
The fluorescence levels detected in the lysate of individual oocytes that had been incubated 
in the absence or presence of calcein-AM is shown in Figure 4-2. Fluorescence was not 
detected above the baseline levels on any channel in either the control or treated oocytes.  
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Green Orange 
Red Yellow 
Figure 4-2: Detection of fluorescence in DO that had been incubated with and without calcein over 40 cycles. 
The blue lines show, in duplicate, a pool of DO that had not been treated with calcein (N=1). The green lines 
show, in duplicate, the DO that had been treated with calcein (N=8).  
 
The fluorescence levels detected in cDNA of DO that had been incubated in the absence or 
presence of calcein-AM is shown in Figure 4-3. Fluorescence was not detected above 
baseline levels on any channel for cDNA from either the control or treated oocytes.  
 
Green Orange 
Red Yellow 
Figure 4-3: Detection of fluorescence in cDNA samples of oocytes that had been incubated with and without 
calcein over 40 cycles. The purple lines show, in duplicate, cDNA from oocytes that were not treated with 
calcein (N=3). The blue lines show, in duplicate, cDNA from oocytes that were treated with calcein (N=5).  
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4.3.2 Correlation of Rpl19 CT value to CC number and oocyte diameter 
CC were collected, counted, and serially diluted to determine the relationship between CC 
number and Rpl19 expression levels as denoted by CT values. This is depicted in Figure 4-4A. 
Expression levels of Rpl19 were highly correlated to the number of CC. The minimum 
number of cells required to measure Rpl19 (i.e. the CT value at the upper sensitivity limit = 
30) was 900. 
The relationship between oocyte diameter and Rpl19 expression levels as denoted by CT 
values is shown in Figure 4-4B. There was no relationship between oocyte diameter and 
Rpl19 expression levels. The average oocyte diameter was 74 μM (range 58–95 μM).  
 
 
Figure 4-4: Correlation between Rpl19 CT value and CC number (A) or oocyte diameter (B). CC were serially 
diluted and the Rpl19 levels were measured using TaqMan qPCR. The Rpl19 mRNA levels in single oocytes were 
measured using TaqMan qPCR and compared to the diameter of each oocyte. 
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4.3.3 Effect of calcein on gene expression 
The effect of calcein-AM treatment with time on expression of the reference gene Rpl19 in 
DO and CC masses is shown in Figure 4-5. The average number of CC collected from each 
COC was 1495 (range 988–2397). Levels of Rpl19 mRNA in the oocyte and CC decreased over 
time in both the untreated and calcein-AM treated groups. No effect of calcein-AM 
treatment was measured for Rpl19 mRNA levels in the oocyte or the CC. A treatment x time 
interaction effect for Rpl19 mRNA levels in CC, but not oocytes, approached significance 
(P=0.058).  
Some of the oocyte samples were contaminated with CC due to improper denuding 
technique. When those oocytes that had >5 CC attached were excluded from the analysis, 
the effect of time on Rpl19 levels remained (P<0.05), but no treatment or treatment x time 
interaction effects were noted.  
For future gene expression studies only the 1 and 25 hour incubation times were used. 
When the 5 and 13 hour times were excluded from the analysis of Rpl19 levels in the oocyte, 
the effect of time remained (P<0.0001) and no effects due to treatment or a treatment x 
time interaction were observed. When the 5 and 13 hour times were excluded from the 
analysis of Rpl19 levels in the CC, a treatment x time interaction effect was measured 
(P<0.01) but no effects of treatment or time were observed.  
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Figure 4-5: Effect of calcein-AM with time on Rpl19 expression levels in oocytes (A) and CC (B). The incubation 
time indicates the pre-calcein incubation + the 1 hour post-calcein incubation. The control (i.e. not exposed to 
calcein-AM) is represented by the unfilled bars ( ), while the calcein-AM treated group is represented by 
the hatched bars ( ). As the reference gene is present in all gene sets, the mRNA value of Rpl19 for each 
oocyte sample was an average from the two oocyte gene quadriplex sets (Atr/ Cycs/Glut1/Rpl19 and 
Gdf9/Bmp1/Cx37/Rpl19). The mRNA value of Rpl19 for each CC sample was an average from the two CC gene 
quadriplex sets (Atr/ Cycs/Glut1/Rpl19 and Cx43/ Gfpt1/Pfkp/Rpl19). Values are shown as means ± SEM 
analysed from linearised gene expression values normalised against the mean of the control group at 1 hour, 
which had a mean of 1. The data represent 6-15 individual samples in each group generated from 3 replicate 
experiments. A two-way ANOVA was performed on natural log-transformed data. 
 
The effects of calcein-AM treatment on the expression levels of candidate genes of interest 
for the oocyte (i.e. Atr, Gdf9, Bmp15, and Cx37) are shown in Figure 4-6. Oocyte-derived 
expression levels of Cycs and Glut1 were also tested, but were below the detectable limit. A 
significant effect of time was observed for Atr mRNA levels, with Atr levels decreasing over 
time in both the control and calcein-AM treated oocytes. No effect of calcein-AM treatment 
was observed for Atr mRNA levels. A significant effect of time was observed for Bmp15 levels 
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in rat oocytes. Overall Bmp15 mRNA levels decreased over time. Bmp15 levels were similar 
between the control and calcein-AM treated groups at all time points except at 13 hours. At 
13 hours, the level of Bmp15 was reduced in the control oocytes but was unchanged in the 
calcein-AM treated oocytes. However, no effect of calcein-AM treatment on Bmp15 levels in 
rat oocytes was observed. Cx37 mRNA levels in rat oocytes were significantly affected by 
both treatment and time. Cx37 mRNA was reduced in the control oocytes after 13 and 25 
hours, however this decrease was not observed in the calcein-AM treated oocytes. 
Significant time and calcein-AM treatment effects were observed for Gdf9 mRNA levels in rat 
oocytes. Gdf9 mRNA was decreased after 13 and 25 hours in the control group, however this 
decrease was not observed in the calcein-AM treated group.  
For most future gene expression studies, only the 1 and 25 hour incubation times were 
included. Therefore, the data were reanalysed with the 5 and 13 hour time points excluded. 
When only the 1 and 25 hour time points were included from the Atr analysis, both 
treatment (P<0.05) and time effects (P<0.0001) were observed. Expression levels of Atr 
mRNA were decreased at 25 hours, compared to 1 hour, in both the control and calcein-AM 
treated oocytes. In addition, Atr mRNA was lower in the calcein-AM treated oocytes 
compared to the control oocytes at both time points. No treatment, time, or treatment x 
time interaction effects were observed for Bmp15 levels. Time effects (P<0.01) were noted 
for Cx37 and Gdf9 levels (P<0.01 and 0.05 respectively), but no treatment or treatment x 
time interaction effects were measured. Cx37 and Gdf9 mRNA levels were decreased over 
time in the control oocytes and, to a lesser extent, in the calcein-AM treated oocytes. These 
results are summarised in Table 4-2.  
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Figure 4-6: Effect of calcein-AM with time on mRNA levels of Atr (A), Bmp15 (B), Cx37 (C), Gdf9 (D) in rat 
oocytes. The incubation time indicates the pre-calcein incubation + the 1 hour post-calcein incubation. The 
control is represented by the unfilled bars ( ), while the calcein-AM treated group is represented by the 
hatched bars ( ). Values are shown as means ± SEM analysed from linearised gene expression values 
normalised against the mean of the control group at 1 hour, which has a value of 1. The data represent 7-16 
readings from individual oocytes in each group generated from 3 replicate experiments. B, C, and D were 
transformed (1/y+1) and A was not transformed prior to analysis by a two-way ANOVA.  
 
Table 4-2: Summary of calcein-AM treatment, time, and interaction effects on mRNA levels of candidate 
genes in rat oocytes. Genes are ordered from most abundant to least abundant.  
Gene Abundance 
relative to 
Rpl19 
All time points 1 and 25 hours only 
Treatment 
effect 
 
Time effect Treatment 
x  Time 
effect 
Treatment 
effect 
 
Time effect Treatment 
x Time 
effect 
Gdf9 7.93 ± 0.36 P<0.05 P<0.01 - - P<0.05 - 
Cx37 7.80 ± 0.61 P<0.01 P<0.05 - - P<0.01 - 
Bmp15 1.62 ± 0.08 - P<0.05 - - - - 
Atr 0.35 ± 0.02 - P<0.05 - P<0.05 P<0.0001 - 
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The effects of calcein-AM treatment on the expression levels of candidate genes of interest 
for the CC (i.e. Atr, Cycs, Cx43, Gfpt1, and Pfkp) are shown in Figure 4-7. Significant 
treatment x time interaction and time effects were observed for Atr mRNA levels in rat CC.  
The mean Atr mRNA levels were more variable in the calcein-AM group as evidenced from 
the SEM. In the control group, Atr mRNA in CC declined progressively after the 5 hour 
incubation whereas this decline wasn't evident in the calcein-AM treated CC until the 25 
hour time point. A significant effect of time was observed for Cx43 levels in rat CC. Cx43 
mRNA levels were markedly reduced from 5 hours onwards in both the control and calcein-
AM treated CC. No effect of calcein-AM treatment was observed for Cx43 expression. 
Significant treatment, time and treatment x time interaction effects were observed for Cycs 
levels in rat CC. Cycs mRNA levels had decreased from 5 hours onwards in the control CC, 
however levels in the calcein-AM treated CC did not decrease until 25 hours. The mean Cycs 
mRNA levels were consistently higher in the calcein-AM treated CC, compared to the control 
CC, at 5, 13, and 25 hours. Significant treatment, time and treatment x time interaction 
effects were observed for Gfpt1 mRNA levels in rat CC. The mean Gfpt1 levels had declined 
from 5 hours and remained low thereafter in the control CC, However, in the calcein-AM 
treated CC, the mean mRNA levels appeared to be different with a decrease noted at 5 
hours but not at 13 or 25 hours. A significant effect of time was observed for Pfkp mRNA 
levels in rat CC. Pfkp mRNA was markedly decreased from 5 hours onwards in both the 
control and the calcein-AM treated CC. No effect of calcein-AM treatment on Pfkp levels was 
observed.  
A further re-evaluation of these data for CC gene expression was undertaken using only the 
1 and 25 hour data sets as it seemed that the effects of calcein-AM had their major 
interactive effects at the 5 and 13 hour time points. When this restricted data set was 
analysed for Atr, a significant effect of time (P<0.05) but no treatment or time x treatment 
interaction effects were observed. For Cx43, Cycs, and Pfkp, significant effects of time (all 
genes, P<0.0001) but no treatment or time x treatment interaction effects were found. 
However, for Gfpt1, there were significant effects of time (P<0.0001), treatment (P<0.05) 
and a treatment x time interaction (P<0.01). These results are summarised in Table 4-3. 
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Figure 4-7: Effect of calcein-AM with time on mRNA levels of Atr (A), Cx43 (B), Cycs (C), Gfpt1 (D), and Pfkp (E) 
in rat CC. The incubation time indicates the pre-calcein incubation + the 1 hour post-calcein incubation. The 
control is represented by the unfilled bars ( ), while the calcein-AM treated group is represented by the 
hatched bars ( ). Values are shown as means ± SEM analysed from linearised gene expression values 
normalised against the mean of the control group at 1 hour, which has a value of 1. The data represent 9-16 
readings from individual oocytes in each group generated from 3 replicate experiments. C was transformed 
(square root(y+0.5)) and E was transformed (natural log) prior to analysis by a two-way ANOVA. A, B and D 
were ranked and a two-way ANOVA was performed on the ranked data.  
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Table 4-3: Summary of calcein-AM treatment, time, and interaction effects on mRNA levels of candidate 
genes in rat CC. Genes are ordered from most abundant to least abundant. 
Gene Abundance 
relative to 
Rpl19 
All time points 1 and 25 hours only 
Treatment 
effect 
 
Time effect Treatment 
x  Time 
effect 
Treatment 
effect 
 
Time effect Treatment 
x Time 
effect 
Cx43 2.231 ± 0.31 - P<0.0001 - - P<0.0001 - 
Pfkp 0.178 ± 0.02 - P<0.0001 - - P<0.0001 - 
Cycs 0.068 ± 0.004 P<0.0001 P<0.0001 P<0.0001 - P<0.0001 - 
Gfpt1 0.056 ± 0.01 P<0.01 P<0.0001 P<0.01 P<0.05 P<0.0001 P<0.01 
Atr 0.047 ± 0.005 - P<0.01 P<0.05 - P<0.05 - 
 
 
4.4 Discussion 
Fluorescence was detected on the green channel in the sample of diluted calcein-AM 
solution, indicating that the thermal cycling caused the removal of the acetoxymethyl group 
resulting in activation of fluorescence. However, fluorescence was not detected in the lysate 
of oocytes from COC that had been treated with calcein-AM suggesting that residual calcein 
contained within the oocytes is at undetectable concentrations. Similarly, no fluorescence 
was detected in cDNA from oocytes that had been treated with calcein-AM. These results 
demonstrate that residual calcein fluorescence in oocytes is unlikely to add to or interfere 
with the fluorescence emitted from any of the TaqMan probes during qPCR reactions.  
In this study, the incubation times of 1, 5, 13, and 25 hours differed in the lengths of time 
COC are incubated before exposure to calcein-AM (i.e. 0, 4, 12, or 24 hours respectively). 
However, thereafter the time that COC are exposed to calcein-AM (i.e. 10 minutes) and the 
subsequent calcein-AM free interval (i.e. 1 hour) were identical for all samples. While it 
might be expected that exposure to calcein-AM would affect gene expression in a similar 
manner across all time points, it is also possible that since the functions of individual COC 
after isolation are so variable, they are much more sensitive to calcein-AM effects over the 
first 13 hours of incubation. As a consequence of this variability, most future gene 
expression studies after calcein-AM treatment were limited to the 1 and 25 hour time 
points.  
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The reference gene (Rpl19) used in this study is a component of the ribosome 60S subunit, 
and is a commonly used reference gene in CC and GC (Dragovic et al., 2006; Feuerstein et al., 
2007; Su et al., 2008). Selection of a stable reference gene that is expressed at similar levels 
to the candidate genes and is not affected by experimental conditions is essential. Two other 
reference genes commonly used for COC are Gadph and 18s RNA. These were not 
considered for the current study as Gapdh levels are affected by oestrogens (Diel et al., 
2000), and therefore would not be suitable when testing compounds with oestrogenic 
activity such as BPA, while 18s RNA is very highly expressed and therefore would not provide 
a good comparison for the candidate genes selected for this study. This current study 
revealed that Rpl19 is strongly correlated to CC number (P<0.0001). All of the CC-derived 
candidate genes were corrected for Rpl19 to remove potentially large amounts of variability 
in CC-derived candidate gene expression as a result of differences in CC number. The 
exposure of COC to the fluorescent dye calcein-AM used in the GJ assay did not directly 
affect expression of Rpl19 in rat CC, when all incubation times were taken into account. 
While, Rpl19 levels declined with time this was likely due to reduced CC number as COC 
diameter was significantly reduced at 13 and 25 hours, compared to at 1 hour (P<0.01; 
Kruskal-Wallis test). Therefore, Rpl19 is a suitable reference gene for rat CC.  
Interestingly, Rpl19 gene expression levels were not correlated to oocyte size. None of the 
oocyte genes were corrected for Rpl19, but were instead corrected for a calibrator control 
sample. Thus for the oocyte genes, mRNA levels were calculated as expression levels in each 
single DO. Although oocyte-derived candidate genes were not corrected for a reference 
gene, Rpl19 was measured in all future DO samples, as levels below the detectable level 
suggested that the RNA extraction was unsuccessful. DO samples that had an Rpl19 CT value 
>30 were excluded for this reason.  
The exposure of COC to the fluorescent dye calcein-AM used in the GJ assay did not directly 
affect expression of Rpl19 in rat CC or DO, when all incubation times were taken into 
account. Thus, we conclude that treatment with calcein-AM does not inhibit or interfere 
with the RNA extraction and cDNA synthesis procedures.  
When analysing only the 1 and 25 hour time points, there was no effect of calcein-AM 
treatment on levels of Rpl19 mRNA in the oocyte. However, a treatment x time interaction 
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was noted for Rpl19 levels in CC. These levels were increased in the calcein-AM treated CC at 
1 hour, but were at similar levels to the control CC at 25 hours. It is unlikely that this 
difference in Rpl19 was a direct result of calcein-AM exposure but rather was due to a 
difference in the number of CC collected. Indeed, when reviewing the pictures that were 
taken of each individual COC, those that were collected in the calcein-AM treated group at 1 
hour had noticeably more CC than those in the untreated group.  
When all of the time points were included in the analyses of the effects of calcein-AM on 
oocyte-derived genes, a treatment effect was observed for two genes (Cx37 and Gdf9). 
Interestingly, Cx37 and Gdf9 were the most abundant genes measured in the oocyte. When 
only the 1 and 25 hour time points were included in the analysis, no treatment effects on 
Cx37 and Gdf9 were observed. In fact, including the 1, 5, and 25 hour time points (i.e. 
excluding the 13 hour time point) also removes the treatment effect. These results indicate 
that the difference in the levels of these genes between the calcein-AM treated and control 
groups at 13 hours contribute disproportionately to the treatment effect observed when all 
the time points were analysed. After 13 hours of incubation, the expression of Cx37 and 
Gdf9 may be particularly sensitive to perturbations. In the control oocytes, both Cx37 and 
Gdf9 were reduced at 13 hours however, calcein-AM may influence this reduction in gene 
expression.  
When only the 1 and 25 hour time points were included in the analyses of the effects of 
calcein-AM on oocyte-derived genes, a treatment effect was observed for Atr. The gene Atr 
was the least abundant of all the oocyte genes measured in this study. Oocyte-derived Atr 
was reduced in the calcein-AM treated group compared to the control group. The effect of 
calcein-AM treatment on oocyte Atr levels was the same at both time points. In addition, the 
expression levels of Atr were closely related to the levels of Rpl19, especially at 1 hour, 
indicating this effect may have been due to differences in RNA input. The effect of calcein-
AM on Atr mRNA levels in the oocyte may be related to the function of ATR as a DNA 
damage sensor and regulator of meiosis. The down-regulation of Atr levels in calcein-AM 
treated oocytes indicate that calcein-AM may protect against DNA damage, resulting in a 
reduced requirement for ATR, or that calcein-AM prevents the oocyte from responding to 
DNA damage by reducing Atr expression. Either way, this effect of calcein-AM may mask any 
potential effects of lifestyle factors on Atr levels and the DNA damage pathway. It is possible 
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that calcein-AM exposure simply reduces the baseline level of Atr in oocytes, however any 
interpretations of Atr levels will be treated with caution in future experiments.  
When all of the time points were included in the analyses of the effects of calcein-AM on CC-
derived genes, a treatment effect was observed for two CC-derived genes (Cycs and Gfpt1) 
while a treatment x time interaction was noted for three of the genes (Atr, Cycs and Gfpt1). 
The genes Atr, Cycs and Gfpt1 were the least abundant of all the genes measured in the CC. 
When only the 1 and 25 hour time points were analysed, the treatment effect was not 
observed for Cycs and no treatment x time interaction effects were noted for Atr or Cycs. 
The Atr mRNA levels reduced over time, and this reduction began after 13 hours. However, 
calcein-AM exposure appeared to delay the reduction in Atr expression, resulting in a large 
difference in levels between the calcein-AM treated and control groups at 13 hours. The 
Cycs and Gfpt1 levels were also reduced over time in the control CC from 5 hours onwards. 
However, calcein-AM treatment appeared to delay the reduction in Cycs levels until 25 
hours. This resulted in large differences in the levels of Cycs mRNA between the calcein-AM 
treated and control CC at 5 and 13 hours. The Gfpt1 levels in the calcein-AM treated CC were 
similar to the control at 5 hours, but were significantly upregulated at 13 and 25 hours.  
When only the 1 and 25 hour time points were included in the analyses of calcein-AM on CC 
gene expression, treatment and treatment x time interaction effects were only observed for 
one gene (Gfpt1). CC-derived Gfpt1 was increased in the calcein-AM treated group at 25 
hours, but not at 1 hour. This treatment x time interaction effect is of particular concern, as 
it indicates that the effect of calcein-AM on Gfpt1 expression is inconsistent over time. These 
results suggest that flux through the hexosamine biosynthetic pathway is upregulated at 25 
hours in calcein-AM treated CC. Thus, the interpretation of CC-derived Gfpt1 expression 
levels over time in COC subjected to the GJ assay will be treated with caution. 
The ability to compare directly the degree of the GJ communication (as determined by the 
GJ assay) and the expression levels of genes thought to be involved in maintenance of 
oocyte health is a very powerful tool.  This study concludes that despite a few small and 
transitory differences in expression levels of a couple of genes following the exposure of COC 
to calcein-AM, it would be acceptable to measure gene expression levels by multiplex qPCR 
in CC and oocytes from COC that were subjected to the GJ assay. However, when gene 
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expression is measured at 1, 5, 13, and 25 hours, caution must be taken when interpreting 
the changes in mRNA levels of oocyte-derived Cx37 and Gdf9 and CC-derived Atr, Cycs, and 
Gfpt1 due to the effects of calcein-AM exposure on expression of these genes. In addition, 
when gene expression is measured at 1 and 25 hours, the levels of oocyte-derived Atr and 
CC-derived Gfpt1 must also be interpreted carefully.  
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5 EFFECT OF TIME IN CULTURE ON COC HEALTH 
5.1 Introduction 
Removal of the COC from the follicle, and subsequent in vitro culture can have a significant 
impact on COC health. As described previously, aspiration of the COC from the follicular 
environment results in the progression of meiosis within the oocyte (Wert and Larsen, 1989). 
Additionally, the communication network comprised of GJs appears to undergo dynamic 
changes following the removal of COC from the follicle. For example, GJ communication in 
bovine COC decreased progressively over 21 hours in vitro (Thomas et al., 2004). However, in 
porcine COC, GJ communication increased over the first 18 hours of culture, before declining 
at 24 hours and then remaining unchanged for 24 hours thereafter (Sasseville et al., 2009a). 
Thus, species differences exist in the impact of removing the COC from its follicular 
environment. 
Alterations in GJ communication within the COC would be expected to be associated with 
molecular and metabolic changes in both the CC and oocyte. Expression of Gdf9 and Bmp15 
mRNA transcripts were reduced in rat DO that had been co-cultured with GC for 24 hours 
(Lin et al., 2012). Utilization of radioactively labelled glucose ([5-3H] glucose) was observed to 
increase during IVM of bovine COC over 24 hours (Steeves and Gardner, 1999). Moreover, 
bovine CC that were isolated from COC that underwent IVM had a two-fold increase in cell 
death, along with increased expression levels of genes involved in apoptosis, compared with 
COC that were matured in vivo. Furthermore, COC that underwent IVM compared with those 
matured in vivo had augmented activation of the TGFβ and MAPK signalling pathways and 
increased mRNA and protein levels of hyaluronan synthase 2, which is responsible for the 
synthesis of hyaluronic acid for CC expansion (Salhab et al., 2012). Therefore, while there is 
some evidence that the removal of the COC from the follicle and its subsequent incubation 
in vitro can have marked changes in cell-to-cell communication, gene expression levels and 
metabolic activity in COC of some species, there is little information regarding these changes 
in the rat.  
The aim of this chapter was to determine the impact of incubation time on the health of rat 
COC in this study. Specifically, the changes in GJ communication, candidate gene expression 
(oocyte-derived Atr, Bmp15, Cx37, and Gdf9 and CC-derived Atr, Cx43, Cycs, Gfpt1, and Pfkp) 
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and protein expression levels (oocyte-derived GDF9 and CC-derived CX43) in COC that had 
been incubated for varying amounts of time were investigated.  
5.2 Methods 
5.2.1 Effect of time on GJ communication 
Ovaries were extracted into dissection media supplemented with 50 μM dipyridamole and 
50 μM rolipram, and the COC were recovered and transferred into a 48-well plate as 
described previously (section 2.1.1 and 2.1.2). The COC were washed twice in wash media 
containing 50 μM dipyridamole and 50 μM rolipram. The COC were then incubated for 0, 4, 
12, or 24 hours in incubation media containing 50 μM dipyridamole and 50 μM rolipram. The 
COC were exposed to 2 μM calcein-AM for 10 minutes before being incubated for a further 
hour in fresh incubation media (calcein-AM free) containing 50 μM dipyridamole and 50 μM 
rolipram. The COC were transferred into incubation media free of PDE inhibitors where the 
oocyte was denuded and then fluorescence was measured. The oocytes and separate CC 
masses were then stored at -80 °C until further processing for RNA extraction. The oocyte 
fluorescence for each individual sample was corrected for the geometric mean of that at 1 
hour. The relative fluorescent levels were analysed by a Kruskal-Wallis test, and where a 
significant difference was observed, a Dunn’s multiple comparison post hoc test was 
performed.  
5.2.2 Effect of time on mRNA levels 
Total RNA was extracted from the DO and CC samples from the GJ bioassay and synthesised 
into cDNA as previously described (Section 2.3.1). Three quadriplex qPCR reactions were 
used to measure expression of candidate gene in CC and/or DO. The candidate genes were 
as follows: CC expression of Cx43, Gfpt1 and Pfkp; oocyte expression of Bmp15, Cx37 and 
Gdf9; and both oocyte and CC expression of Atr, Cycs and Glut1. The reference gene Rpl19 
was included in each of qPCR multiplexes. The expression of each gene in each sample was 
measured in duplicate. Relative levels of mRNA were calculated as described previously 
(Section 2.3.5). Expression levels of CC genes were corrected for Rpl19, enabling candidate 
gene expression to be standardized relative to CC number. Expression levels of oocyte genes 
were corrected for an internal calibrator control, giving total candidate gene expression per 
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oocyte. These data were analysed by a Kruskal-Wallis test. Where significant differences 
were measured, a Dunn’s multiple comparison post-hoc test was performed.  
5.2.3 Effect of time on protein expression 
Ovaries were extracted into dissection media supplemented with 50 μM dipyridamole and 
50 μM rolipram, and the COC were recovered and transferred into a 48-well plate as 
described previously. The COC were transferred into incubation media containing 50 μM 
dipyridamole and 50 μM rolipram and incubated for 1, 5, 13 or 25 hours. These incubation 
times were chosen to reflect the total incubation period during the GJ assay (i.e. 4 hours 
incubation plus 1 hour post-calcein incubation). The COC were washed twice in PBS and 
were collected into a microcentrifuge tube (100 COC/tube). The COC were pelleted by 
centrifugation and were resuspended in 15 μL PBS containing proteinase inhibitors. A total 
of 200 COC were collected per group, comprising of pooled samples from two collection 
days. 
A 10 μL aliquot (the equivalent of ~67 COC) of each pool of COC was taken and analysed for 
protein concentration using the BCA assay as previously described (Section 2.4.1). Briefly, 
BCA reagent was added to each sample in a 96-well plate, the plate was incubated at 60 °C 
for 2 hours, and the absorbance at 490 nm was measured. The total protein content was 
calculated by comparing against the 490 nm absorbance values of a bovine serum albumin 
standard curve. The remaining 20 μL aliquot (the equivalent of ~133 COC) was analysed for 
the expression of CX43 and GDF9 proteins using Western blotting as described in Section 
2.4. To determine band specificity, the blot was also incubated with either the CX43 or GDF9 
specific antibodies pre-absorbed with the appropriate control peptide or recombinant 
protein.  
Band densities were analysed using the ImageJ software. For the CX43 blots, the density of 
the 43 kDa band was measured. For the GDF9 blots, the densities of the 49 kDa promature 
and, when present, the 20 kDa mature bands were measured. When multiple bands were 
unresolved (e.g. when doublet or triplet bands were present for CX43) the density of all 
bands was measured. The band densities for CX43 protein were corrected for total protein 
amount, as determined by the BCA assay. The band densities for GDF9 protein were 
uncorrected to give total GDF9 protein expressed by a known number of oocytes.  
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5.3 Results 
5.3.1 Effect of time on GJ communication 
The effect of increasing incubation time on GJ communication in rat COC is depicted in 
Figure 5-1. Oocyte fluorescence was increased at 5, 19, or 25 hours, compared to that at 1 
hour. The proportion of oocytes with a visible GV progressively and significantly decreased 
over time, with all oocytes containing a GV at 1 hour, but only 44 % of oocytes containing a 
GV after 25 hours (Table 5-1).  
 
 
Figure 5-1: Effect of incubation time on fluorescent dye transfer from adjacent CC to oocytes. The incubation 
time indicates the pre-calcein incubation + the 1 hour post-calcein incubation. Values are shown as geometric 
means ± 95 % confidence intervals of fluorescent ratios normalised against the geometric mean of the 1 
control. The data represent 16-17 readings from individual oocytes at each time generated from 3 replicate 
experiments. The data were analysed using the Kruskal-Wallis test, and where significant differences were 
observed, a Dunn’s multiple comparison post-hoc test was performed. Groups that do not share a letter are 
significantly different (P<0.05).The mean ± SEM fluorescent reading at 1 hour was 357 ± 28. 
 
Table 5-1: Effect of selected incubation times on the proportion of oocytes with a visible GV. The table shows 
the proportion (%) of oocytes with a visible GV, with the actual number of oocytes with a GV in brackets.  The 
data from 3 replicate experiments (N=16-17) was analysed by a Fisher’s exact test. Groups that do not share a 
letter are significantly different from one another (P<0.05).  
Time (hours) % GV oocytes 
1 100a (16) 
5 88ab (14) 
13 56bc (9) 
25 44c (7) 
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5.3.2 Effect of time on mRNA levels in rat oocytes and CC 
The effect of increasing incubation time on mRNA levels in cultured rat oocytes is depicted in 
Figure 5-2. It appeared that levels of Atr mRNA in oocytes declined progressively after 1 
hour, and were significantly lower (P<0.05) at 25 hours. Conversely, the expression levels of 
Bmp15, Cx37, and Gdf9 mRNA in oocytes did not change over time. Oocyte-derived Rpl19 
mRNA levels remained unchanged at 5 hours, compared to 1 hour, but appeared to decline 
at 13 and 25 hours, however this was not significant. Oocyte-derived Cycs and Glut1 mRNA 
levels were below the detection limit.  
The effect of increasing incubation time on mRNA levels in cultured rat CC is depicted in 
Figure 5-3. The levels of Atr mRNA in CC had increased by 13 hours, compared to 1 hour 
(P<0.05), in culture but this effect had dissipated by 25 hours. The levels of Cx43 mRNA in CC 
were clearly reduced (P<0.0001) at 5 and 13 hours, compared to that at 1 hour, and 
remained low after 25 hours. Two samples at 25 hours contained relative Cx43 levels of 1.29 
and 1.19 (compared to relative levels of 0.013-0.678 in the other CC samples) and these 
samples masked the clear reduction in Cx43 mRNA levels at this time point during the 
statistical analysis. However, these samples were not excluded from the analysis, as the 
Rpl19 CT values were well within the sensitive range. The levels of Cycs mRNA remained 
constant until 25 hours, at which time they had significantly declined (P<.05). The levels of 
Gfpt1 mRNA in CC increased between 5 and 13 hours (P<0.01), but this effect was 
attenuated by 25 hours. The levels of Pfkp mRNA were markedly reduced (P<0.01) at all time 
points, compared to 1 hour. Similar to that observed in the oocyte, Rpl19 mRNA levels 
declined with time, with a significant difference at 13 and 25 hours compared to 1 hour 
(P<0.05 for both time points). CC-derived Glut1 mRNA levels were below the detection limit.  
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Figure 5-2: Effect of incubation time on mRNA levels of Atr (A), Bmp15 (B), Cx37 (C), Gdf9 (D), and Rpl19 (E) in 
rat oocytes. Values are shown as means ± upper/lower limit of linearised CT values normalised against the 
mean of that at 1 hour. The data represent 7-16 readings from individual oocytes in each group generated from 
3 replicate experiments. The data were analysed using the Kruskal-Wallis test, and where significant differences 
were observed, a Dunn’s multiple comparison post-hoc test was performed. For Atr levels groups that do not 
share a letter are significantly different (P<0.05). No significant effects of time on Bmp15, Cx37, Gdf9, or Rpl19 
levels were noted.  
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Figure 5-3: Effect of incubation time on mRNA levels of Atr (A), Cx43 (B), Cycs (C), Gfpt1 (D), Pfkp (E), and 
Rpl19 (F) in rat CC masses. Values are shown as means ± upper/lower limit of linearised CT values normalised 
against the mean of that at 1 hour. The data represent 7-16 readings from individual CC masses in each group 
generated from 3 replicate experiments. The data were analysed using the Kruskal-Wallis test, and where 
significant differences were observed, a Dunn’s multiple comparison post-hoc test was performed. In all 
graphs, groups that do not share a letter are significantly different (P<0.05).  
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The relationship between oocyte fluorescence and expression levels of Cx43 and Cx37 
mRNA, as denoted by CT values, in each individual sample is shown in Figure 5-4. There was a 
very weak relationship between oocyte fluorescence and Cx43 expression levels. Oocytes 
with higher fluorescence readings tended to be associated with CC with lower Cx43 mRNA 
levels (high CT value). No relationship was observed between oocyte fluorescence and 
expression levels of Cx37 mRNA (denoted by CT values).  
 
 
Figure 5-4: Correlation between oocyte fluorescence values and CT values for Cx43 (A) and Cx37 (B).  
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5.3.3 Effect of time on protein levels 
The effect of increasing incubation time on CX43 protein expression in rat COC in culture is 
depicted in Figure 5-5. Multiple bands were detected in the positive control of both 
replicates, while no bands were observed in the negative control. A band corresponding to 
the size of CX43 protein (i.e. 43 kDa) was detected in the positive control of the first 
replicate (Figure 5-5A), along with unidentified bands around 65 and 22 kDa in size. In the 
second replicate, a 43 kDa band was not detected in the positive control (Figure 5-5B). In 
contrast to the COC lysates from the second replicate where only a 43 kDa band was 
observed, an additional strong unidentified 22 kDa band was observed in the COC lysate 
from the first replicate. Following stripping of the blot and re-probing with the CX43 
antibody that had been pre-absorbed with the control peptide, the bands that had 
previously been visualised were not apparent (Figure 5-5C).  
In comparison with that in COC after 1 hour in culture, the corrected CX43 protein levels 
appeared to be slightly reduced at 5 hours (Figure 5-6), markedly increased at 13 hours (~3 
fold higher) and slightly increased at 25 hours (1-2.5 fold higher). There was a large 
variability in CX43 protein levels between replicates at 25 hours.  
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Figure 5-5: The in vitro effect of incubation time on CX43 protein levels in rat COC. Western blots were 
performed in duplicate (A and B) to determine the level of CX43 protein in COC lysate. COC were either 
incubated for 1, 5, 13, or 25 hours. Rat ovary lysate (A) or rat aorta lysate (B) were included as positive controls 
(+) and E. coli produced recombinant ovine BMP15 was included as a negative control (-).A control experiment 
(C) was also run where the membrane (B) was stripped and re-probed with the CX43-specific antibody that had 
been pre-absorbed with its control peptide. Molecular sizes (kDa) are indicated to the left of each blot. The 
density of the band of interest (indicated by an arrowhead) was measured and corrected for the control at 1 
hour. Total protein (μg) in each sample was determined using the BCA assay. The relative band densities were 
corrected for total protein amount, as calculated by the BCA assay.  
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Figure 5-6: Effect of incubation time on relative CX43 levels in rat COC. The bars depict the mean relative CX43 
band densities corrected for protein amount at each time point, with each individual band density represented 
by the dashes. 
 
The effect of increasing the incubation time of rat COC on GDF9 protein levels is depicted in 
Figure 5-7. Multiple bands between 20 and 114 kDa were detected in the positive control 
(Figure 5-7A and C) and the COC lysates (Figure 5-7A, B & C) of both replicates. These 
included bands of 49 and 20 kDa in size, corresponding to the promature and mature forms 
of GDF9, respectively. Additional prominent bands of 93, 70, and 40 kDa were also observed. 
To better visualise the mature 20 kDa band in the COC lysate, the first replicate was 
subjected to an increased exposure time (Figure 5-7B) and revealed the absence of this band 
at 5 hours in culture.  No bands were observed in the negative control (Figure 5-7A & C).  
Following stripping of the blot and re-probing with the GDF9 antibody that had been pre-
absorbed with recombinant GDF9, the bands that had been visualised were not apparent, 
with the exception of one band that was markedly reduced in intensity (Figure 5-7D).  
Overall, the relative levels of the promature and mature GDF9 proteins did not change over 
time (Figure 5-8A and B, respectively). There was large variation in the relative levels of both 
forms of GDF9 at all time points, and especially at 25 hours (i.e. the promature form ranged 
from 0.8-2 fold; the mature form ranged from 0.5-3.4 fold).  
0
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Figure 5-7: The in vitro effects of incubation time on GDF9 protein levels in rat COC. Western blots were 
performed in duplicate (A and C) to determine the level of GDF9 protein in COC lysate. COC were either 
incubated for 1, 5, 13, or 25 hours. Rat ovary lysate was included as a positive control (+) and E. coli produced 
recombinant ovine BMP15 was included as a negative control (-).A longer exposure time was performed for 
blot (A) to better visualise the mature band (B). A control experiment (D) was also run where the membrane (B) 
was stripped and re-probed with the GDF9-specific antibody that had been pre-absorbed with E. coli produced 
recombinant ovine GDF9. Molecular sizes (kDa) are indicated to the left of each blot. The densities of the bands 
of interest (indicated by arrowheads) were measured and corrected for the control at 1 hour. Total protein (μg) 
in each sample was determined using the BCA assay.  
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Figure 5-8: Effect of incubation time on promature (A) and mature (B) GDF9 protein levels in rat COC. The 
bars depict the mean relative GDF9 band densities at each time point, with each individual band density 
represented by the dashes. 
 
5.4 Discussion 
The purpose of this chapter was to determine the effects of incubating rat COC in vitro over 
an extended time period on GJ communication and the expression of oocyte- and CC-derived 
candidate genes and proteins. The candidate genes and proteins were selected due to their 
key roles in COC health. These results demonstrate that a number of cellular processes were 
altered over time when rat COC were cultured in vitro.  
GJ communication in COC showed a biphasic pattern over time in culture where levels 
increased from 2-5 hours, declined to low levels between 9-13 hours, and then increased 
again from 19-25 hours. This pattern of GJ activity is markedly different to that seen in 
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cultured porcine and bovine COC (Thomas et al., 2004; Sasseville et al., 2009b). Interestingly 
in the current study, the pattern of GJ communication over time was not strongly correlated 
with gene or protein expression levels of the connexins. This indicates that the regulation of 
GJ communication in rat COC is more complex than connexin expression levels alone, and 
may be further regulated by post-translational modifications. In contrast to the current 
study, GJ communication increased for up to 18 hours in culture in porcine COC, before 
declining after 24 hours. Moreover, an elegant study by Sasseville et al. (2009b) showed that 
mechanical rupture of a porcine COC from the follicle results in a transcriptional-dependent 
upregulation of CX43 protein after 4 hours in culture, which was concomitant with an 
increase in GJ communication. However, the following decrease in GJ communication by 22 
hours in culture in the Sasseville et al. study was not associated to CX43 protein levels, but to 
GVBD and compartmentalisation of CX43 into lipid rafts in a gonadotrophin-dependent 
manner. Taking into account that the timings may be different, it appears this pattern of 
events does not occur in the rat. The increase in GJ communication in rat COC observed after 
5 hours in culture in the current study was concomitant with a marked decline in both mRNA 
and proteins levels of CX43, and no change in Cx37 mRNA levels. Furthermore, the decrease 
in GJ communication in rat COC after 13 hours in culture was associated with a large 
increase in CX43 protein levels. However it is not known whether this decline in GJ 
communication was associated with post-translational or cellular localisation changes of 
CX43 within the COC. One similarity between this study and that of Sasseville et al. was that 
this decline in GJ communication after 13 hours was associated with an increased proportion 
of oocytes undergoing GVBD. However in the current study, GJ communication increased 
thereafter despite the increased proportion of oocytes resuming meiosis. 
Interestingly, after 25 hours in our culture system, ~50 % of rat oocytes still contained a 
visible GV indicating that half of the oocytes were able to maintain meiotic arrest for longer 
than 25 hours. There was no apparent correlation with time between the level of GJ 
communication and the proportion of oocytes that had resumed meiosis. It is well 
established that oocytes require a connection with the CC to maintain meiotic arrest (Sela-
Abramovich, 2006; Norris et al., 2009; Conti et al., 2012). Whilst the exact molecule supplied 
by the CC for this purpose is currently being debated, it is clear that the critical end-point is 
high intra-oocyte cAMP levels. In the present study, PDE inhibitors were added to maintain 
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GJ communication and oocyte meiotic arrest over a long incubation period. This was likely to 
have decreased the need for the transfer of the meiotic maintenance molecule through the 
GJs, thus confounding any correlation between GJ communication and nuclear maturation 
that exists in the absence of PDE inhibitors.  
The amount of RNA from the individual oocytes, as indicated by Rpl19 mRNA levels, was 
similar across all time points. Therefore, despite not correcting oocyte-derived candidate 
gene expression levels against Rpl19 mRNA levels, differences in gene levels are likely to be 
due to changes in expression, rather than differences in RNA input. The level of Atr mRNA in 
the oocyte progressively decreased with the lowest levels measured after 25 hours in 
culture. The reduced level of Atr expression indicates that the DNA damage checkpoint is 
less active after 25 hours incubation. Both Atr mRNA levels and the proportion of oocytes 
with a GV decreased over time which is consistent with the role of Atr in the regulation of 
meiosis. ATR detects DNA damage in the oocyte at the pachytene stage of meiotic prophase 
(Garcia-Cruz et al., 2009). Activated ATR phosphorylates downstream targets, including 
CHK1, BRCA1, and NBS1, resulting in G2/M arrest (Abraham, 2001). However, the level of Atr 
mRNA was not significantly associated with the presence or absence of a GV (data not 
shown). The mRNA levels of Bmp15, Cx37, and Gdf9 remained steady over time. Previously 
(Chapter 4), it was found that treatment with calcein-AM prevented a time-dependent 
decrease in Cx37 and Gdf9 levels. Thus, the finding that Cx37 and Gdf9 did not change over 
time in this study may be attributable to the treatment of all samples with calcein-AM. 
Interestingly, levels of the promature GDF9 protein also remained steady over time, 
correlating with Gdf9 mRNA levels. Taken together, these results suggest that the oocyte 
health is generally unaffected by a 25 hour in vitro incubation period. However, a reduction 
in the activity of the DNA damage sensing pathway may occur at 13 hours.   
The mRNA levels of all of the CC genes tested showed a change over time. The Rpl19 mRNA 
levels were reduced at the 13 and 25 hour time points, suggesting that fewer CC were 
attached to the oocyte at later times. Since each candidate gene was corrected for Rpl19, 
this discrepancy in the number of CC collected at each time point was taken into account. 
The Atr mRNA levels in CC were increased at 13 hours, compared to 1 hour, indicating that 
the DNA damage checkpoint is more active at 13 hours, and may correspond to increased 
DNA damage in those CC that are still attached to the oocyte. In pigs, DNA damage in the 
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oocyte as a result of oxidative stress generated by the xanthine oxidoreductase (XOD) 
enzyme system was reduced when the oocytes were cultured as COC, rather than as DO 
(Tatemoto et al., 2000). Given the finding that oocyte Atr levels were relatively constant until 
13 hours in culture, and then reduced at 25 hours, this supports the hypothesis that the CC 
protect the oocyte from DNA damage. As discussed previously, Cx43 mRNA levels were 
reduced in CC from 5 hours onwards but this change did not correlate with GJ 
communication in the COC. The levels of Pfkp mRNA in CC were reduced after 5 hours, 
suggesting a significant reduction in glycolytic activity. Interestingly, mRNA levels of Cycs 
were also reduced in the CC although this did not occur until 25 hours. Levels of Gfpt1 mRNA 
were upregulated in the CC at 13 hours, compared to 5 hours. Given the concurrent 
reduction in Cycs and Pfkp expression, these results suggest that glucose is directed to the 
hexosamine pathway at 13 hours, rather than the glycolytic pathway. The hexosamine 
biosynthetic pathway is involved in the production of substrates for O-linked glycosylation 
and in the synthesis of hyaluronic acid for CC expansion, while the glycolytic pathway is 
involved in energy production. Therefore, the results presented here suggest that CC energy 
production is reduced at 13 hours and that glucose is instead used for O-linked glycosylation 
and CC expansion, although CC expansion was not observed at any time point in this study 
(data not shown). Previously (Chapter 4), it was established that calcein-AM treatment 
prevented a time-dependent decrease in Cycs levels. It was also found that calcein-AM 
treatment resulted in increased Gfpt1 levels at 13 and 25 hours, and an increase in Atr 
mRNA at 13 hours. Therefore, the time dependent changes in Atr, Cycs, and Gfpt1 mRNA 
levels may be influenced by calcein-AM. However, the results presented here strongly 
support the notion that glucose metabolism is altered over time under in vitro conditions.  
Western blotting was used to analyse changes in expression levels of CX43 and GDF9 in rat 
COC over time in culture. The Western blot protocol yielded variable results probably due to 
the limited number of replicate samples (N=2) able to be collected (i.e. each replicate 
sample consisted of 200 COC). Therefore, the results presented here are preliminary and 
further replicates need to be carried out in the future. Nevertheless, multiple bands were 
detected using the CX43-specific antibody, including a 43 kDa band assumed to be CX43, and 
two unidentified bands around 63 and 22 kDa in size. Interestingly, the 43 kDa band and 
both of the unidentified bands were absent after the blot had been stripped and the CX43 
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antibody added had been pre-absorbed with the control peptide. However, pre-absorption 
of the antibody with an antigen proves that the antibody binds to that antigen but does not 
prove the specificity of single bands (Swaab et al., 1977; Willingham, 1999). Thus, it is 
possible that the 63 and 22 kDa bands were visualised as a result of nonspecific binding by 
the CX43 antibody. These bands may also represent differentially processed forms of CX43 
protein however this has not been previously reported to the best of my knowledge. A 43 
kDa band was notably absent in the rat aorta lysate positive control of the second replicate 
experiment. The phosphorylation pattern of CX43 is tissue specific (Kadle et al., 1991) thus 
CX43 from rat aorta may have a different migration pattern to that from the CC.  
 Multiple bands were also detected using the GDF9-specific antibody, including a 49 kDa 
band assumed to be the promature protein, a 20 kDa band assumed to be the mature 
protein (Lin et al., 2012), and unidentified bands of 90, 70, and 40 kDa sizes. All of these 
bands were absent following stripping of the blot and re-probing with the GDF9-specific 
antibody that had been pre-absorbed with a recombinant ovine GDF9 protein. It is likely that 
some of these bands were differentially processed forms of GDF9. Indeed, a preproprotein 
also exists within the oocyte and is a non-secreted form. Furthermore, GDF9 contains five N-
linked glycosylation sites (Jaatinen et al., 1999) and is a target for phosphorylation 
(McMahon et al., 2008).  
Analysis of the band densities was undertaken using the ImageJ software. The 43 kDa band 
was analysed exclusively for the CX43 Western blots. For the GDF9 blots, the 49 kDa and 20 
kDa bands were analysed separately. The total protein content was measured in each 
sample using the BCA assay. The band densities for CX43 were corrected for total protein 
amount to reduce the variation caused by differences in CC number. The band densities for 
GDF9 were not corrected for total protein, to provide an indication of the total amount of 
protein produced by a known number of oocytes.  
This study revealed that expression of CX43 protein in COC was increased at 13 hours in 
culture, compared to 1 and 5 hours, and the levels of CX43 at 25 hours were variable. As 
discussed previously, CX43 protein levels were not correlated to the pattern of GJ 
communication over time. This may be due to various GJ regulatory mechanisms, such as 
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voltage gating, phosphorylation, and incorporation into GJ plaques, playing a major role in 
up- or down-regulating GJ communication.  
Overall levels of promature GDF9 protein did not change over time. However, relatively large 
variability was observed in the levels of promature GDF9 measured in cultured COC at 5, 13, 
and 25 hours. The promature band was much denser than the mature band, indicating that 
the promature form is much more abundant in the cell than the mature form. A previous 
study found that the mature form of GDF9 was the predominant form detected in rat 
oocytes, and that promature protein was undetectable (Lin et al., 2012). However, there 
were significant experimental differences between the Lin et al. (2012) study and the 
experiments presented here. Most notably, the Lin et al. study measured GDF9 expression 
following 24 hours of culturing DO, as opposed to COC in this present study. Therefore, the 
presence of intact CC layers around the oocyte may alter the processing of uncleaved 
promature GDF9. The band representing the mature GDF9 protein was faint and highly 
variable in density between replicates. Although the mature form of the protein is the 
bioactive region, immunization against the proregion of GDF9 in mice resulted in ovaries 
with more corpora lutea and smaller litter sizes. This indicates that the GDF9 proregion may 
also play an important role in regulating fertility (McIntosh et al., 2012). While this influence 
is likely to be through interactions between the cleaved proregion and the mature region 
(McIntosh et al., 2008), this may also be as a result of undetermined biological activity of the 
uncleaved promature protein.  
In summary, these results demonstrate that the communication pathways between the 
oocyte and CC remain active in rat COC throughout 49 hours of in vitro culture. In contrast to 
other species, levels of connexin mRNA (i.e. Cx43 and Cx37) or CX43 protein were not good 
indicators of functional GJ communication in rat COC. The levels of oocyte-derived mRNAs 
(with the exception of Atr) and GDF9 protein remained stable for up to 25 hours in culture. 
In the CC, expression levels of genes involved in the glycolytic pathway (i.e. Pfkp and Cycs) 
were reduced after 25 hours. However, Gfpt1 expression was similar at 25 hours compared 
to that at 1 hour. These results indicate that culturing rat COC in vitro may favour the 
hexosamine biosynthetic pathway, rather than the glycolytic pathway, for glucose utilisation. 
Moreover, these results validate the use of the GJ bioassay, qPCR and Western blotting 
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methodologies to detect changes in key regulatory pathways that are involved in 
maintaining COC health. 
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6 EFFECTS OF IN VITRO EXPOSURE OF COC TO LIFESTYLE FACTORS 
ON CC-OOCYTE GJ COMMUNICATION 
6.1 Introduction 
Maintenance of GJ communication within the COC is essential for oocyte development and 
maturation. The function of GJ are regulated at multiple levels including transcription, 
translation, post-translational modifications, incorporation into GJ plaques, voltage gating, 
and other slow gating processes (Bukauskas et al., 2000; Harris, 2002; Goodenough and Paul, 
2009). Disruptions to any of these mechanisms have the potential to modify GJ 
communication. Moreover, suppression of GJ communication may result in the oocyte not 
receiving adequate nutrients for development and/or maturation (Kidder and Mhawi, 2002). 
In this context, blocking GJs between the CC and oocyte, using carbenoxolone, inhibited the 
transfer of a fluorescent glucose analogue (6-NBDG) and cAMP (Webb et al., 2002; Wang et 
al., 2012). Moreover, blocking GJs using octanol and heptanol resulted in a decreased 
proportion of bovine oocytes reaching the blastocyst stage of development (Atef et al., 
2005). On the other hand, increasing GJ communication is likely to enhance the transfer of 
nutrients to the oocyte. This may be advantageous, due to more substrates entering the 
oocyte for energy production and maturation processes. Conversely, excessive GJ 
communication may also have a negative impact on oocyte quality by transferring more 
nutrients than necessary for oocyte growth, or may be indicative of a stressed oocyte 
requiring an increased need for energy-consuming RNA surveillance mechanisms (Baumann 
et al., 2007).  
The closure of GJs between the oocyte and CC is necessary for normal nuclear maturation 
(Shimada et al., 2001; Norris et al., 2008). For example, suppression of inhibitory 
phosphatidylinositol 3 kinase mediated phosphorylation of CX43 in porcine COC resulted in a 
decreased proportion of MII oocytes following in vitro culture (Shimada and Terada, 2001). 
The timing of meiotic resumption is critical. Blastocyst formation was reduced in bovine 
oocytes pre-incubated with cyclohexamide (meiosis inhibitor) for 24 or 48 hours prior to IVM 
and fertilised under inhibitor-free conditions, compared to oocytes not exposed to meiotic 
inhibitors (Saeki et al., 1997). The effects of increased GJ communication on nutrient transfer 
to the oocyte have not been examined to the best of my knowledge. However, it is 
reasonable to assume that increased GJ communication results in more glucose and glucose 
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metabolites being transferred to the oocyte, and indeed, this occurs under hyperglycaemic 
conditions (Wang et al., 2012). Hyperglycaemic conditions result in increased O-linked 
glycosylation (Brownlee, 2001; Schelbach et al., 2010), increased production of reactive 
oxygen species, and decreased glutathione concentrations in the oocyte (Hashimoto et al., 
2000). Hyperglycaemic conditions also lead to an increased rate of oocyte meiotic 
maturation (Downs et al., 1998; Sutton-McDowall et al., 2005). Increased glucose 
concentrations are also correlated with increased FSH-induced CC expansion in bovine COC 
(Sutton-McDowall, 2004).  
A number of environmental contaminants and lifestyle factors, including BPA, caffeine, and 
nicotine metabolites, have been found at measureable concentrations in follicular fluid as 
well as in serum of women (Zenzes et al., 1996; Ikezuki et al., 2002; Al-Saleh et al., 2010). 
Some of these compounds have also been reported to negatively affect female fertility 
(Emanuele et al., 2002; Klonoff-Cohen, 2005; Anderson, 2010). The environmental 
contaminant BPA and the lifestyle factors caffeine, ethanol and nicotine have all previously 
been reported to affect GJ communication in various tissue types (Flagg-Newton et al., 1981; 
Tsai et al., 2004; Mustonen et al., 2005; Lee and Rhee, 2007). However, the effects of 
physiological concentrations of these and other highly addictive and potentially detrimental 
compounds (e.g. MDMA and THC) on GJ communication within the COC have not been 
tested. Moreover, the large number of connexin isoforms, their combinations in differing 
tissue types and the unique regulatory properties of each isoform suggest that alterations in 
GJ communication in response to regulatory factors between tissue types will be unique.   
The aims of this chapter were to determine the in vitro effects of high physiological 
concentrations of BPA, caffeine, ethanol, nicotine, MDMA, or THC with time on cultured COC 
in regards to (1) the degree of GJ communication between the oocyte and CC and (2) the 
timing of meiotic resumption of the oocyte. 
6.2 Methods 
6.2.1 COC collection 
A full description of the COC collection procedure for the in vitro culture experiments is 
described in Section 2.1.2. In brief, ovaries were extracted, follicles were punctured with a 
20 gauge needle, and morphologically healthy COC were transferred into 48-well plates 
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containing dissection media containing 50 μM dipyridamole and 50 μM rolipram. All COC 
were washed twice in wash media containing 50 μM dipyridamole and 50 μM rolipram.  
6.2.2 Exposure to lifestyle factors 
Stock solutions of each of the treatment reagents are listed in Table 6-1. The treatments 
were generally purchased from Sigma with the exception of BPA (donated by Phil Conveny; 
Nuplex Industries, NZ), MDMA (donated by Richard Moore; VUW), and THC (donated by 
Ryan Steel, VUW). The final concentrations chosen were based on levels that had been 
measured in biological fluids (see Table 1.1). Following the wash steps described above, COC 
were transferred into incubation media containing 50 μM dipyridamole and 50 μM rolipram 
without (control) or with (treated) the appropriate treatment. After 0, 4, 12, or 24 hours 
incubation at 37 °C in 5 % CO2, and 96 % humidity, the COC were transferred into incubation 
media containing 2 μM calcein-AM, 50 μM dipyridamole and 50 μM rolipram as well as the 
appropriate treatment for 10 minutes. The COC were then transferred into fresh incubation 
media (calcein-AM free) containing 50 μM dipyridamole and 50 μM rolipram and the 
appropriate treatment, and incubated for a further hour. The COC were washed twice in PBS 
and the oocyte was denuded of CC and measured for fluorescence as described previously. 
Thereafter, the oocyte was washed twice more in PBS. These individual DO and separated CC 
masses were suspended in 10 μL PBS in the 96-well plates and stored at -80 °C until further 
analyses (see Chapter 2.1.3).  
To reduce the number of samples, the experiments involving the treatments with caffeine 
and nicotine were combined, and the experiments involving the treatments with MDMA and 
THC were combined such that the treatments in each experiment were compared to one 
control group.  
As described previously (Section 2.1.3.1), the raw fluorescence measurement for each 
individual oocyte was corrected for the geometric mean of the control group at 1 hour (i.e. 
those COC pre-incubated for 0 hours followed by a 1 hour post-calcein incubation). The data 
were tested for normality using the D'Agostino & Pearson normality test and data that were 
not normally-distributed were transformed (square root or natural log transformations) and 
were assessed again for normality. The data were then analysed using a two-way ANOVA.  
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Table 6-1: Stock and final concentrations of treatment reagents in media. With the exception of ethanol, 
which was stored in dH2O, all other reagents were stored in DMSO.  
Treatment reagents Stock concentration Final Concentration  
BPA 4 μg/mL 20 ng/mL 
Caffeine 20 mg/mL 100 μg/mL 
Ethanol 750 mg/mL 7.5 mg/mL (0.95 % w/v) 
Nicotine 10 μg/mL 500 ng/mL 
MDMA 400 μg/mL 2 μg/mL 
THC 10 μg/mL 500 ng/mL 
 
 
6.3 Results 
6.3.1 Effect of BPA on GJ communication in rat COC 
The effect of exposure of rat COC to 20 ng/mL BPA in vitro on GJ communication over time is 
depicted in Figure 6-1. A significant effect of BPA treatment on oocyte fluorescence was 
noted, but no effects of time or treatment x time interaction were observed. Although no 
significant effect of time was measured, oocyte fluorescence appeared marginally increased 
in the control COC at 13 hours, compared to 1 hour, but was decreased at 25 hours. This 
reduction in oocyte fluorescence in the control COC at 25 hours was not mirrored in the 
BPA-treated COC. Instead, mean oocyte fluorescence in the BPA-treated COC increased 
progressively at each consecutive time point, although no significant effect of time was 
demonstrated. The proportion of oocytes with a visible GV declined over time in both the 
control and BPA-treated groups (Table 6-2). There was no difference in the proportion of 
oocytes with a visible GV between the control and BPA-treated groups. 
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Figure 6-1: Effect of BPA on fluorescent dye transfer from adjacent CC to oocytes over time in vitro. The 
incubation time indicates the pre-calcein incubation + the 1 hour post-calcein incubation. The control (i.e. 
untreated) group is represented by the unfilled bars ( ), while the BPA-treated group is represented by the 
hatched bars ( ). Values are shown as geometric means ± 95 % confidence intervals of fluorescent ratios 
normalised against the geometric mean of the control group at 1 hour. The data represent 11-12 readings from 
individual oocytes in each group generated from 3 replicate experiments. The data were transformed (square 
root) prior to being analysed by a two-way ANOVA. The mean ± SEM fluorescent reading in the control group at 
1 hour was 167 ± 39. 
 
Table 6-2: Effect of BPA on the proportion of oocytes with a visible GV. The table shows the proportion of 
oocytes with a visible GV (%), with the actual number of oocytes with a GV in brackets. The data from 3 
replicate experiments (N=11-12/group) were analysed by Fisher’s exact test. No effect of BPA on the presence 
of a GV was noted.  
Time Control BPA 
1 100 (12) 75 (9) 
5 42 (5) 75 (9) 
13 67 (8) 58 (7) 
25 42 (5) 50 (6) 
 
 
6.3.2 Effect of caffeine on GJ communication in rat COC 
The effect of exposure of rat COC to 100 μg/mL caffeine in vitro on GJ communication over 
time is depicted in Figure 6-2. Overall, there were no significant effects of treatment, time or 
treatment x time interaction. It is worth noting that the treatment effect almost reached 
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significance (P=0.052). Mean oocyte fluorescence in the control COC remained essentially 
unchanged for the first 13 hours but by 25 hours, a lower (albeit not significant) mean level 
of fluorescence was evident. This reduction in oocyte fluorescence at 25 hours was not 
observed in the caffeine-treated COC. Instead, the mean oocyte fluorescence levels in the 
caffeine-treated COC were essentially unchanged over 25 hours. The proportion of oocytes 
with a visible GV declined over time in both the control and caffeine-treated groups (Table 
6-3). There was no difference in the proportion of oocytes with a visible GV between the 
control and caffeine-treated groups. 
 
 
Figure 6-2: Effect of caffeine on fluorescent dye transfer from adjacent CC to oocytes over time. The 
incubation time indicates the pre-calcein incubation + the 1 hour post-calcein incubation. The control (i.e. 
untreated) group is represented by the unfilled bars ( ), while the caffeine-treated group is represented by 
the hatched bars ( ). Values are shown as geometric means ± 95 % confidence intervals of fluorescent ratios 
normalised against the geometric mean of the control group at 1 hour. The data represent 10-12 readings from 
individual oocytes in each group generated from 3 replicate experiments. The data were transformed (square 
root) and then analysed by a two-way ANOVA. The mean ± SEM fluorescent reading in the control group at 1 
hour was 224 ± 24.  
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Table 6-3: Effect of caffeine on the proportion of oocytes with a visible GV. The table shows the proportion of 
oocytes with a visible GV (%), with the actual number of oocytes with a GV in brackets. The data from 3 
replicate experiments (N=10-12/group) were analysed by a Fisher’s exact test. No effect of caffeine on the 
presence of a GV was noted. 
Time Control Caffeine 
1 83 (10) 83 (10) 
5 75 (9) 75 (9) 
13 42 (5) 67 (8) 
25 42 (5) 58 (7) 
 
 
6.3.3 Effect of ethanol on GJ communication in rat COC 
The effect of exposure of rat COC to 7.5 mg/mL ethanol in vitro on GJ communication over 
time is depicted in Figure 6-3. No effects due to treatment or time, or treatment x time 
interaction were observed. The proportion of oocytes with a visible GV decreased over time 
in both the control and ethanol-treated groups (Table 6-4). When the data from all time 
points were pooled, there was a greater proportion of oocytes with a visible GV in the 
ethanol-treated group compared to the control group (P<0.05).  
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Figure 6-3: Effect of ethanol on fluorescent dye transfer from adjacent CC to oocytes over time in vitro. The 
incubation time indicates the pre-calcein incubation + the 1 hour post-calcein incubation. The control (i.e. 
untreated) group is represented by the unfilled bars ( ), while the ethanol-treated group is represented by 
the hatched bars ( ). Values are shown as geometric means ± 95 % confidence intervals of fluorescent 
ratios normalised against the geometric mean of the control group at 1 hour. The data represent 9-12 readings 
from individual oocytes in each group generated from 3 replicate experiments. The data were transformed 
(square root) and analysed by a two-way ANOVA. The mean ± SEM fluorescent reading in the control group at 1 
hour was 313 ± 71. 
 
Table 6-4: Effect of ethanol on the proportion of oocytes with a visible GV. The table shows the proportion of 
oocytes with a visible GV, with the actual number of oocytes with a GV in brackets. The data from 3 replicate 
experiments (N=9-12/group) were analysed by a Fisher’s exact test.   
Time Control Ethanol 
1 62 (7) 83 (10) 
5 50 (6) 75 (9) 
13 29 (4) 75 (9) 
25 33 (4) 42 (5) 
 
 
6.3.4 Effect of nicotine on GJ communication in rat COC 
The effect of exposure of rat COC to 500 ng/mL nicotine in vitro on GJ communication over 
time is depicted in Figure 6-4. No significant effects of treatment or time were detected but 
a significant treatment x time interaction was noted. The mean oocyte fluorescence in the 
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control COC remained essentially unchanged over the first 13 hours but appeared to be 
lower at 25 hours. This lower (albeit not significant) level at 25 hours in the control group 
was not evident in the nicotine-treated group where the mean fluorescence levels remained 
essentially unchanged over the 25 hour period. There was no difference in the proportion of 
oocytes with a visible GV between the control and nicotine-treated groups (Table 6-5). 
 
 
Figure 6-4: Effect of nicotine on fluorescent dye transfer from adjacent CC to oocytes over time in vitro. The 
incubation time indicates the pre-calcein incubation + the 1 hour post-calcein incubation. The control (i.e. 
untreated) group is represented by the unfilled bars ( ), while the nicotine-treated group is represented by 
the hatched bars ( ). Values are shown as geometric means ± 95 % confidence intervals of fluorescent 
ratios normalised against the geometric mean of the control group at 1 hour. The data represent 12 readings 
from individual oocytes in each group generated from 3 replicate experiments. The data were transformed 
(square root) and analysed by a two-way ANOVA. The mean ± SEM fluorescence reading in the control group at 
1 hour was 224 ± 24. 
 
Table 6-5: Effect of nicotine on the proportion of oocytes with a visible GV. The table shows the proportion of 
oocytes with a visible GV (%), with the actual number of oocytes with a GV in brackets. The data from 3 
replicate experiments (N=12/group) were analysed by a Fisher’s exact test. No effect of nicotine on the 
presence of a GV was noted.  
Time Control Nicotine 
1 83 (10) 67 (8) 
5 75 (9) 67 (8) 
13 42 (5) 42 (5) 
25 42 (5) 67 (8) 
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6.3.5 Effect of MDMA on GJ communication in rat COC 
The effect of exposure of rat COC to 2 μg/mL MDMA in vitro on GJ communication over time 
is shown in Figure 6-5. A significant effect of time but not treatment was noted. Moreover, 
there was no significant treatment x time interaction. Overall, mean oocyte fluorescence 
was lower at 13 and 25 but not 5 hours in both the control and MDMA-treated groups. The 
proportion of oocytes with a visible GV decreased over time in both the control and MDMA-
treated groups (Table 6-6). When observations from all time points were pooled, there was a 
lower proportion of oocytes with a visible GV in the MDMA-treated group compared to the 
control group (P<0.001).  
 
 
Figure 6-5: Effect of MDMA on fluorescent dye transfer from adjacent CC to oocytes over time. The 
incubation time indicates the pre-calcein incubation + 1 hour the post-calcein incubation. The control (i.e. 
untreated) group is represented by the unfilled bars ( ), while the MDMA-treated group is represented by 
the hatched bars ( ). Values are shown as geometric means ± 95 % confidence intervals of fluorescent 
ratios normalised against the geometric mean of the control group at 1 hour. The data represent 11-12 
readings from individual oocytes in each group generated from 3 replicate experiments. The data were 
transformed (square root) and analysed by a two-way ANOVA. The mean ± SEM fluorescent reading in the 
control group at 1 hour was 139 ± 31. 
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Table 6-6: Effect of MDMA on the proportion of oocytes with a visible GV. The table shows the proportion of 
oocytes with a visible GV (%), with the actual number of oocytes with a GV in brackets. The data from 3 
replicate experiments (N=11-12/group) were analysed by a Fisher’s exact test.   
Time Control MDMA 
1 92 (11) 92 (11) 
5 83 (10) 25 (3) 
13 67 (8) 25 (3) 
25 58 (7) 17 (2) 
 
 
6.3.6 Effect of THC on GJ communication in rat COC 
The effect of exposure of rat COC to 500 ng/mL THC in vitro on GJ communication over time 
is depicted in Figure 6-6. Overall, there was a significant effect of incubation time but no 
effect of treatment and no treatment x time interaction. Mean oocyte fluorescence was 
lower at 13 and 25 hours in both the control and THC-treated groups. The proportion of 
oocytes with a visible GV declined over time in both the control and THC-treated groups 
(Table 6-7). When observations from all time points were pooled, the difference in the 
proportion of oocytes with a visible GV between the control and THC-treated groups almost 
reached significance (P=0.054). When observations from the 5, 13, and 25 hour time points 
were pooled, the proportion of oocytes with a visible GV was significantly reduced in the 
THC-treated group compared to the control (P<0.05).  
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Figure 6-6: Effect of THC on fluorescent dye transfer from adjacent CC to oocytes over time in vitro. The 
incubation time indicates the pre-calcein incubation + the 1 hour post-calcein incubation. The control (i.e. 
untreated) group is represented by the unfilled bars ( ), while the THC-treated group is represented by the 
hatched bars ( ). Values are shown as geometric means ± 95 % confidence intervals of fluorescent ratios 
normalised against the geometric mean of the control group at 1 hour. The data represent 12 readings from 
individual oocytes in each group generated from 3 replicate experiments. The data were transformed (natural 
log) and analysed by a two-way ANOVA. The mean ± SEM fluorescent reading in the control group at 1 hour 
was 139 ± 31. 
 
Table 6-7: Effect of THC on proportion of oocytes with a visible GV. The table shows the proportion (%) of 
oocytes with a visible GV, with the actual number of oocytes with a GV in brackets. The data from 3 replicate 
experiments (N=12/group) were analysed by a Fisher’s exact test.   
Time Control THC 
1 92 (11) 92 (11) 
5 83 (10) 42 (5) 
13 67 (8) 50 (6) 
25 58 (7) 33 (4) 
 
 
6.4 Discussion 
The focus of this study was to investigate the effects of several lifestyle factors and 
environmental contaminants on the COC communication system and hence their influence 
oocyte health. The results reveal that there was no treatment effect noted after in vitro 
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exposure of rat COC to high physiological concentrations of caffeine, ethanol, MDMA or THC 
on fluorescent dye transfer over 25 hours relative to the controls. It is possible that there is 
an effect of caffeine as this treatment approached significance. However, further studies are 
needed to confirm whether this is of biological significance. In contrast, exposure to nicotine 
resulted in a treatment x time interaction, as a result of a dramatic decline in dye transfer 
that was noted in the control group after 13 hours whereas no change in dye transfer over 
25 hours was measured in the nicotine-treated group. The only treatment effect 
independent of time in vitro was noted for BPA where the pattern of fluorescent dye 
transfer was similar to that for nicotine: again no change was noted for the treated group 
over 25 hours whereas a dramatic decline after 13 hours was noted for the control. Thus, 
exposure of COC to BPA and nicotine may require oocytes to demand a higher level of CC-
derived factors to mitigate the possible negative effects of these reagents.  With respect to 
measures of oocyte maturation status (i.e. the presence of a GV) after exposure to lifestyle 
factors, it was noted that in vitro exposure to ethanol suppressed oocyte meiotic 
maturation, whereas in vitro exposure to MDMA or THC enhanced the proportion of oocytes 
undergoing GVBD.  
In general, the compounds tested in the present study were at concentrations 10-fold higher 
than that measured previously in biological fluids. These concentrations were chosen as they 
were above the normal physiological range, but were not so high to induce a false positive 
result. The concentrations of those compounds that had not been measured previously in 
follicular fluid were determined based on the concentration in blood. In general, the 
concentrations of small molecules are comparable between plasma and follicular fluid 
(Edwards, 1974). 
The exposure of rat COC to BPA caused an overall increase in GJ communication. The largest 
difference in oocyte fluorescence between the treated and control COC occurred after 25 
hours in culture. The reduction in oocyte fluorescence that occurred in control COC after a 
25 hour culture period was not observed in those COC exposed to BPA. This observation 
suggests that BPA prevents closure of the GJs. Interestingly, previous in vitro studies using a 
higher dose of BPA found that BPA suppressed GJ communication in an epithelium-derived 
rat breast cancer cell line in vitro (Lee and Rhee, 2007). Similarly, BPA has also been reported 
to suppress spontaneous GJ-dependent Ca2+ oscillations in mouse oocytes (Mohri and 
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Yoshida, 2005). However, it is important to note that the concentrations of BPA used in 
these studies were between 4- and 1000-fold higher than that used in the present study. 
Whilst the concentration used in this study was lower, it was nevertheless above the normal 
physiological range. In future studies it would be of interest to test BPA concentrations 
within the expected physiological range. As discussed previously, the consequence of 
increased GJ communication may include increased transfer of cAMP, glucose metabolites, 
and other nutrients to the oocyte. BPA has previously been reported to reduce oocyte 
quality in both mice and humans (Eichenlaub-Ritter et al., 2008; Fujimoto et al., 2010). 
Furthermore, in vitro exposure to BPA did not affect oocyte nuclear maturation, as the 
proportion of oocytes undergoing GVBD was unchanged following exposure to BPA for up to 
25 hours. It should be noted here that the number of samples used in this study was small 
resulting in the inability to detect small differences between groups. While the Fisher’s exact 
test is more sensitive than the traditional chi-square test, it still lacks power with small 
sample sizes (Upton, 1992). Previous reports indicate that BPA does promote meiotic arrest 
in oocytes. For example, a greater proportion of mouse oocytes underwent GVBD following 
exposure to 10 μg/mL, but not lower concentrations, of BPA (Eichenlaub-Ritter et al., 2008). 
Additionally another study revealed that exposure of mouse oocytes to BPA was associated 
with a decreased ability of oocytes to resume meiosis, and in those that do, an increased 
proportion arrest after GVBD and fail to extrude a first polar body (Lenie et al., 2008). Again, 
both of these studies used much higher concentrations of BPA than that used in this study 
(340-fold and 500-fold higher respectively). Interestingly, the former study found that lower 
concentrations of BPA did not affect meiotic maturation of the oocyte even after 16 hours of 
exposure to BPA. Therefore the results from the present study are in agreement with 
previous publications that determined that high physiological concentrations of BPA do not 
affect oocyte meiotic maturation.  
Overall, caffeine appeared to promote GJ communication in rat COC at some time points 
although this did not quite reach significance. Similar to BPA-treated oocytes, the largest 
difference in oocyte fluorescence between the caffeine-treated and control COC occurred 
after 25 hours in culture. Additionally oocyte fluorescence was highest in the caffeine-
treated COC at 5 hours. Again, the reduction in oocyte fluorescence that occurred in control 
COC after a 25 hour culture period was not observed in those COC exposed to caffeine. This 
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is consistent with previous reports that caffeine increased GJ communication in rat 
fibroblasts and epithelial cells in vitro (Flagg-Newton et al., 1981). These results suggest that 
caffeine may affect oocyte quality by preventing closure of the GJs. In vitro exposure to 
caffeine has also been reported to increase the glutathione content of ovine oocytes, and to 
improve the embryo cleavage rate (Ye et al., 2010). However, evidence regarding the effect 
of caffeine consumption on female fertility and oocyte quality in humans is inadequate and 
controversial (Anderson, 2010). Interestingly in the current study, caffeine did not have a 
significant effect on the proportion of oocytes that underwent GVBD over time. Caffeine is a 
broad-range PDE inhibitor (Rahimi et al., 2010), that has been shown to maintain meiotic 
arrest in mouse and porcine oocytes (Jagiello et al., 1972; Kren et al., 2004). However in 
contrast to the current study, neither of these studies added other specific PDE inhibitors 
into the culture medium. The use of rolipram and dipyridamole in this study may have 
inhibited the relevant PDEs to a maximal level, thus potentially masking the PDE inhibitory 
effects of caffeine.  
The exposure of rat COC to ethanol had no overall effects on GJ communication. A study 
investigating rat gastric mucosal cells showed that ethanol reduced GJ communication, 
although a higher dose (~8 fold) was used than that in the present study (Mustonen et al., 
2005). It is entirely plausible that the incubation conditions may cause ethanol to evaporate 
out of the media, causing variable or false negative results. However, this has been tested in 
other studies and 96 ± 2 % of the added ethanol remained in the media following a 25 hour 
incubation at 37 °C (Messing et al., 1986). Interestingly, ethanol appeared to inhibit oocyte 
meiotic maturation, as the proportion of oocytes that underwent GVBD was significantly 
lower over time in the ethanol-treated group compared to the control. A previous study 
involving the exposure of ovulated mouse oocytes to 7 % ethanol reported a stimulation of 
parthenogenetic activation (i.e. progression of meiosis from metaphase II to completion), as 
measured by the number of unfertilized oocytes that had extruded a second polar body 
(O’Neill et al., 1989). This suggests that ethanol modulates progression of meiosis II in 
oocytes. However to the best of my knowledge the effect of ethanol on meiosis I (i.e. prior 
to ovulation) has not been investigated.  
Nicotine had no overall effect on GJ communication in rat COC however there was a 
significant treatment x time interaction. The reduction in oocyte fluorescence that occurred 
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in control COC after a 25 hour culture period was not observed in those COC exposed to 
nicotine, as was also the case for BPA and caffeine. These results are in contrast to previous 
studies that found that in vitro exposure to nicotine resulted in decreased GJ communication 
in human umbilical vein endothelial cells (Tsai et al., 2004). However, the concentration of 
nicotine used in the study was 195-fold greater than that used in the current study. It is 
important to note that nicotine is rapidly metabolised into the two major metabolites, 
cotinine and nicotine-N-oxide by the enzymes cytochrome p450 2A6 (CYP2A6) and flavin-
containing monooxygenase 3 (FMO3), respectively (Benowitz, 1986; Hukkanen et al., 2005). 
The enzyme CYP2A6 has been detected in mouse ovaries (Cannady et al., 2003) and cotinine 
has been measured at concentrations of ~700 ng/mL in follicular fluid and 50-200 ng/mL in 
plasma of active smokers (Zenzes et al., 1996; Shoaib and Stolerman, 1999). To my 
knowledge, there is no available data on the activity of FMO3 or the levels of nicotine-N-
oxide in the ovary. Nicotine did not have a significant effect on the proportion of oocytes 
that underwent GVBD over time. In contrast to this study, nicotine has previously been 
reported to promote oocyte nuclear maturation in bovine oocytes (Liu et al., 2008). 
However, the Liu study used a concentration of nicotine more than 1200-fold greater than 
was used in the current study.  
The effects of the active ingredients in two illicit drugs (i.e. MDMA and THC) on GJ 
communication in COC was also tested for the first time in this study. Exposure to MDMA did 
not affect the ability of the oocyte to import dye from the CC. Interestingly though, meiotic 
maturation of the oocyte was affected by MDMA. Significantly, fewer oocytes with a visible 
GV were present in the MDMA-treated group compared to the controls. These results 
suggest that MDMA prematurely advances meiotic progression in rat COC. In the present 
study, exposure of COC to THC also had no effect on transfer of calcein from the CC to the 
oocyte compared to the controls. A previous study found that in vitro exposure to THC 
inhibited GJ communication in a rat liver epithelial cell line (Upham et al., 2003). However, 
the concentrations used were ~8-fold greater than in the present study. The results in this 
study indicate that exposure to THC may prematurely advance oocyte meiotic maturation, as 
there were fewer oocytes remaining with a visible GV after exposure to THC compared to 
the controls. This in agreement with a previous study that found that exposure of rat follicles 
to THC in vitro induced resumption of meiosis (Reich et al., 1982).  
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The study design for the GJ bioassay meant that COC were incubated for 0, 4, 12, or 24 hours 
in the presence or absence of the appropriate treatment followed by incubation with 
calcein-AM and a subsequent 1 hour post calcein-AM incubation with or without treatment. 
Incubating COC with the lifestyle factors for up to 24 hours prior to calcein-AM exposure 
allowed for identification of factors that slowly regulated GJ communication. The 1 hour post 
calcein-AM incubation was carried out to allow for transfer of the fluorescent dye. 
Performing the post calcein-AM incubation in the absence of treatment may have released 
the regulatory action of that treatment, providing a false negative result. Thus, the post 
calcein-AM incubation was carried out in the presence or absence of treatment, as 
appropriate.  
In summary, this in vitro study found that exposure to 20 ng/mL BPA and 500 ng/mL nicotine 
prevented a time-dependent decrease of GJ communication in rat COC. A reduction in 
oocyte fluorescence was measured in the control group after 25 hours but not in the BPA or 
nicotine-treated COC. Moreover, exposure of COC to 100 μg/mL caffeine in vitro may 
promote GJ communication, however this effect was negligible.  In contrast, exposure to 7.5 
mg/mL ethanol, 2 μg/mL MDMA or 500 ng/mL THC did not affect GJ communication in rat 
COC. In vitro exposure to ethanol inhibited oocyte meiotic maturation, as measured by the 
proportion of oocytes with a visible GV, while exposure to MDMA or THC promoted oocyte 
meiotic maturation. None of the other treatments affected the proportion of oocytes with a 
visible GV. 
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7 EFFECTS OF IN VITRO EXPOSURE OF COC TO LIFESTYLE FACTORS 
ON GENE EXPRESSION IN OOCYTES 
7.1 Introduction 
Oocyte competency, defined as the ability of an oocyte to develop into a viable embryo, is 
dependent upon a two-way communication system between the oocyte and CC that 
facilitates a co-ordinated maturation process of all follicular constituents (Gilchrist et al., 
2008). The oocyte indirectly regulates its own growth and maturation through secretion of 
oocyte growth factors that act on the CC. The key oocyte growth factors GDF9 and BMP15 
regulate important developmental events in GC (e.g. proliferation, steroidogenesis and 
differentiation, prevention of premature luteinisation and apoptosis, and CC mucification) as 
well as the synthesis and delivery of essential reagents and substrates from the GC to the 
oocyte (Gilchrist et al., 2008; Su et al., 2009). Levels of mature GDF9 in follicular fluid have 
been reported to be positively associated with high quality embryos during IVF (Gode et al., 
2011). A number of other processes are also indicative of oocyte competence including 
glucose uptake and metabolism (Krisher and Bavister, 1999), DNA damage repair (Marangos 
and Carroll, 2012), and mitochondrial function (Stojkovic et al., 2001). 
Within an antral follicle, the CC that surround the oocyte are in direct contact with follicular 
fluid. In humans, numerous studies have shown that after exposure to certain chemical 
contaminants such as BPA, caffeine or cotinine, these reagents are able to cross from the 
blood stream into follicular fluid. In this context, these contaminants have the potential to 
influence oocyte functions (Zenzes et al., 1996; Ikezuki et al., 2002; Al-Saleh et al., 2010). 
Moreover, results from Chapter 6 established that in vitro exposure of rat COC to BPA or 
nicotine resulted in increased trafficking from CC to the oocyte via GJ communication. 
Conversely, these results also showed that in vitro exposure to caffeine, ethanol, MDMA, or 
THC did not affect GJ communication in rat COC. While transfer of nutrients to the oocyte is 
important for oocyte maturation, this does not provide information about the health of the 
oocyte itself. Oocyte health may be indirectly measured by quantifying the expression levels 
of key genes involved in critical pathways that regulate normal oocyte function. 
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The aim of this chapter was to determine the effects of in vitro exposure of rat COC to BPA, 
caffeine, ethanol, nicotine, MDMA, or THC on Atr, Bmp15, Cx37, and Gdf9 mRNA expression 
levels within the oocyte. 
7.2 Methods 
DO were collected at completion of a GJ bioassay (those samples collected for Chapter 6). 
The samples were stored at -80 °C prior to extraction of total RNA as described in Section 
2.3.1. The mRNA levels of Atr, Cycs, Glut1; and Gdf9, Bmp15 and Cx37 were measured using 
multiplex TaqMan qPCR as previously described (Section 2.3.2). Levels of Cycs and Glut1 
were below the detection limit, and were not included in the analyses. Expression levels of 
the reference gene Rpl19 were also measured in each of these multiplex reactions. Each 
reaction run included a calibrator sample which contained cDNA from a pool of rat COC and 
this allowed comparison between reaction runs. The mRNA levels for each candidate gene 
were corrected for the mRNA levels of the same gene in the calibrator sample. 
Subsequently, the data were analysed using the 2(-ΔΔCT) method (Livak and Schmittgen, 
2001). The relative linear mRNA levels were analysed for normality using the D'Agostino & 
Pearson normality test. Data that were not normally-distributed were transformed (using 
natural logarithms, squared, or square root transformations) and reanalysed by the 
D'Agostino & Pearson normality test to confirm a normal distribution. Normally-distributed 
data were analysed by a two-way ANOVA.  
7.3 Results 
7.3.1 Effect of BPA on gene expression in rat oocytes 
The effect of in vitro exposure of rat COC to 20 ng/mL BPA on mRNA levels of oocytes is 
depicted in Figure 7-1. For all candidate genes (i.e. Atr, Bmp15, Cx37 and Gdf9), there were 
no significant effects of time or treatment although a treatment x time interaction was close 
to being significant for Cx37 (P=0.058). This appeared to be due to the mean Cx37 levels 
decreasing over time in the BPA-treated oocytes, whilst that in the control oocytes appeared 
to increase. Very similar patterns of gene expression were observed for Atr, Bmp15, and 
Gdf9.  There was a significant effect of time but not treatment on Rpl19 mRNA levels and no 
treatment x time interaction was observed. Overall, the levels of Rpl19 mRNA were lower at 
25 hours compared to 1 hour. 
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Figure 7-1: Effect of BPA on mRNA levels of Atr (A), Bmp15 (B), Cx37 (C), Gdf9 (D), and Rpl19 (E) in rat 
oocytes. The control group is represented by the unfilled bars ( ), while the BPA-treated group is 
represented by the hatched bars ( ). Values are shown as means ± upper/lower limit of linearised CT values 
normalised against the mean of the control group at 1 hour. The data were generated from a total of 10-12 
readings from individual oocytes in each group. A two-way ANOVA was performed on untransformed data (B, 
C), natural log transformed data (A, E) or squared data (D). 
 
7.3.2 Effect of caffeine on gene expression in rat oocytes 
The effect of in vitro exposure of rat COC to 100 μg/mL caffeine on mRNA levels of oocytes is 
depicted in Figure 7-2. There was no effect of treatment or time, nor any treatment x time 
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interactions for any of the candidate genes (i.e. Atr, Bmp15, Cx37, and Gdf9). Atr levels 
appeared to decrease over time, however this was not significant (P=0.069). The Rpl19 levels 
were similar across both treatment groups and exposure times. 
 
 
Figure 7-2: Effect of caffeine on mRNA levels of Atr (A), Bmp15 (B), Cx37 (C), Gdf9 (D), and Rpl19 (E) in rat 
oocytes. The control group is represented by the unfilled bars ( ), while the caffeine-treated group is 
represented by the hatched bars ( ). Values are shown as means ± upper/lower limit of linearised CT values 
normalised against the mean of the control group at 1 hour. The data were generated from a total of 10-12 
readings from individual oocytes in each group. A two-way ANOVA was performed on untransformed data (B, 
C, D), square-root transformed data (A), or natural log transformed data (E). 
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7.3.3 Effect of ethanol on gene expression in rat oocytes 
The effect of in vitro exposure of rat COC to 7.5 mg/mL ethanol in mRNA levels of oocytes is 
depicted in Figure 7-3. There were no significant effects of treatment, time or treatment x 
time interactions on Atr, Bmp15, Cx37, Gdf9, or Rpl19 mRNA levels. No significant effects of 
treatment or time, or treatment x time interactions on Rpl19 levels were observed. Rpl19 
levels appeared to be higher in the ethanol-treated DO than the control however this was 
not significant (P=0.065).  
7.3.4 Effect of nicotine on gene expression in rat oocytes 
The effect of in vitro exposure of rat COC to 500 ng/mL nicotine on mRNA levels of oocytes is 
depicted in Figure 7-4. There was no effect of treatment or time, or a treatment x time 
interaction on Atr, Bmp15 or Gdf9 levels in rat oocytes. While not significant, Atr levels did 
appear to decline with time (P=0.068). For Cx37, there was no significant effect of treatment 
or time however a significant treatment x time interaction was noted.  Whilst Cx37 mRNA 
levels were similar at both time points in the control oocytes, Cx37 levels appeared to 
decrease with time in the nicotine-treated oocytes. There was no effect of treatment or 
time, or a treatment x time interaction on Rpl19 levels in rat oocytes. 
7.3.5 Effect of MDMA on gene expression in rat oocytes 
The effect of in vitro exposure of rat COC to 2 μg/mL MDMA on mRNA levels of oocytes is 
depicted in Figure 7-5. There were no significant effects of treatment or time, or treatment x 
time interactions with respect to the levels of Atr, Bmp15, Cx37, Gdf9, or Rpl19 mRNA in rat 
oocytes. 
7.3.6 Effect of THC on gene expression in rat oocytes 
The effect of in vitro exposure of rat COC to 500 ng/mL THC on mRNA levels of oocytes is 
depicted in Figure 7-6. There were no significant effects of treatment or time, or treatment x 
time interactions with respect to levels of Atr or Gdf9 mRNA in rat oocytes. For Bmp15 and 
Cx37, there were significant effects of time but there were no treatment or treatment x time 
interactions: the levels for both of these genes increased with time, especially in the THC-
treated groups. There were no significant effects of treatment, time, or treatment x time 
interactions on Rpl19 levels in rat oocytes.  
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Figure 7-3: Effect of ethanol on mRNA levels of Atr (A), Bmp15 (B), Cx37 (C), Gdf9 (D), and Rpl19 (E) in rat 
oocytes. The control group is represented by the unfilled bars ( ), while the ethanol-treated group is 
represented by the hatched bars ( ). Values are shown as means ± upper/lower limit of linearised CT values 
normalised against the mean of the control group at 1 hour. The data were generated from a total of 10-12 
readings from individual oocytes in each group. A two-way ANOVA was performed on untransformed data (B, 
C, D), or square root transformed data (A, E).  
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Figure 7-4: Effect of nicotine on mRNA levels of Atr (A), Bmp15 (B), Cx37 (C), Gdf9 (D), and Rpl19 (E) in rat 
oocytes. The control group is represented by the unfilled bars ( ), while the nicotine-treated group is 
represented by the hatched bars ( ). Values are shown as means ± upper/lower limit of linearised CT values 
normalised against the mean of the control group at 1 hour. The data were generated from a total of 9-12 
readings from individual oocytes in each group. A two-way ANOVA was performed on untransformed data (A, 
B, C, D) or natural log transformed data (E).  
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Figure 7-5: Effect of MDMA on mRNA levels of Atr (A), Bmp15 (B), Cx37 (C), Gdf9 (D), and Rpl19 (E) in rat 
oocytes. The control group is represented by the unfilled bars ( ), while the MDMA-treated group is 
represented by the hatched bars ( ). Values are shown as means ± upper/lower limit of linearised CT values 
normalised against the mean of the control group at 1 hour. The data were generated from a total of 10-12 
readings from individual oocytes in each group. A two-way ANOVA was performed on untransformed data (B, 
C, D, E) or square-root transformed data (A).  
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Figure 7-6: Effect of THC on mRNA levels of Atr (A), Bmp15 (B), Cx37 (C), Gdf9 (D), and Rpl19 (E) in rat 
oocytes. The control group is represented by the unfilled bars ( ), while the THC-treated group is 
represented by the hatched bars ( ). Values are shown as means ± upper/lower limit of linearised CT values 
normalised against the mean of the control group at 1 hour. The data were generated from a total of 10-12 
readings from individual oocytes in each group. A two-way ANOVA was performed on untransformed (B, C, D, 
E) or natural log transformed data (A).  
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7.4 Discussion 
These results reveal that the expression of the oocyte-derived genes measured in this study 
are mostly unchanged following exposure to a range of lifestyle factors and environmental 
contaminants. There was a treatment x time interaction for Cx37 mRNA expression following 
nicotine exposure, where nicotine caused a reduction in Cx37 mRNA levels over time in rat 
oocytes, compared to an increase in control oocytes. Surprisingly, in vitro exposure to BPA, 
caffeine, ethanol, MDMA, or THC alone had no effect on the mRNA levels in rat oocytes of 
any of the genes tested. 
CX37 is the primary component of oocyte-derived GJ channels (Simon et al., 1997; Teilmann, 
2005) and is essential for transfer of nutrients to the oocyte. Ratchford et al. (2008) 
demonstrated an association between the reduced health of oocytes from diabetic mice, 
reduced Cx37 mRNA levels, and impaired GJ coupling between the oocyte and CC. Therefore, 
the changes in Cx37 expression levels after exposure to nicotine may be of biological 
significance.  
The oocytes used in this study were collected following a GJ dye transfer assay. As discussed 
previously (Chapter 6), this GJ assay involved COC being exposed to a treatment for 0, 4, 12, 
or 24 hours. Thereafter COC were incubated with calcein-AM for 10 minutes and then 
incubated for a further hour in calcein-free media, but still in the presence of the treatment. 
The results presented in this chapter suggest that nicotine raises Cx37 expression in the 
oocyte following a 1 hour exposure, but this effect is attenuated after a 25 hour exposure. 
The finding that nicotine had different effects depending on exposure time may be related 
to the metabolism of nicotine over time. It is reasonable to expect that after a 1 hour 
exposure, most of the nicotine would not have been metabolised. However, after 25 hours 
in vitro it is possible that most of the nicotine had been metabolised. As discussed in Chapter 
6, CYP2A6, which catalyses the conversion of nicotine to cotinine, is expressed in the mouse 
ovary (Cannady et al., 2003). Moreover, cotinine has been detected in follicular fluid (Zenzes 
et al., 1996; Shoaib and Stolerman, 1999).  
Interestingly, exposure to BPA, caffeine, ethanol, MDMA, or THC did not affect mRNA levels 
of any of the oocyte-derived genes tested. This was unexpected, as BPA, caffeine, and 
ethanol have all been reported to directly affect oocyte quality following in vitro exposure 
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(Jagiello et al., 1972; O’Neill et al., 1989; Lenie et al., 2008). However, the oocytes in the 
present study were cultured as intact COC. The CC may have acted as a protective barrier, 
perhaps preventing at least a proportion of the harmful factors from direct action on the 
oocyte. In addition, the variability that exists between the maturation stages of individual 
oocytes may have masked any treatment effects.  
The levels of oocyte-derived Rpl19 were not affected by any of the treatments tested in this 
study. Similarly, levels of Rpl19 were not affected by incubation time with the notable 
exception of the BPA experiment. Levels of Rpl19 decreased over time in the BPA 
experiment, indicating that oocytes containing less total RNA were selected at the 25 hour 
time point. Expression levels of many of the candidate genes showed a similar pattern to 
that of Rpl19. Overall these results reveal that expression levels of oocyte-derived Atr, 
Bmp15, Cx37, and Gdf9 are generally stable regardless of time that the COC spent in culture.  
In summary, the major finding from this chapter was that exposure of rat COC to potentially 
detrimental compounds (i.e. BPA, caffeine, ethanol, MDMA, or THC) did not alter the overall 
expression of oocyte genes measured in this study. The exposure of nicotine did result in 
increased oocyte-derived Cx37 at 1 hour, but decreased Cx37 at 25 hours. The changes in 
Cx37 expression levels following exposure to nicotine may influence the availability of 
nutrients and other molecules necessary for oocyte health. 
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8 EFFECTS OF IN VITRO EXPOSURE OF COC TO LIFESTYLE FACTORS 
ON GENE EXPRESSION IN CC 
8.1 Introduction 
During follicular development, the CC provide the oocyte with glucose metabolites, 
cholesterol metabolites, cAMP, ions and amino acids. Thus, the CC have a nurturing role 
during oocyte maturation. This is facilitated by the passing of these low molecular weight 
compounds to the oocyte through GJ (Kidder and Vanderhyden, 2010). However, in addition 
to important substrates for oocyte maturation, the follicular fluid microenvironment 
contains exudates from the plasma so that the COC can also be exposed to a number of 
potentially harmful environmental or lifestyle factors (Weiss and Eckert, 1989; Zenzes et al., 
1996; Al-Saleh et al., 2010).  
As the CC surround the oocyte within the follicle, they are also considered to have a 
protective role for the oocyte. For example, the CC protect the oocyte from oxidative stress 
during follicular development (Tatemoto et al., 2000). Exposure to a reactive oxidative 
species generating system (XOD) caused meiotic arrest in DO, and this was coincident with 
the activation of caspase-3 and thus increased activation of the apoptotic pathway. In 
contrast, COC that were exposed to XOD did not exhibit this activation of caspase-3 and had 
higher levels of the antioxidant glutathione (Tatemoto et al., 2000).  
In Chapter 6 it was determined that in vitro exposure of COC to BPA or nicotine resulted in 
increased GJ transfer from the CC to the oocyte. However, in vitro exposure of COC to 
caffeine, ethanol, MDMA, or THC did not affect GJ communication. In Chapter 7, it was 
found that an interaction between time and nicotine treatment was observed for the oocyte 
GJ gene, Cx37. The effects of these compounds on gene expression in oocytes are most likely 
facilitated through regulatory mechanisms within CC. Thus, these compounds would be 
expected to cause even larger perturbations in gene expression levels of CC. 
The aim of this chapter was to determine the effects of in vitro exposure of rat COC to BPA, 
caffeine, ethanol, nicotine, MDMA, or THC on Atr, Cx43, Cycs, Gfpt1, and Pfkp mRNA 
expression levels in the CC. 
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8.2 Methods 
The collection of CC masses from individual COC was undertaken following completion of the 
GJ bioassays described in Chapter 6. The samples were stored at -80 °C prior to total RNA 
extraction as described in Section 2.3.1. The incubation times referred to henceforth indicate 
the total time each COC was incubated with the treatment in Chapter 6 (i.e. a 0 or 24 hour 
pre-calcein incubation followed by a 1 hour post-calcein incubation). The mRNA levels of the 
candidate genes were measured in quadriplex reaction (Atr/Cycs/Glut1 and 
Cx43/Gfpt1/Pfkp, respectively) using multiplex TaqMan qPCR as previously described 
(Section 2.3.2). Glut1 was excluded from the final analysis, as expression levels were below 
the detection limit. The final gene in each multiplex reaction was the reference gene Rpl19, 
which was used to correct gene expression for RNA input. Each reaction run included a 
calibrator sample which contained cDNA from a pool of rat COC; this allowed comparisons to 
be made between reaction runs. The mRNA levels for each candidate gene were corrected 
for the Rpl19 levels of that sample. Subsequently, the data were analysed using the 2(-ΔΔCT) 
method (Livak and Schmittgen, 2001).  
The relative linear mRNA levels were analysed for normality using the D'Agostino & Pearson 
normality test. Data that were not normally-distributed were transformed (using natural log, 
square root, square root(y+0.5), y/y+1, or squared transformations) and reanalysed to 
confirm a normal distribution. The normally-distributed data were analysed by a two-way 
ANOVA.  
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8.3 Results 
8.3.1 Effect of BPA on gene expression in rat CC 
The effect of in vitro exposure of COC to 20 ng/mL BPA on mRNA levels in CC is depicted in 
Figure 8-1. There were no effects of time or treatment, or a treatment x time interaction on 
Atr, Gfpt1, and Pfkp mRNA levels: the apparent decline in Pfkp levels with time in culture in 
the control group was not significant (P=0.068) However, there was a treatment x time 
interaction for Cx43 mRNA levels, along with treatment and time main effects. The 
expression levels for Cx43 remained steady over time in the control CC, but had increased 
markedly after 25 hours in culture in the BPA-treated CC. There was a significant decline in 
Cycs mRNA levels over time in both the control and BPA-treated CC. There were no effects of 
time, treatment, or a treatment x time interaction on Rpl19 mRNA levels. 
8.3.2 Effect of caffeine on gene expression in rat CC 
The effect of in vitro exposure of COC to 100 μg/mL caffeine on mRNA levels in rat CC is 
depicted in Figure 8-2. There were no significant effects of treatment, time, or a treatment x 
time interaction on Atr mRNA levels although the mean expression levels were ~50 % lower 
(P=0.069) at 25 hours in both the control and caffeine-treated CC. Both treatment and time 
effects were measured for Cx43 mRNA where levels were reduced at 25 hours, compared to 
1 hour, in both control and caffeine-treated CC. Moreover, Cx43 mRNA was further reduced 
in the caffeine-treated CC, compared to control CC at both time points. There was an effect 
due to time, but not treatment, or a treatment x time interaction for Cycs, Gfpt1, and Pfkp 
mRNA levels. Expression levels of all of these genes were reduced at 25 hours, compared to 
1 hour, in both the control and caffeine-treated groups. There were no effects of time, 
treatment, or a treatment x time interaction on Rpl19 mRNA levels. 
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Figure 8-1: Effect of BPA on mRNA levels of Atr (A), Cx43 (B), Cycs (C), Gfpt1 (D), Pfkp (E), and Rpl19 (F) in rat 
CC. The control group is represented by the unfilled bars ( ), while the BPA-treated group is represented by 
the hatched bars ( ). Values are shown as means ± upper/lower limit of linearised CT values normalised 
against the mean of the control group at 1 hour. The data were generated from a total of 11-12 readings from 
individual oocytes in each group. A two-way ANOVA was performed on untransformed data (B, E), natural log 
transformed data (D, F) or squared-root transformed data (A), square-root(y+0.5) transformed data (C). 
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Figure 8-2: Effect of caffeine on mRNA levels of Atr (A), Cx43 (B), Cycs (C), Gfpt1 (D), Pfkp (E), and Rpl19 (F) in 
rat CC. The control group is represented by the unfilled bars ( ), while the caffeine-treated group is 
represented by the hatched bars ( ). Values are shown as means ± upper/lower limit of linearised CT values 
normalised against the mean of the control group at 1 hour. The data were generated from a total of 10-12 
readings from individual oocytes in each group. A two-way ANOVA was performed on untransformed data (A, 
C, D, E), natural log transformed data (B, F).  
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8.3.3 Effect of ethanol on gene expression in rat CC 
The effect of in vitro exposure of COC to 7.5 mg/mL ethanol on mRNA levels in rat CC is 
depicted in Figure 8-3. There were no effects of time, treatment, or a treatment x time 
interaction on Atr mRNA levels. A treatment x time interaction was observed for Cx43 
expression levels: this was likely due to the mean Cx43 levels in ethanol-treated CC being 
higher than the controls at 1 hour, but similar at 25 hours. An effect of time was observed 
for Cycs, Gfpt1, and Pfkp mRNA levels where expression levels of all these genes were lower 
at 25 hours relative to 1 hour in both groups. Whilst expression levels of Gfpt1 appeared to 
be further reduced in the ethanol-treated, compared to the control, CC, this did not reach 
significance (P=0.14). The mean levels of Gfpt1 expression in the ethanol-treated groups 
were skewed by one outlier at 1 hour (relative Gfpt1 level of 0.012) and two outliers at 25 
hours (relative Gfpt1 levels of 0.004 and 0.008). However, these did not appear to affect the 
statistical analysis. These samples were not removed from the analysis as the Rpl19 CT value 
was within the sensitive range. There were no effects of time, treatment, or a treatment x 
time interaction on Rpl19 mRNA levels.   
8.3.4 Effect of nicotine on gene expression in rat CC 
The effect of in vitro exposure of COC to 500 ng/mL nicotine on mRNA levels in rat CC is 
depicted in Figure 8-4. There were no effects of time, treatment, or a treatment x time 
interaction on Atr mRNA levels. Although levels of Atr mRNA were lower in control CC at 25 
hours compared to that at 1 hour this was not significant (P=0.17). There were effects of 
time on Cx43, Cycs, Gfpt1 and Pfkp mRNA levels. Mean expression levels of each gene were 
reduced at 25 hours, compared to 1 hour, in both the control and nicotine-treated groups. 
Moreover, Cx43 mRNA was further reduced (P=0.052) in the nicotine-treated group, 
compared to control group at 25 hours. Conversely, the levels of Cycs mRNA were higher 
although not significantly so (P=0.07), in the nicotine-treated group compared to the control 
at 25 hours. There were no effects of time, treatment, or a treatment x time interaction on 
Rpl19 mRNA levels. 
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Figure 8-3: Effect of ethanol on mRNA levels of Atr (A), Cx43 (B), Cycs (C), Gfpt1 (D), Pfkp (E), and Rpl19 (F) in 
rat CC. The control group is represented by the unfilled bars ( ), while the ethanol-treated group is 
represented by the hatched bars ( ). Values are shown as means ± upper/lower limit of linearised CT values 
normalised against the mean of the control group at 1 hour. The data were generated from a total of 10-12 
readings from individual oocytes in each group. A two-way ANOVA was performed on untransformed data (B, 
C, D, E), natural log transformed data (F) and 1/(y+1) transformed data (A).  
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Figure 8-4: Effect of nicotine on mRNA levels of Atr (A), Cx43 (B), Cycs (C), Gfpt1 (D), Pfkp (E), and Rpl19 (F) in 
rat CC. The control group is represented by the unfilled bars ( ), while the nicotine-treated group is 
represented by the hatched bars ( ). Values are shown as means ± upper/lower limit of linearised CT values 
normalised against the mean of the control group at 1 hour. The data were generated from a total of 11-12 
readings from individual oocytes in each group. A two-way ANOVA was performed on untransformed data (A, 
C, D), natural log transformed data (B, E, F).  
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8.3.5 Effect of MDMA on gene expression in rat CC 
The effect of in vitro exposure of COC to 2 μg/mL MDMA on mRNA levels in rat CC is 
depicted in Figure 8-5. A time effect was observed for Atr mRNA whereby expression levels 
had increased in both groups at 25 hours, compared to 1 hour. There were treatment effects 
on expression levels of both Cx43 and Gfpt1. Expression levels of Cx43 and Gfpt1 levels were 
increased in the MDMA-treated group, compared to the control, at both time points. There 
were effects of time x treatment interactions for Cycs and Pfkp expression. The mean Cycs 
levels in the MDMA-treated group were similar at 1 hour, but reduced at 25 hours, relative 
to the control.  Pfkp levels in the MDMA-treated group were increased at 1 hour, but were 
reduced at 25 hours, relative to the control group. There were no effects of time or 
treatment on Rpl19 mRNA levels. 
8.3.6 Effect of THC on gene expression in rat CC 
The effect of in vitro exposure of COC to 500 ng/mL THC on mRNA levels in rat CC is depicted 
in Figure 8-6. There was an effect of time on Atr expression whereby levels were increased in 
both THC-treated and control groups at 25 hours, compared to that at 1 hour. The 
expression levels of Cx43 were affected by treatment and time. The mean levels of Cx43 
mRNA were similar between the two time points in the control group, but had increased 
with time in the THC-treated group. An effect of time was observed for both Cycs and Pfkp 
genes where expression levels of both Cycs and Pfkp were decreased in the control and THC-
treated groups at 25 hours, compared to 1 hour. Additionally, Gfpt1 mRNA levels were 
increased in the THC-treated group at both time points, compared to the control. There 
were no effects of time or treatment on Rpl19 mRNA levels. 
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Figure 8-5: Effect of MDMA on mRNA levels of Atr (A), Cx43 (B), Cycs (C), Gfpt1 (D), Pfkp (E), and Rpl19 (F) in 
rat CC. The control group is represented by the unfilled bars ( ), while the MDMA-treated group is 
represented by the hatched bars ( ). Values are shown as means ± upper/lower limit of linearised CT values 
normalised against the mean of the control group at 1 hour. The data were generated from a total of 12 
readings from individual oocytes in each group. A two-way ANOVA was performed on untransformed data (A, 
B, C, D, F), natural log transformed data (E). 
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Figure 8-6: Effect of THC on mRNA levels of Atr (A), Cx43 (B), Cycs (C), Gfpt1 (D), Pfkp (E), and Rpl19 (F) in rat 
CC. The control group is represented by the unfilled bars ( ), while the THC-treated group is represented by 
the hatched bars ( ). Values are shown as means ± upper/lower limit of linearised CT values normalised 
against the mean of the control group at 1 hour. The data were generated from a total of 12 readings from 
individual oocytes in each group. A two-way ANOVA was performed on untransformed data (B, C, D, E), 
squared data (A), or square-root transformed data (F). 
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8.4 Discussion 
These results reveal that the function of CC within rat COC is influenced by lifestyle or 
environmental contaminants in the surrounding environment. This study shows that the in 
vitro exposure of COC to BPA, caffeine, ethanol, MDMA and THC, but not nicotine, resulted 
in modified expression levels of one or more of CC-derived genes.  
The finding that Cx43 mRNA levels increased after a long (i.e. 25 hour) but not a short-term 
(i.e. 1 hour) exposure to BPA indicates that BPA may act indirectly to modify Cx43 
expression. The increased levels of Cx43 mRNA suggest that prolonged exposure to BPA may 
increase the number of GJs and/or hemichannels present in the CC. Interestingly, exposure 
to BPA did not affect Atr expression, a gene that mediates the response to DNA damage by 
causing G2/M arrest. BPA inhibits mitosis in murine GC resulting in G2/M arrest (Xu et al., 
2002), however, the Xu study used a dose of BPA that was >1000-fold higher than that used 
in the current study.  
Conversely, the exposure of cultured rat COC to caffeine resulted in an overall reduction in 
Cx43 mRNA in CC. This result was surprising as caffeine is a broad-range PDE inhibitor that 
has been shown to both promote GJ communication and increase intracellular cAMP levels 
in rat fibroblasts and epithelial cells in vitro (Flagg-Newton et al., 1981). Indeed, a previous 
study found that increases in intracellular cAMP levels that induced GJ communication in a 
rat hepatoma cell line were coincident with increased Cx43 mRNA levels (Mehta et al., 
1992). Therefore, it was expected that caffeine would increase Cx43 levels. However as 
discussed in Chapter 6, the addition of PDE inhibitors for the entire incubation period in the 
current study may have maximally-inhibited PDE activity therefore masking any similar 
effects of caffeine. Thus, the mechanism by which caffeine elicits a reduction of Cx43 mRNA 
may not be related to the PDE inhibitory properties of caffeine.  
Exposing rat COC to ethanol for a short-term period i.e. 1 hour) caused a slight increase in 
CC-derived Cx43 mRNA levels, but following a long term exposure, the mean Cx43 mRNA 
levels were similar to the control. The results presented here suggest that short exposures to 
ethanol resulted in an increased number of CX43 GJ channels/hemichannels in rat CC. 
Thereafter, either receptor desensitization or metabolism of ethanol may result in a 
reduction of Cx43 mRNA to levels similar to that of the control. Ethanol is metabolised by 
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alcohol dehydrogenase (ADH) isoenzymes, the expression of which have been confirmed in 
murine oocytes (Rout and Armant, 2002). However the major isoenzyme that metabolises 
ethanol, namely ADH1, was not detected. Desensitization of the cellular response to ethanol 
over long exposure times has previously been reported in a neuroblastoma cell line (Gordon 
et al., 1986). Initial exposure of neuroblastoma cells to ethanol resulted in increased 
production of cAMP, however chronic exposure caused desensitization of the heterologous 
receptors that are coupled to the GTP-binding protein GS, resulting in reduced cAMP 
production (Gordon et al., 1986; Mochly-Rosen et al., 1988). The finding in this present study 
that Cx43 mRNA is increased in rat CC following exposure to ethanol for 1 hour is consistent 
with increased intracellular cAMP (Mehta et al., 1992). In addition, the finding that the 
ethanol-mediated increase in Cx43 mRNA was attenuated following a 25 hour exposure is 
consistent with desensitization of rat CC.   
Interestingly, nicotine treatment did not significantly affect mRNA levels of any of the 
candidate genes tested in CC. However, the results presented in this study suggest that in 
vitro exposure to nicotine may result in a small reduction (P=0.052) in Cx43 mRNA levels in 
rat CC. This is in contrast with a previous study which found that exposure to nicotine in vitro 
resulted in increased Cx43 mRNA levels in human umbilical vein endothelial cells (Tsai et al., 
2004). However as discussed in Chapter 6, the concentration of nicotine used by the Tsai 
group was 195 times greater than that used in this study.  
The effects of MDMA on gene expression levels in CC were more pronounced than the other 
aforementioned treatments in that treatment effects or treatment x time effects were 
observed in four out of the five candidate genes tested. Expression levels for both Cx43 and 
Gfpt1 mRNA were higher at both time points in the MDMA-treated, compared to control CC. 
In addition, a time x treatment interaction was observed for Cycs and Pfkp levels where Pfkp 
levels were higher at 1 hour but lower at 25 hours in the MDMA-treated CC, and Cycs levels 
were similar at 1 hour but lower at 25 hours in the MDMA-treated CC, compared to controls. 
These results indicate that MDMA acts directly on CC (i.e. within 1 hour) to regulate gene 
expression. To the best of my knowledge this is the first study that has examined the effect 
of MDMA on Cycs, Gfpt1, or Pfkp mRNA levels in any tissue type. The increase in Cx43 mRNA 
suggests that exposure to MDMA results in an increase in the number of GJs and/or 
hemichannels present between rat CC which is in contrast to neonatal rat ventricular 
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myocytes where MDMA reduced expression levels of Cx43 (Zhuo et al., 2013). Interestingly, 
these results also strongly suggest that MDMA affects expression of genes involved in 
glucose metabolism. MDMA has been shown to regulate glucose metabolism in several 
areas of the brain, although the effects are dependent upon the location within the brain 
(Obrocki et al., 1999). In the present study, MDMA increased the expression patterns of 
Gfpt1 and Pfkp at 1 hour, indicating that energy production via the hexosamine and 
glycolytic pathways was increased. The simultaneous increase of both glucose utilisation 
rate-limiting enzymes in conjunction with increased Cx43 mRNA is possibly due to increased 
glucose uptake by CC however the expression levels of the glucose transport Glut1 mRNA 
were below detection limits. Enhanced glucose uptake may lead to an increase in all four 
glucose utilisation pathways in the COC (i.e. glycolysis, hexosamine, pentose phosphate, and 
polyol pathways) which is linked with an increase in reactive oxygen species and precocious 
resumption of nuclear maturation (Sutton-McDowell et al., 2010). Interestingly, Cycs and 
Pfkp levels were reduced after 25 hours exposure to MDMA. The metabolism of MDMA 
occurs by two pathways: demethylenation which is catalysed by CYP2D1 and CYP3A2 in rats 
to produce 3,4-dihydroxymethamphetamine (HHMA); and N-demethylation which is 
catalysed by CYP1A2 and CYP2D1 to produce 3,4-methylenedioxyamphetamine (MDA) 
(Green et al., 2003). The four aforementioned CYP enzymes has been detected in the rat 
ovary (Hiroi et al., 1998; Lee et al., 2012). However, the expression of these enzymes has not 
been reported in particular ovarian cell types (i.e. the GC, CC, or oocyte). Therefore, a 
complex interplay between un-metabolised MDMA, HHMA, and MDA may exist to 
differentially regulate expression levels of Cx43, Cycs, Gfpt1, and Pfkp in rat CC over time.  
The exposure of rat COC to THC also resulted in an overall treatment effect for both Cx43, 
and Gfpt1 mRNA levels. The results presented here suggest that more CX43 
GJs/hemichannels may be present in the CC following a 25 hour exposure to THC. The 
finding that THC takes a longer time to modify Cx43 mRNA levels, suggests that Cx43 is less 
sensitive than Gfpt1 to THC, or that a THC metabolite is mediating the change in Cx43 levels. 
The primary enzymes involved in first pass metabolism of THC are CYP2C and CYP3A 
(Shimada et al., 1994). Almost 100 metabolites of THC have been identified, however the 
major metabolite is 11-OH-THC (Lemberger et al., 1973; Grotenhermen, 2003). The finding 
that Gfpt1 levels were upregulated at both time points in the THC-treated CC indicates that 
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the activity of the hexosamine biosynthetic pathway may be preferentially increased over 
the glycolytic pathways. This is a very interesting result as the major glucose utilisation 
pathway utilised in the COC is the glycolytic pathway while only a small proportion of 
glucose is utilised by the hexosamine pathway. The hexosamine pathway is involved in CC 
expansion, however inappropriate upregulation of this pathway has been linked to 
compromised developmental competence (Sutton-McDowell et al 2010). 
This study reveals that the most sensitive gene of those tested in rat CC was the GJ 
component Cx43. The levels of Cx43 were affected by all of the treatments included in this 
study, although the effect of nicotine did not quite reach significance (P=0.052). It is perhaps 
unsurprising that this was the case, as mRNA levels of Cx43 are rapidly regulated in response 
to many external stimuli including cAMP (Mehta et al., 1992), prostaglandin E2 and 
parathyroid hormone (Civitelli et al., 1998), and epidermal growth factor (Rivedal et al., 
1996). The half-life of most connexins is <10 hours (Hervé et al., 2007) suggesting that 
transcription and translation are important processes by which GJ communication may be 
regulated. Additionally, transcriptional regulation of the Cx43 gene in response to external 
stimuli may be an important mechanism by which the CC protect and nurture the oocyte.  
In summary, the main findings of this study were that the gene responsible for GJ transfer 
potential in CC (Cx43) was regulated by most of the compounds tested in this study. Overall, 
exposure of rat COC to BPA, MDMA, and THC increased CC-derived Cx43 mRNA levels but 
exposure of rat COC to caffeine, ethanol, and nicotine either lowered Cx43 mRNA levels or 
had little effect. Moreover, exposure of rat COC to MDMA and THC in vitro resulted in an 
overall increase in Gfpt1 mRNA, whilst a treatment x time interaction for Cycs and Pfkp was 
observed following MDMA exposure. 
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9 EFFECTS OF IN VITRO EXPOSURE OF COC TO LIFESTYLE FACTORS 
ON PROTEIN EXPRESSION 
9.1 Introduction 
Quantifying the expression level of a gene that encodes a particular protein only gives an 
indication of how much protein a cell is instructed to synthesise. Subsequent post-
transcriptional and post-translational modifications may further enhance or restrict the level 
of biologically-active protein that is available. Thus, while quantification of gene expression 
levels are very informative, a true account of the amount of protein being synthesised at any 
one time is only obtained by measuring protein expression levels.  The synthesis of both 
CX43 and GDF9 proteins are regulated by post-translational events. 
GJ communication is regulated in a dynamic manner throughout folliculogenesis by 
gonadotrophins (Granot and Dekel, 2002), cAMP and PKA (Yogo et al., 2002), and MAPK 
(Norris et al., 2008). Rats treated with pregnant mare’s serum gonadotrophin had increased 
levels of CX43 protein whereas an additional hCG injection resulted in a marked reduction in 
CX43 levels (Granot and Dekel, 1997). The Cx43 gene contains two exons separated by a 30 
kilobase intron; the first exon contains a 5’-untranslated region (UTR), while the second exon 
contains the protein coding region and a 3’-UTR. The first exon is differentially spliced to 
form at least nine different Cx43 species in mice, and six different species in rat (Pfeifer et 
al., 2004). These Cx43 species had varying translation efficiencies both between different 
species and in different cell lines. Therefore, as previously stated, levels of Cx43 gene 
expression may not correlate with protein levels. 
An important mechanism by which GJ communication is regulated is through 
phosphorylation of connexin proteins. For example, several forms of CX43 are often 
detected using Western blotting, including a non-phosphorylated form (P0), and two 
differentially phosphorylated forms (P1 and P2) that migrate at a slower rate (Solan and 
Lampe, 2009). Phosphorylation on Ser365 is responsible for the altered migration of the P1 
form (Solan et al., 2007), while phosphorylation at Ser325, Ser328, and Ser330 is responsible for 
the altered migration of the P2 form (Lampe et al., 2006). These phosphorylation sites are 
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thought to be involved in promoting GJ formation and activity (Yogo et al., 2002; Solan and 
Lampe, 2009). 
GDF9 is the primary oocyte-secreted factor involved in regulation of CC/GC function in 
rodents (Lin et al., 2012). Post-translational modifications are required for GDF9 signalling. 
As with other members of the TGFβ family, GDF9 is initially synthesised as a preproprotein. 
The signal peptide is removed upon secretion from the oocyte and the promature protein is 
released into the follicular fluid in humans, mice and sheep (Gilchrist et al., 2004b; McNatty 
et al., 2006; Gode et al., 2011). The proregions of TGFβ proteins are cleaved by proprotein 
convertase subtilisin/kexin enzymes (Harrison et al., 2011) and evidence exists that this 
cleavage occurs both intracellularly and extracellularly (Blanchet et al., 2008; Susan-Resiga et 
al., 2011). Generally, the mature protein has been considered to be the bioactive form. 
However, a recent study suggests that the proregion also plays an important role in female 
reproduction. When female mice were immunized with a GDF9 proregion peptide, these 
mice had more corpora lutea but smaller litter sizes (McIntosh et al., 2012). The exact role of 
the proregion is unknown, however for other TGFβ proteins it mediates dimer formation and 
targets the protein to the receptor (Sengle et al., 2008; Walton et al., 2009).  
Therefore, while transcriptional regulation of gene expression is an important indicator of an  
effect that a treatment has on a cell, this does not always correspond to what occurs at a 
protein level (Gygi et al., 1999). In addition, post-translational modifications play an 
important role in protein bioactivity and function.  
The aim of this chapter was to determine the effect of in vitro exposure of rat COC to BPA, 
caffeine, ethanol, nicotine, MDMA, or THC on the expression levels of CC-derived CX43 and 
oocyte-derived GDF9 proteins.  
9.2 Methods 
9.2.1 COC collection 
Ovaries from prepubescent Sprague-Dawley rats were collected in PBS and the COC were 
extracted as previously described (Section 2.1.2). The COC were incubated either with 
treatment or without treatment (control group) for 1 or 25 hours at 37 °C with 5 % CO2 and 
96 % humidity, to mimic the incubation conditions used in the GJ assay (see Chapter 6 and 
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Table 6-1). Subsequently, 100 COC were washed in PBS before being transferred into a 
microcentrifuge tube. The tubes were centrifuged at 800 x g for 10 minutes, the supernatant 
removed, and the COC resuspended in PBS supplemented with protease inhibitors. Each 
COC collection experiment was performed twice, and the samples were pooled so that the 
final number of COC in each sample was 200. The samples were stored at -20 °C until further 
processing.  
9.2.2 BCA Assay  
Total protein concentration was measured using the BCA assay (Section 2.4.1). Briefly, a 
bovine serum albumin standard was serially diluted in PBS and 25 μL was added in triplicate 
into a 96-well plate. One third of each COC sample (~67 COC in ~10 μL) was serially diluted in 
PBS and aliquoted in duplicate into a 96-well plate. BCA working reagent (200 μL) was added 
to each well, and the plate was then incubated at 37 °C (original assays) or 60 °C (subsequent 
assays) for 2 hours. The plates were cooled to room temperature and the absorbance at 490 
nm was measured using a VICTOR3 multilabel plate reader (PerkinElmer; Surrey Hills, 
Australia). The concentration of protein in each COC sample was calculated using the 
equation obtained from the bovine serum albumin standard curve.  
9.2.3 Western blotting 
Two-thirds of each COC sample (~133 COC in ~20 μL) was added to sample buffer, incubated 
at 95 °C in a water bath for 10 minutes, before being loaded onto a polyacrylamide gel. The 
proteins were separated according to size by SDS-PAGE, transferred onto a nitrocellulose 
membrane, and CX43 or GDF9 protein expression was detected using Western blotting. In 
brief, CX43 was identified using the monoclonal antibody MAB3067. To determine MAB3067 
specificity, the antibody was pre-absorbed with 5x the corresponding MAB3067 control 
peptide. GDF9 was detected using a monoclonal antibody (MAB47B) which was generated 
against the C-terminal region that corresponds to the mature region of ovine GDF9. To 
determine MAB47B specificity, the antibody was pre-absorbed with 5x E. coli produced 
recombinant ovine GDF9. The membranes were incubated with electrochemiluminescence 
reagents for 1 minute before being exposed to an X-ray film for between 1 and 10 minutes.  
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9.2.4 Data analysis 
The density of the bands present on the Western blots was measured using ImageJ software. 
For the CX43 blots, the density of the 43 kDa band was measured. For the GDF9 blots, the 
densities of the 49 kDa promature and, when present, the 20 kDa mature bands were 
measured. When multiple bands were present (e.g. when doublet or triplet bands were 
present for CX43) the density of all bands was measured. The total protein amount in each 
sample was used to correct for CX43, but not GDF9, protein levels. The reasoning behind this 
was that samples contained entire COCs which consisted mostly of large numbers of CC and 
a few (i.e. ~200) oocytes. Thus, differences in total protein levels between samples would 
predominantly be due to differences in the number of CC, and not oocytes. Therefore, CX43 
protein levels are referred to as corrected levels and GDF9 protein levels are referred to as 
uncorrected levels. 
Each experiment comprised of 200 COC for each experimental group at each time point, 
therefore there were only two replicated experimental samples at each time point. Thus 
statistical analysis was inappropriate and therefore interpretation of the data is simply based 
on the evidence of two replicate but independent studies. 
9.3 Results 
9.3.1 Effect of BPA and caffeine on protein levels in rat COC  
The effects of in vitro exposure of rat COC to 20 ng/mL BPA or 100 μg/mL caffeine on CX43 
protein levels are depicted in Figure 9-1. A 43 kDa band was observed in the positive control 
in both experimental replicates, while no bands were observed in the negative control in 
either replicate. There was some non-specific background signal in the first replicate (Figure 
9-1A), however this did not obscure the bands of interest. A 43 kDa band was observed in 
each of the lanes containing COC lysate. When the CX43 antibody was pre-absorbed with the 
control peptide, no bands were detected (Figure 9-1C).  
In the first replicate experiment (Figure 9-1A), a 1.7-fold reduction in CX43 levels with time in 
culture was noted in the control COC. Following exposure to BPA and caffeine for 1 hour, 
CX43 levels were 2.0-fold and 1.8-fold greater than the levels in the control at that time. 
Similar to the control, CX43 levels decreased over time in the BPA-treated and caffeine-
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treated COC whereby a 10-fold and 1.8-fold reduction in CX43 levels over time were 
observed for these treatments so that levels were 3-fold lower and 1.7-fold greater than the 
levels in the control at 25 hours.  
The treatment responses in the second replicate relative to the control differed somewhat 
from the first replicate but the CX43 levels over time followed the same pattern in all 
treatment groups (Figure 9-1B). CX43 levels in the control COC declined 10-fold with time in 
culture. CX43 levels were 1.4-fold lower or 1.4-fold greater after incubation with BPA and 
caffeine for 1 hour, compared to the control. Similar to the control, 1.8-fold and 7-fold 
reductions in CX43 levels were observed with time in culture so that levels were 4-fold and 
2-fold greater than that in the control following 25 hours incubation with BPA and caffeine, 
respectively.  
Regardless of treatment, there was a consistent decrease in the mean CX43 levels in 
cultured COC with time (Figure 9-2). CX43 levels following exposure to BPA were not 
different from that in the control, although there was variability between the BPA treated 
replicates after 1 hour of culture. Exposure of COC to caffeine after 1 hour resulted in a 
reproducible increase in CX43 levels compared to controls, however the overall decline in 
expression over 25 hours was similar to that noted in the control and BPA treated groups.  
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Figure 9-1: The effects of exposing rat COC to BPA and caffeine in vitro on CX43 protein levels over time. 
Western blots were performed in duplicate (A and B) to determine the level of CX43 protein in COC lysate. COC 
were either incubated for 1 or 25 hours with the solvent control (U), BPA (B), or caffeine (C). Rat ovary lysate 
was included as a positive control (+) and E. coli produced recombinant ovine BMP15 was included as a 
negative control (-). A control experiment (C) was also performed where the blot shown in (B) was stripped and 
re-probed with the CX43-specific antibody that had been pre-absorbed with its control peptide. Molecular sizes 
(kDa) are indicated to the left of each blot. The density of the band of interest (indicated by an arrowhead) was 
measured and corrected for the control at 1 hour. Total protein (μg) in each sample was determined using the 
BCA assay. The relative band densities were corrected for total protein amount, as calculated by the BCA assay.  
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Figure 9-2: Effect of BPA and caffeine on relative CX43 levels in rat COC. The control group is represented by 
the unfilled bars ( ), the BPA-treated group is represented by the striped bars ( ), while the caffeine-
treated group is represented by the dotted bars ( ). The bars represent the means, while the dashes 
represent each individual band density measurement. 
 
The effects of exposing rat COC to 20 ng/mL BPA or 100 μg/mL caffeine on GDF9 protein 
levels are depicted in Figure 9-3. Multiple bands between 20 and 114 kDa were detected in 
the positive control in both replicates. The bands in the positive control of the first replicate 
(Figure 9-3A) were overexposed, so most individual bands were unable to be distinguished. 
Bands of 49 and 20 kDa in size, corresponding to the promature and mature forms of GDF9 
respectively, were detected in the positive control lanes. Additional prominent bands of 93, 
70, and 40 kDa were observed. No bands were observed in the negative control.  When the 
GDF9 antibody was pre-absorbed with recombinant GDF9, no bands were observed (Figure 
9-3C). Multiple bands corresponding to the aforementioned molecular weights observed in 
the positive controls were observed in each of the lanes containing COC lysate.  
In the first replicate experiment (Figure 9-3A), promature GDF9 in control COC declined 5-
fold over time. Promature GDF9 levels were 2-fold and 3.3-fold lower than the control 
following incubation with BPA and caffeine for 1 hour. In contrast to the pattern of 
promature GDF9 levels over time in the control, the amount of promature GDF9 in the BPA-
treated and caffeine-treated COC increased 1.6-fold or 2.7-fold with time so that levels were 
4-fold greater in both the BPA- and caffeine-treated groups than that in the control at 25 
hours. Mature GDF9 protein was only detected in the control COC at 1 hour and in the 
treated COC at 25 hours. 
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In the second replicate experiment (Figure 9-3B), promature GDF9 levels in control COC 
decreased slightly (1.3-fold) with time. Promature GDF9 levels were 3.3-fold and 1.3-fold 
lower than the control following 1 hour exposure to BPA and caffeine respectively. In 
contrast to the pattern of promature GDF9 levels with time in the control, levels of 
promature GDF9 levels increased 6-fold and 2.4-fold with time in the BPA-treated and 
caffeine-treated COC, so that levels were 2.3-fold and 2.4-fold greater than the control at 25 
hours. Similar to the first replicate, mature GDF9 was only detected in the control COC at 1 
hours and the treated COC at 25 hours. 
Overall in the control COC, the mean promature GDF9 levels declined over time (Figure 9-4), 
notwithstanding the variability between the replicates after 25 hours in culture. Compared 
to the control, the mean levels of promature GDF9 for the BPA-treated and caffeine-treated 
group were lower after 1 hour in culture but both had recovered to levels above that in the 
controls after 25 hours in culture. 
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Figure 9-3: The effects of exposing rat COC to BPA and caffeine in vitro on GDF9 protein levels over time. 
Western blots were performed in duplicate (A and B) to determine the level of GDF9 protein in COC lysate. COC 
were either incubated for 1 or 25 hours with the solvent control (U), BPA (B), or caffeine (C). Rat ovary lysate 
was included as a positive control (+) and E. coli produced recombinant ovine BMP15 was included as a 
negative control (-). A control experiment (C) was also performed where the blot shown in (B) was stripped and 
re-probed with the GDF9-specific antibody that had been pre-absorbed with E. coli produced recombinant 
ovine GDF9. Molecular sizes (kDa) are indicated to the left of each blot. The densities of the bands of interest 
(indicated by arrowheads) were measured and corrected for the control at 1 hour. Total protein (μg) in each 
sample was determined using the BCA assay.  
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Figure 9-4: Effect of BPA and caffeine on relative GDF9 levels in rat COC. The control group is represented by 
the unfilled bars ( ), the BPA-treated group is represented by the striped bars ( ), while the caffeine-
treated group is represented by the dotted bars ( ). The bars represent the means, while the dashes 
represent each individual band density measurement. 
 
9.3.2 Effect of ethanol on protein levels in rat COC 
The effect of exposing COC to 7.5 mg/mL ethanol in vitro on CX43 protein levels is depicted 
in Figure 9-5. A 43 kDa band was observed in the positive control of both experimental 
replicates, while no bands were observed in the negative control of either. A 43 kDa band 
was observed in each of the lanes containing COC lysate. Multiple smaller bands were also 
present in all lanes however the identities of these bands are unknown. When the CX43 
antibody was pre-absorbed with the control peptide no bands were observed (Figure 9-5C). 
In the first replicate experiment (Figure 9-5A), CX43 levels in control COC did not change 
over time. CX43 levels were similar between the ethanol-treated and control COC at 1 hour. 
In the ethanol-treated COC, the CX43 levels decreased slightly (1.4-fold) over time and were 
1.3-fold lower after 25 hours of culture compared to the controls.  
A similar response was observed in the second replicate experiment (Figure 9-5B). Levels of 
CX43 in the control COC did not change over time. After ethanol exposure CX43 levels were 
1.3-fold greater after 1 hour, compared to the control and by 25 hours had decreased 1.6-
fold at which time the levels were 1.3-fold lower than that measured in the control. 
Overall in the control COC, CX43 levels did not change with time in culture (Figure 9-6). 
However in the ethanol-treated COC, there was a consistent reduction in CX43 levels after 
25 hours in culture, however this was negligible.  
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Figure 9-5: The effects of exposing rat COC to ethanol in vitro on CX43 protein levels over time. Western blots 
were performed in duplicate (A and B) to determine the level of CX43 protein in COC lysate. COC were either 
incubated for 1 or 25 hours with the solvent control (U) or ethanol (E). Rat ovary lysate was included as a 
positive control (+) and E. coli produced recombinant ovine BMP15 was included as a negative control (-). A 
control experiment (C) was also performed where the blot shown in (B) was stripped and re-probed with the 
CX43-specific antibody that had been pre-absorbed with its control peptide. Molecular sizes (kDa) are indicated 
to the left of each blot. The density of the band of interest (indicated by an arrowhead) was measured and 
corrected for the control at 1 hour. Total protein (μg) in each sample was determined using the BCA assay. The 
relative band densities were corrected for total protein amount, as calculated by the BCA assay. 
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Figure 9-6: Effect of ethanol on relative CX43 levels in rat COC. The control group is represented by the 
unfilled bars ( ), while the ethanol-treated group is represented by the striped bars ( ). The bars 
represent the means, while the dashes represent each individual band density measurement. 
 
The effect of exposing rat COC to 7.5 mg/mL ethanol on GDF9 protein levels are depicted in 
Figure 9-7. Multiple bands between 20 and 114 kDa were detected in the positive control of 
both replicates. The bands in the positive control of the first replicate (Figure 9-7A) were 
overexposed, so most individual bands were unable to be distinguished. Bands of 49 and 20 
kDa in size, corresponding to the promature and mature forms of GDF9 respectively were 
detected in the positive control lanes. Additional prominent bands of 93, 70, and 40 kDa 
were observed. No bands were observed in the negative control.  When the GDF9 antibody 
was pre-absorbed with recombinant GDF9, no bands were detected (Figure 9-7C). Multiple 
bands were observed in each of the lanes containing COC lysate, corresponding to the 
aforementioned molecular weights in the positive control.  
In the first replicate (Figure 9-7A), levels of promature GDF9 increased 2.4-fold over time in 
the controls. Promature GDF9 levels were 1.4-fold lower in ethanol-treated COC at 1 hour, 
compared to the control. Similar to the control, levels of promature GDF9 in the ethanol-
treated COC increased 3.4-fold over time such that levels were similar between the ethanol-
treated and control COC at 25 hours.  
In the second replicate, levels of promature GDF9 increased 1.6-fold over time in the 
controls (Figure 9-7B). Promature GDF9 levels were 1.3-fold lower following incubation with 
ethanol for 1 hour, compared to the control. In the ethanol-treated COC, levels of promature 
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GDF9 only increased slightly (1.3-fold) with time in culture so that levels were 1.6-fold lower 
at 25 hours, compared to the control.   
Overall, levels of promature GDF9 consistently increased after 25 hours in culture in both the 
control and ethanol-treated samples (Figure 9-8). However, no difference in the levels of 
promature GDF9 following incubation treatment were noted.  
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Figure 9-7: The effects of exposing rat COC to ethanol in vitro on GDF9 protein levels over time. Western 
blots were performed in duplicate (A and B) to determine the level of GDF9 protein in COC lysate. COC were 
either incubated for 1 or 25 hours with the solvent control (U) or ethanol (E). Rat ovary lysate was included as a 
positive control (+) and E. coli produced recombinant ovine BMP15 was included as a negative control (-). A 
control experiment (C) was also performed where the blot shown in (B) was stripped and re-probed with the 
GDF9-specific antibody that had been pre-absorbed with E. coli produced recombinant ovine GDF9. Molecular 
sizes (kDa) are indicated to the left of each blot. The density of the band of interest (indicated by an 
arrowhead) was measured and corrected for the control at 1 hour. Total protein (μg) in each sample was 
determined using the BCA assay. 
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Figure 9-8: Effect of ethanol on relative GDF9 levels in rat COC. The control group is represented by the 
unfilled bars ( ), while the ethanol-treated group is represented by the striped bars ( ). The bars 
represent the means, while the dashes represent each individual band density measurement. 
 
9.3.3 Effect of nicotine on protein levels in rat COC 
The effect of exposing rat COC to 500 ng/mL nicotine on CX43 protein levels is depicted in 
Figure 9-9. A 43 kDa band was observed in the positive control of both experimental 
replicates, while no bands were observed in the negative control of either replicate. A 43kDa 
band was observed in each of the lanes containing COC lysate. Multiple smaller bands were 
also present in all lanes however the identities of these bands are unknown. When the CX43 
antibody was pre-absorbed with the control peptide, the bands that had previously been 
visualised disappeared (Figure 9-9C).  
In the first replicate experiment (Figure 9-9A), CX43 levels decreased 5-fold over time in the 
control group. Levels of CX43 were 5-fold lower after incubation with nicotine for 1 hour 
when compared to the control group.  After 25 hours of culture, the CX43 levels increased 
2.5-fold over time in the nicotine-treated group such that levels were 2.5-fold greater in the 
nicotine-treated group compared to the control at 25 hours.  
A similar response was observed in the second replicate experiment (Figure 9-9B), CX43 
levels decreased 2.5-fold over time in the control group. Similar to the first replicate 
experiment, CX43 levels were 5-fold lower in COC incubated with nicotine for 1 hour 
compared to the control. CX43 levels increased 7.5-fold over time in the nicotine-treated 
COC increased, such that levels were 3.8-fold greater in the nicotine-treated group 
compared to the control at 25 hours.  
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Overall, there was a consistent decrease in CX43 levels with time in culture in the control 
group (Figure 9-10). Conversely, CX43 levels were markedly lower at 1 hour incubation in 
nicotine-treated COC compared to the controls but were higher than the equivalent controls 
after 25 hours of incubation. 
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 Figure 9-9: The effects of exposing rat COC to nicotine in vitro on CX43 protein levels in rat COC over time. 
Western blots were performed in duplicate (A and B) to determine the level of CX43 protein in COC lysate. COC 
were either incubated for 1 or 25 hours with the solvent control (U) or nicotine (N). Rat ovary lysate was 
included as a positive control (+) and E. coli produced recombinant ovine BMP15 was included as a negative 
control (-). A control experiment (C) was also run where the blot shown in (B) was stripped and re-probed with 
the CX43-specific antibody that had been pre-absorbed with its control peptide. Molecular sizes (kDa) are 
indicated to the left of each blot. The density of the band of interest (indicated by an arrowhead) was 
measured and corrected for the control at 1 hour. Total protein (μg) in each sample was determined using the 
BCA assay. The relative band densities were corrected for total protein amount, as calculated by the BCA assay. 
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Figure 9-10: Effect of nicotine on relative CX43 levels in rat COC. The control group is represented by the 
unfilled bars ( ), while the nicotine-treated group is represented by the striped bars ( ). The bars 
represent the means, while the dashes represent each individual band density measurement. 
 
The effects of exposing rat COC to 500 ng/mL nicotine on GDF9 protein levels are depicted in 
Figure 9-11. Multiple bands between 20 and 114 kDa were detected in the positive control 
of both replicates. The bands in the positive control of the first replicate (Figure 9-11A) were 
overexposed, so most individual bands were indistinguishable. Bands of 49 and 20 kDa in 
size, corresponding to the promature and mature forms of GDF9 respectively were detected 
in the positive control lanes. Additional prominent bands of 93, 70, and 40 kDa were 
observed. No bands were observed in the negative control.  When the GDF9 antibody was 
pre-absorbed with recombinant GDF9, no bands were detected (Figure 9-11C). Multiple 
bands were observed in each of the lanes containing COC lysate, corresponding to the 
aforementioned molecular weights in the positive control.  
In the first replicate experiment (Figure 9-11A), promature GDF9 levels did not change over 
time in the control group. Incubation of COC for 1 hour with nicotine resulted in promature 
GDF9 levels 2.5-fold lower than that in the control. However, promature GDF9 levels 
increased 3.3-fold with time in the nicotine-treated group such that levels were similar to 
that in control COC at 25 hours. Mature GDF9 was detected in the control COC after 1 hour 
of incubation, but the levels declined 1.7-fold with time. Mature GDF9 was undetectable in 
the nicotine-treated COC at 1 hour in culture but had increased by 25 hours in culture to 
levels nearly twice that of control COC. 
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Similar to the first replicate, promature GDF9 levels in the second replicate experiment did 
not change over time in the control group (Figure 9-11B). Levels of promature GDF9 were 
1.3-fold greater in the nicotine-treated group at 1 hour compared to the control, however 
decreased 1.2-fold with time to levels similar to that in the control at 25 hours. Mature GDF9 
was undetectable at all time points regardless of treatment. 
Overall, due to the large difference between replicates in the promature GDF9 levels in the 
nicotine-treated group at the 1 hour time point, no effect of time or treatment was observed 
for promature GDF9 levels (Figure 9-12).   
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Figure 9-11: The effects of exposing rat COC to nicotine in vitro on GDF9 protein levels over time. Western 
blots were performed in duplicate (A and B) to determine the level of GDF9 protein in COC lysate. COC were 
either incubated for 1 or 25 hours with the solvent control (U) or nicotine (N). Rat ovary lysate was included as 
a positive control (+) and E. coli produced recombinant ovine BMP15 was included as a negative control (-). A 
control experiment (C) was also run where the blot shown in (B) was stripped and re-probed with the GDF9-
specific antibody that had been pre-absorbed with E. coli produced recombinant ovine GDF9. Molecular sizes 
(kDa) are indicated to the left of each blot. The densities of the bands of interest (indicated by arrowheads) 
were measured and corrected for the control at 1 hour. Total protein (μg) in each sample was determined 
using the BCA assay. 
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Figure 9-12: Effect of nicotine on relative GDF9 levels in rat COC. The control group is represented by the 
unfilled bars ( ), while the nicotine-treated group is represented by the striped bars ( ). The bars 
represent the means, while the dashes represent each individual band density measurement. 
 
9.3.4 Effect of MDMA and THC on protein levels in rat COC 
The effects of exposing rat COC to 2 μg/mL MDMA and 500 ng/mL THC on CX43 protein 
levels are depicted in Figure 9-13. A 43 kDa band was observed in the positive control of 
both experimental replicates, while no bands were observed in the negative control of either 
replicate. A 43 kDa band was observed in each of the lanes containing COC lysate. When the 
CX43 antibody was pre-absorbed with the control peptide, no bands were detected (Figure 
9-13C).  
In the first replicate experiment (Figure 9-13A), CX43 levels decreased 2.5-fold with time in 
the control COC. Similarly, the levels of CX43 also decreased 3.3-fold with time in the THC-
treated COC, so that levels were similar to the controls at both times. In contrast, CX43 levels 
were 1.25-fold lower in the MDMA-treated COC at 1 hour compared to the control, and did 
not change with time so that the levels were 1.75-fold greater than that in the control COC 
at 25 hours.  
In the second replicate experiment, levels of CX43 decreased 3.3-fold with time in the 
control COC (Figure 9-13B). CX43 levels were similar between experimental groups after 1 
hour of culture time, and a reduction in CX43 levels over time was noted in all groups (Figure 
9-13B). Levels of CX43 decreased 2-fold and 1.2-fold with time in the MDMA- and THC-
treated COC respectively. The CX43 levels in COC incubated with MDMA and THC for 25 
hours were 1.7-fold and 3-fold greater respectively compared to the control. 
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A consistent trend of a decrease in CX43 levels over time was observed in all experimental 
groups but this was more evident in the control group (Figure 9-14). The smaller decreases 
in the MDMA- and THC-treated group resulted in CX43 levels being higher in the treated 
COC, compared to the control, after 25 hours in culture.  
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Figure 9-13: The effects of exposing rat COC to MDMA and THC in vitro on CX43 protein levels over time. 
Western blots were performed in duplicate (A and B) to determine the level of CX43 protein in COC lysate. COC 
were either incubated for 1 or 25 hours with the solvent control (U), MDMA (M) or THC (T). Rat ovary lysate 
was included as a positive control (+) and E. coli produced recombinant ovine BMP15 was included as a 
negative control (-). A control experiment (C) was also performed where the blot shown in (B) was stripped and 
re-probed with the CX43-specific antibody that had been pre-absorbed with its control peptide. Molecular sizes 
(kDa) are indicated to the left of each blot. The density of the band of interest (indicated by an arrowhead) was 
measured and corrected for the control at 1 hour. Total protein (μg) in each sample was determined using the 
BCA assay. The relative band densities were corrected for total protein amount, as calculated by the BCA assay. 
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Figure 9-14: Effect of MDMA and THC on relative CX43 levels in rat COC. The control group is represented by 
the unfilled bars ( ), the MDMA-treated group is represented by the striped bars ( ), while the THC-
treated group is represented by the dotted bars ( ). The bars represent the means, while the dashes 
represent each individual band density measurement. 
 
The effects of exposing of rat COC to 2 μg/mL MDMA and 500 ng/mL THC on GDF9 protein 
levels are depicted in Figure 9-15. Multiple bands between 20 and 114 kDa were detected in 
the positive control of both replicates. Bands of 49 and 20 kDa in size, corresponding to the 
promature and mature forms of GDF9 respectively were detected in the positive control 
lanes. Additional prominent bands of 93, 70, and 40 kDa were observed. No bands were 
observed in the negative control.  When the GDF9 antibody was pre-absorbed with 
recombinant GDF9, no bands were detected (Figure 9-11C). Multiple bands were observed in 
each of the lanes containing COC lysate, corresponding to the aforementioned molecular 
weights in the positive control.  
In the first replicate experiment (Figure 9-15A), levels of promature GDF9 decreased 1.25-
fold with time in the control group. Levels of promature GDF9 were similar after 1 hour in 
culture in all experimental groups. Promature GDF9 levels increased slightly (1.4-fold and 
1.2-fold) with time in the MDMA- and THC-treated COC to levels 1.6-fold greater in the 
MDMA- and THC-treated compared to the control COC at 25 hours. Mature GDF9 was 
detected at every time point regardless of treatment. Mature GDF9 levels declined 2.5-fold 
with time in the control COC. Following incubation with MDMA or THC for 1 hour, mature 
GDF9 levels were 2.5-fold lower than that in the control. Mature GDF9 levels increased 2.75-
fold with time in the MDMA-treated COC so that levels were 2.8-fold greater than the 
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control at 25 hours. Mature GDF9 levels remained constant in the THC-treated COC so that 
levels were similar to the control at 25 hours. 
Similar to the first replicate, levels of promature GDF9 decreased 2-fold with time in the 
control group (Figure 9-15B). Promature GDF9 levels were 1.7-fold and 5-fold lower in the 
MDMA- and THC-treated COC compared to the control COC at 1 hour. Levels of promature 
GDF9 in COC incubated with MDMA or THC increased with time by 1.5-fold and 6-fold 
respectively. This resulted in the levels of promature GDF9 being 1.8-fold and 2.4-fold higher 
in the MDMA- and THC-treated COC than the control COC at the 25 hour time point. Mature 
GDF9 levels were undetectable at any time point regardless of treatment. 
The levels of promature GDF9 consistently decreased over time in the control group (Figure 
9-16). Conversely, there was high variability in regards to the effect of treatment on the 
promature GDF9 levels after 1 hour in culture. However with time, both the MDMA and 
THC-treated COC showed an increase in promature GDF9 levels.   
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Figure 9-15: The effects of exposing rat COC to MDMA and THC in vitro on GDF9 protein levels over time. 
Western blots were performed in duplicate (A and B) to determine the level of GDF9 protein in COC lysate. COC 
were either incubated for 1 or 25 hours with the solvent control (U), MDMA (M) or THC (T). Rat ovary lysate 
was included as a positive control (+) and E. coli produced recombinant ovine BMP15 was included as a 
negative control (-). A control experiment (C) was also performed where the blot shown in (B) was stripped and 
re-probed with the GDF9-specific antibody that had been pre-absorbed with E. coli produced recombinant 
ovine GDF9. Molecular sizes (kDa) are indicated to the left of each blot. The densities of the bands of interest 
(indicated by arrowheads) were measured and corrected for the control at 1 hour. Total protein (μg) in each 
sample was determined using the BCA assay. 
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Figure 9-16: Effect of MDMA and THC on relative GDF9 levels in rat COC. The control group is represented by 
the unfilled bars ( ), the MDMA-treated group is represented by the striped bars ( ), while the THC-
treated group is represented by the dotted bars ( ). The bars represent the means, while the dashes 
represent each individual band density measurement. 
 
9.4 Discussion 
This study revealed a consistent pattern of CX43 protein expression in cultured rat COC with 
time that enabled the effects of short and long-term exposures to common lifestyle factors 
and environmental contaminants to be assessed. Overall, the CX43 protein levels were lower 
after rat COC were cultured for 25 hours, compared to that after 1 hour. However exposure 
of rat COC to nicotine, MDMA, and THC for 25 hours resulted in CX43 protein levels that 
were higher than in the appropriate controls. It was interesting to note that the CX43 levels 
were sometimes altered after a 1 hour exposure of rat COC to some compounds.  
Specifically, CX43 protein levels were enhanced following a 1 hour exposure to caffeine, and 
reduced after exposure to nicotine. The effect of time on GDF9 protein expression in 
cultured rat COC was variable across experiments, thereby confounding interpretations 
concerning the effects of treatments on protein expression levels. Nevertheless, the 
evidence did suggest that promature GDF9 levels were reduced following short-term in vitro 
exposures (i.e. 1 hour) to BPA and caffeine, but enhanced after longer exposures (i.e. 25 
hours) to BPA, caffeine, MDMA, and THC.  
CX43 levels in COC cultured with BPA were not different to the levels in the control group 
however there was variability between the replicates noted after a 1 hour exposure to BPA. 
In Chapter 6 it was established that BPA enhanced GJ communication between the CC and 
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oocyte, particularly after 25 hours exposure. Therefore, it seems that the BPA-mediated 
upregulation of GJ communication does not occur through changes in CX43 protein 
expression. The findings from this study are consistent with a previous study which found 
that BPA did not affect CX43 levels in a rat epithelium derived mammary cell line (Lee and 
Rhee, 2007). Levels of both promature and mature GDF9 in COC were reduced after a 1 hour 
exposure to BPA, suggesting a reduction in oocyte growth factor signalling. However, after 
25 hours exposure to BPA, promature and mature GDF9 levels were increased, indicating 
enhanced oocyte growth factor signalling. The finding that short and long term exposures to 
BPA have opposing effects on GDF9 levels suggest that desensitisation or metabolism of BPA 
occurs, or that two different regulatory mechanisms are at play in the COC. Given the role of 
GDF9 in regulating CC functions such as proliferation, metabolism, and apoptosis, further 
investigation into these pathways would provide insight into how BPA affects COC health.  
Rat COC that were exposed to caffeine for 1 hour had increased CX43 levels compared to the 
control, however this effect was attenuated after a 25 hour exposure. Interestingly, in 
Chapter 6 it was determined that caffeine may enhance GJ communication (P=0.052), and 
that this effect was most notable after a 25 hour exposure. Therefore, as with BPA, these 
results suggest that changes in CX43 protein levels are not responsible for the increase in GJ 
communication that was seen in COC incubated with caffeine for 25 hours. Similar to the 
effect of BPA on GDF9 protein, levels of promature and mature GDF9 were reduced in COC 
incubated with caffeine for 1 hour, but were markedly higher than the controls following a 
25 hour exposure to caffeine. Again, these findings suggest that metabolism or 
desensitization to caffeine occurs in the COC, or that two different regulatory mechanisms 
are at play. The marked effects of caffeine on GDF9 protein levels indicates that CC functions 
mediated by oocyte-secreted factors may be altered following exposure to caffeine in vitro. 
Specifically, functions such as CC proliferation and metabolism that are enhanced by oocyte-
secreted factors may be reduced following a short exposure to caffeine, but increased 
following a long exposure. Further investigation into oocyte-mediated CC functions will 
reveal how caffeine affects these pathways.  
CX43 levels in COC were not noticeably influenced by ethanol either after a 1 or 25 hour 
exposure. These results are consistent with those reported in Chapter 6, where it was shown 
that ethanol did not affect GJ communication in COC. A previous study found markedly 
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reduced levels of CX43 protein in rat liver epithelial cells that had been exposed to ethanol 
for 24 hours (Bokkala et al., 2001). Interestingly, in that study CX43 protein levels were also 
correlated with a reduction in GJ communication. In the current study, a doublet band was 
observed in both replicates, indicating CX43 was differentially phosphorylated (Solan and 
Lampe, 2009). However, no consistent pattern of phosphorylation was observed. It should 
be noted that no effect of culture time on CX43 was noted in the control group of the 
ethanol experiment. In all other experiments, CX43 levels declined markedly over time in the 
control group. The reason for this is unknown, however the solvent control used for ethanol, 
was dH2O, in contrast to the use of DMSO as the solvent control for all other experiments. 
Exposure to ethanol did not affect levels of promature GDF9, and the mature protein was 
not detected in either experiment.  
CX43 levels in nicotine-treated COC were markedly reduced at 1 hour, whereas were 
increased at 25 hours, compared to the control. The variability that was noted in the effect 
of nicotine over time suggests that metabolism or desensitisation to nicotine occurs in the 
COC.  The effect of nicotine on CX43 protein levels was not dissimilar to the pattern of GJ 
communication in COC following incubation with nicotine (Chapter 6). GJ communication in 
COC was unaffected by a 1 hour exposure to nicotine, however it was increased after a 25 
hour incubation. These results suggest that the increase in GJ communication in COC 
following long term exposure to nicotine is mediated by a concomitant increase in CX43 
protein levels. However, the reduction in CX43 protein following a 1 hour exposure of COC to 
nicotine was not observed to influence GJ communication in COC (Chapter 6). Furthermore, 
the finding that the reduction in CX43 levels over time in the control that was not seen in the 
nicotine-treated COC indicates that nicotine may, in some manner, prevent the degradation 
of CX43 protein over time. Interestingly, the results presented in this chapter are in contrast 
to a previous study which showed that CX43 levels were unaffected by short exposures to 
nicotine (between 0 and 8 hours) but that long exposures (24 hours) decreased CX43 in 
human umbilical vein endothelial cells, (Tsai et al., 2004). In the present study, doublet 
bands were observed in all samples, indicating differentially phosphorylated forms of CX43 
are present. The slow migrating form of CX43 likely corresponds to a phosphorylated form 
(Solan and Lampe, 2009) and generally displayed a reduced intensity compared to the faster 
migrating isoform. Exposure to nicotine in vitro did not affect levels of GDF9 protein in COC.  
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CX43 and GDF9 levels in COC that were incubated with MDMA for 25 hours were increased 
slightly compared to the control group. However, a short exposure time (i.e. 1 hour) was 
without effect. The levels of CX43 protein noted here do not correlate to the pattern of GJ 
communication in COC following incubation with MDMA (Chapter 6). Indeed, no effect of 
MDMA on GJ communication was measured. Therefore, while MDMA may increase overall 
CX43 levels, these connexins may not form functional GJ channels. Furthermore, the finding 
that MDMA partially prevented the time-dependent decrease in CX43 levels that was seen in 
the control suggests that MDMA prevents CX43 degradation. The results presented in this 
chapter are in contrast to a previous study in which MDMA reduced CX43 levels in rat 
ventricular myocytes following a 1 hour exposure (Zhuo et al., 2013). The effect of MDMA on 
GDF9 has not been investigated previously, to the best of my knowledge. These results 
suggest that long-term exposures of COC to MDMA are likely to modulate oocyte-CC 
interactions and thereby modulate CC functions such as metabolism and proliferation.  
Exposure to THC did not affect CX43 levels in rat COC. These results correlate with those 
from Chapter 6, whereby incubation of COC with THC in vitro did not affect GJ 
communication. Conversely, incubation of COC with THC for 25 hours resulted in increased 
levels of promature GDF9 compared to the control. Mature GDF9 was only detected in the 
first replicate experiments however these preliminary results suggest that mature GDF9 was 
reduced after a 1 hour exposure to THC. Taken together, these results demonstrate that long 
exposures to THC may influence oocyte-secreted factor production, and thus oocyte-
mediated CC functions such as proliferation or metabolism. 
In general, these protein expression studies gave less reliable results than the gene 
expression or GJ communication studies presented in Chapters 6, 7, and 8. Therefore, 
confirmation of these preliminary results by additional replicate experiments is necessary. 
The variation observed in the Western blot results is likely attributable to the Western 
blotting technique used and that only two replicate experiments were carried out due to 
challenge in undertaking several replicate experiments. Small differences in Western 
transfer efficiency, primary and/or secondary antibody concentrations, and developing 
reagents can result in large differences in band density. A commonly used approach to 
compensate for differences in protein loading is to correct band densities for a reference 
protein such as GADPH (Ratchford et al., 2008; Wang et al., 2009). In this study the blots 
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were stripped and re-probed three times (i.e. for CX43, GDF9, and the two pre-absorbed 
antibody controls). As repeated stripping of the blot can remove protein in addition to the 
bound antibodies, a reference protein was omitted from this study and instead the total 
protein content was determined using the BCA assay. Moreover, a constant number of COC 
(i.e. 200) were included in each group. However, these methods are limited in that they do 
not account for loading error or differences in protein transfer (Aldridge et al., 2008).  
The total protein content of each sample was expected to be influenced mainly by the 
number of CC. Therefore, the levels of CC-derived CX43 protein was corrected for total 
protein amount. The amount of protein calculated in each of the samples was extremely 
variable between experiments, despite using the same number of COC in each. An adapted 
BCA assay protocol was utilised for some experiments, where the plates were incubated at 
60 °C rather than 37 °C. This provided much greater sensitivity and allowed for a more 
accurate detection of protein content however this may have contributed to the variability 
seen between experiments. Since the total protein content was used relative to the other 
samples in each experiment, and was not used to compare samples across experiments, this 
should not have affected interpretation of the results. In contrast to the protein levels for 
CX43, those for GDF9 were not corrected for total protein as the relative band densities 
were produced by a known number of oocytes.  
The CX43-specific antibody, MAB3067, used in this study was relatively specific. However, 
additional, unidentified 24 and 68 kDa bands were seen in some experiments that were not 
apparent when the antibody was pre-absorbed with the control peptide. In some 
experiments, differentially phosphorylated forms of CX43 were identified as doublet bands 
(Solan and Lampe, 2009) however these doublet bands were not always resolved. 
Preliminary testing of an antibody specific for CX43 phosphorylated on serine residues 
279/282 (sc12900; Santa Cruz Biotechnology, USA) was undertaken during these studies. 
Phosphorylation of these residues is involved in the MAPK-dependent reduction in GJ 
communication following the LH surge (Norris et al., 2008). Furthermore, an antibody 
specific to CX37 was also tested for the measurement of CX37 in rat COC (CX37B12-A; Alpha 
Diagnostic, USA). However, the levels of CX37 and these phosphorylated forms of CX43 were 
extremely low in rat COC. Hence given the challenge in generating large numbers of COC for 
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protein measurements it was considered to be impractical to include these proteins in the 
current study.  
The GDF9-specific antibody, MAB47B, used in this study was produced by Oxford Brooks 
University for AgResearch. A large number of bands were detected using this antibody. It is 
likely that the band or set of bands around 49 kDa in size represent uncleaved promature 
GDF9 while the 20 kDa band likely represents mature GDF9 (Lin et al., 2012). It is possible 
that some of the other bands observed were differentially processed forms of GDF9 such as 
the preproprotein and glycosylated and/or phosphorylated forms. It is important to note 
that that immunoneutralisation of GDF9 using MAB47B blocked the ability of rat oocytes to 
stimulate rat GC proliferation (Lin et al., 2012), demonstrating that MAB47B recognises 
bioactive GDF9. When the monoclonal antibody was pre-absorbed with recombinant ovine 
GDF9, none of the aforementioned bands were detected. This  indicated that the antibody is 
specific for GDF9 and is capable of recognising multiple forms although this test alone does 
not  confirm complete antibody specificity (Swaab et al., 1977). Thus, there is a possibility 
that some of the bands detected with MAB47B are due to non-specific binding. On the other 
hand, the antibody was probing both secreted forms of GDF9 and intracellular protein that 
were being synthesized and processed. Thus, it is perhaps not surprising that multiple forms 
were present. In this context, a similar caveat can be applied to the measure of the forms of 
CX43. In the present study, the promature form of GDF9 was in higher abundance compared 
to mature GDF9, however at the present time the bioactivity of the promature protein form 
relative to the mature form of GDF9 is unknown. In addition to the GDF9-specific antibody 
that was used, several BMP15-specific antibodies were tested for application in this study 
(H-83 and A-20, Santa Cruz Biotechnology; MAB61a, produced by Oxford Brookes University 
for AgResearch). However, consistent with a previous study also on rat COC (Lin et al., 2012), 
the levels of BMP15 protein were very low and therefore, measurement of this protein was 
not undertaken any further. In summary, this chapter demonstrates that short and long term 
effects of lifestyle factors on CC-derived CX43 protein levels were detected using Western 
blotting. Levels of CX43 protein following a short-term exposure to caffeine were increased, 
but to nicotine were reduced. Furthermore, a long-term exposure to nicotine or MDMA 
increased CX43 protein in rat COC. The use of Western blotting to determine the effects of 
lifestyle on oocyte-derived GDF9 protein levels was less definitive due to inconsistencies 
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between the patterns of GDF9 expression in the control groups. Nevertheless, levels of GDF9 
were reduced following short-term exposure to BPA and caffeine, but were increased 
following long-term exposure to BPA, caffeine, MDMA, or THC. It is important to note that 
these protein expression studies provide preliminary results, due to the limited number of 
replicates, and that these results need to be confirmed.  
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10 EFFECTS OF IN VIVO EXPOSURE TO MDMA ON COC FUNCTION 
10.1 Introduction 
In vitro studies are invaluable for testing the effects of specific compounds on isolated cells 
however these compounds may elicit different effects on the same cells in vivo. This 
difference in responsiveness is due to many variables such as the route of access to the 
blood stream, half-life of the compound in the circulation, transit efficiency to the target 
cells and rate of peripheral metabolism. MDMA (ecstasy) is an amphetamine derivative that 
is primarily used by young people (Schenk, 2009). Acute physiological effects of MDMA 
include euphoria, increased energy levels, increased heart rate and blood pressure, chills, 
sweating, tremor, and muscle tension (Easton and Marsden, 2006). While the use of MDMA 
is typically infrequent, 35% of subjects interviewed in an Australian study had binged on 
ecstasy in the past 6 months, with the median length of a binge around 3 days (Topp et al., 
1999). In humans and rats, first pass metabolism of MDMA includes N-demethylation that 
produces 3,4-methylenedioxyamphetamine (MDA), and demethylation which produces 3,4-
dihydroxymethamphetamine (HHMA) (Green et al., 2003). In vivo, these products are further 
processed into 12 additional metabolites which have varying biological activities.  
There is little available information regarding the effect of MDMA on fertility and 
reproductive health in either males or females. Both acute and chronic exposure to MDMA 
perturbed the gonadal-hypothalamic axis in male rats resulting in reduced levels of 
hypothalamic GnRH mRNA expression and serum testosterone (Dickerson et al., 2008). 
Chronic exposure to MDMA in utero in rats was found to disrupt the fertility of male 
offspring, through elevated levels of DNA damage in sperm, increased interstitial oedema, 
and decreased sperm counts and motility (Barenys et al., 2010). Similarly, adult male rats 
that were chronically exposed to MDMA also had increased DNA damage in sperm, tubular 
degeneration, and interstitial oedema in the testes, however sperm motility, morphology 
and ability to induce pregnancy were unaffected (Barenys et al., 2009). In the current study 
it was established that in vitro exposure of rat COC to MDMA affected CC function through 
altered levels of Cx43, Cycs, Gfpt1, and Pfkp mRNA (Chapter 8) and CX43 protein (Chapter 9).  
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The aim of this chapter was to investigate the effects of in vivo exposure of female rats to 
MDMA on COC health. Specifically, the levels of CC-derived Atr, Cx43, Cycs, Gfpt1 and Pfkp 
mRNA, and oocyte-derived Atr, Bmp15, Cx37 and Gdf9 mRNA were measured. In addition, 
the effects of in vivo exposure to MDMA on protein levels of CX43 and GDF9 in rat COC were 
determined. 
10.2 Methods 
Pre-pubescent female rats (N=12/group) were administered 5 mg/kg/day of MDMA 
(treated) or the vehicle (saline; control) alone via ip injection once per day for three days. 
The rats were habitualised in locomotor activity boxes for 30 minutes prior to receiving the 
injection. After the injections were performed, the rats were returned to the locomotor 
activity boxes for 60 minutes thereafter. Whilst in the locomotor activity boxes, the 
ambulatory counts for each rat were measured at 5 minute intervals as described in Section 
2.2.1. Approximately 18 hours after the final injection, the rats were sacrificed and the 
ovaries were collected in sterile PBS. The COC from rats in the same treatment group were 
extracted and pooled. The COC were subsequently collected into PBS for either qPCR or 
Western blotting.  
The COC that were collected for qPCR were transferred individually into a 96-well plate 
containing 10 μL PBS, where the CC were stripped from the oocyte as described previously. 
The oocyte was washed twice in PBS, before being transferred into 10 μL PBS. The 96-well 
plates containing the DO and CC were stored at -80 °C. Total RNA was extracted from the DO 
and CC, and was synthesised into cDNA. Multiplex TaqMan qPCR was used to measure the 
mRNA levels of the following candidate genes: Gdf9, Bmp15, and Cx37 in oocytes; Cx43, 
Gfpt1, and Pfkp in CC; and Atr, Cycs, Glut1 in oocytes and CC. The reference gene Rpl19 was 
included in each reaction set to correct for cDNA template input. A calibrator sample was 
included in every run to correct for between-run variation. Those samples which had an 
Rpl19 CT value >30 were excluded from the analysis due to insufficient mRNA levels. For each 
oocyte gene within each sample, the CT value was corrected for the CT value of the calibrator 
sample from the appropriate run. For each CC gene within each sample, the CT value was 
corrected for the Rpl19 CT value from the same sample. The data was subsequently analysed 
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by the 2(-ΔΔCT) method (Livak and Schmittgen, 2001). The data were examined for normality 
using the D'Agostino & Pearson test and thereafter subjected to Mann Whitney analyses.  
The COC that were collected for Western blotting were transferred into a microcentrifuge 
tube (200 COC/tube) and additional PBS was added to make the volume up to 500 μL. The 
COC were centrifuged at 800 x g for 10 minutes, the supernatant was removed, and the COC 
were resuspended in PBS supplemented with protease inhibitors. The samples were stored 
at -20 °C until further processing. 
One-third of the volume of each sample (~66 COC) was analysed for total protein amount 
using the BCA assay. The proteins in the remaining two-thirds of each sample were 
separated by size using SDS-PAGE and transferred onto a membrane. Western blotting 
procedures were then performed to detect and quantify CX43 and GDF9 protein expression. 
To determine band specificity, the blot was stripped and incubated with either the CX43 or 
GDF9 antibodies that had been pre-absorbed with the MAB3067 control peptide, or E. coli 
produced recombinant ovine GDF9 respectively. The density of each protein band was 
analysed using ImageJ software. For the CX43 blots, the density of the 43 kDa band was 
measured. For the GDF9 blots, the densities of the 49 kDa promature and, when present, the 
20 kDa mature bands were measured. When multiple bands were present (e.g. when 
doublet or triplet bands were present for CX43) the density of all bands was measured. The 
band densities for CX43 were corrected for the total protein present in the sample, as 
determined by the BCA assay. The band densities for GDF9 were uncorrected to give total 
GDF9 produced by a known number of oocytes.  
10.3 Results 
The effect of administering three doses of 5 mg/kg MDMA, each 24 hours apart, on 
ambulatory count before and after each injection in female rats is depicted in Figure 10-1. 
The mean ambulatory count began relatively high in both the treated and control groups 
during the habitualisation period, but this declined to baseline levels before injection of 
MDMA or saline at Time 0. Following MDMA or saline administration, the mean ambulatory 
counts were initially raised in both groups, but the counts for the control group declined 
rapidly to baseline levels. In the MDMA-treated group, the mean ambulatory count rose 
steadily, peaking at 20-25 minutes post injection. The mean ambulatory count began to 
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decline thereafter, but did not reach baseline levels before the end of the measurement 
period.  
 
 
Figure 10-1: Effects of MDMA on ambulatory counts in female rats. The average ambulatory counts before 
and after the first injection (A), second injection (B), and third injection (C). Values represent the mean ± SEM 
from 12 individuals. The control group is represented by the filled circles ( ) while the MDMA-treated 
group is represented by the unfilled triangles ( ).  
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The effect of administering MDMA or the vehicle alone to female rats on meiotic arrest in 
COC is depicted in (Table 10-1). There was no difference in the proportion of oocytes that 
underwent GVBD between the control and MDMA-treated groups.  
 
Table 10-1: Effect of MDMA on the proportion of oocytes with a visible GV in female rats. The table shows 
the proportion of oocytes with a visible GV (%), with the actual number of oocytes with a GV in brackets. The 
data (N=12 oocytes/group from 12 rats) were analysed by a Fisher’s exact test.   
Control MDMA 
83 (10) 92 (11) 
 
 
The effect of administering MDMA or the vehicle alone to female rats on candidate gene 
expression in CC and DO is depicted in Figure 10-2. There were no differences in mRNA levels 
of any of the genes between the control and MDMA-treated groups.   
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Figure 10-2: The effect of MDMA on candidate gene expression in CC (A) and oocytes (B) in female rats. The 
control group is represented by the unfilled bars ( ), while the BPA treated group is represented by the 
hatched bars ( ). Values are shown as means ± upper/lower limit of linearised CT values normalised against 
the mean of the control group. The data were generated from a total of 12 readings from individual oocytes or 
CC masses in each group. A Mann-Whitney test was performed for each gene.  
 
The effect of administering MDMA or the vehicle alone to female rats on CX43 protein levels 
in COC is depicted in Figure 10-3. A 43 kDa band was observed in the positive control of both 
experimental replicates, along with two smaller bands. No bands were observed in the 
negative controls of either replicate experiment. A 43 kDa band was observed in both of the 
lanes containing COC lysate, along with one smaller band. The bands in the COC lanes in the 
second replicate (Figure 10-3B) were overexposed, so a shorter exposure time was 
undertaken to visualise the bands better (Figure 10-3C). When the CX43 antibody was pre-
absorbed with the control peptide, no bands were observed (Figure 10-3C).  
Quantified CX43 protein levels in COC of rats administered MDMA or the vehicle alone are 
depicted in Figure 10-3. A double band of 43 kDa in size is observed. The protein that 
migrated faster (i.e. the bottom band) is assumed to be the non-phosphorylated form to 
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which the antibody is produced against, and the slow-migratory band (i.e. top band) which is 
assumed to be a phosphorylated form. In the first replicate, CX43 protein levels were 5-fold 
higher in COC of MDMA-treated, compared to control rats. A similar result was observed in 
the second replicate where CX43 protein levels were 2.7-fold higher in COC of MDMA-
treated, compared to control, rats. Overall, CX43 protein levels were increased in COC from 
MDMA-treated rats, compared to the control (Figure 10-4). 
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Figure 10-3: The effect of MDMA on CX43 protein levels in COC from female rats. Western blots were 
performed in duplicate (A and B) to determine the level of CX43 protein in COC lysate. COC were collected from 
rats injected with either the vehicle control (U), or 5 mg/kg/day MDMA (M). Rat ovary lysate was included as a 
positive control (+) and E. coli produced recombinant ovine BMP15 was included as a negative control (-). The 
second replicate (B) was developed for a shorter amount of time to allow visualisation of the individual bands 
(C). A control experiment (D) was also performed where the blot shown in (B) was stripped and re-probed with 
the CX43-specific antibody that had been pre-absorbed with its control peptide. Molecular sizes (kDa) are 
indicated to the left of each blot. The density of the band of interest (indicated by an arrowhead) was 
measured and corrected for the control at 1 hour. Total protein (μg) in each sample was determined using the 
BCA assay. The relative band densities were corrected for total protein amount, as calculated by the BCA assay. 
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Figure 10-4: Effect of in vivo exposure to MDMA on relative CX43 levels in rat COC. The bars indicate the 
means, while the dashes represent each individual relative band density measurement. 
 
The effects of administering MDMA or the vehicle alone to female rats on GDF9 protein 
levels in COC is depicted in Figure 10-5. Multiple bands between 45 and 90 kDa in size were 
observed in the positive control of both replicates. These included a band at 49 kDa which 
corresponds to promature GDF9. No bands were observed in the negative control of either 
replicate. When the GDF9-specific antibody was pre-absorbed with recombinant GDF9, no 
bands were detected (Figure 10-5C). Multiple bands between 45 and 70 kDa were detected 
in the lanes containing COC lysate.  
In the first replicate (Figure 10-5A), levels of promature GDF9 were similar in COC of MDMA-
treated and control rats. Conversely in the second replicate (Figure 10-5B), levels of 
promature GDF9 were 4.8-fold higher in COC of MDMA-treated rats compared to that in 
control rats. Mature GDF9 (20 kDa) was not detected in either replicate. Due to the variable 
response to MDMA between replicate experiments, the effect of MDMA on GDF9 promature 
levels in female rats observed were equivocal (Figure 10-6). Despite this, it is evident that 
GDF9 promature levels do not decline in COC following in vivo exposure to MDMA in female 
rats.  
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Figure 10-5: Effect of MDMA on GDF9 protein levels in COC from female rats. Western blots were performed 
in duplicate (A and B) to determine the level of GDF9 protein in COC lysate. COC were collected from rats 
injected with either the vehicle control (U), or 5 mg/kg/day MDMA (M). Rat ovary lysate was included as a 
positive control (+) and E. coli produced recombinant ovine BMP15 was included as a negative control (-). A 
control experiment (C) was also performed where the blot shown in (B) was stripped and re-probed with the 
GDF9-specific antibody that had been pre-absorbed with E. coli produced recombinant ovine GDF9. Molecular 
sizes (kDa) are indicated to the left of each blot. The density of the band of interest (indicated by an 
arrowhead) was measured and corrected for the control at 1 hour. Total protein (μg) in each sample was 
determined using the BCA assay.  
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Figure 10-6: Effect of in vivo exposure to MDMA on relative promature GDF9 levels in rat COC. The bars 
indicate the means, while the dashes represent each individual relative band density measurement.  
 
10.4 Discussion 
This study indicates there is a marked increase in CX43 protein levels in COC of female rats 
following the administration of MDMA over three consecutive days. This observation is 
consistent with that observed in the in vitro study (Chapter 9) where a 25 hour incubation of 
rat COC with MDMA resulted in a 1.7-fold increase in CX43 levels, compared to control COC. 
However in contrast to the effects of MDMA in vitro, administration of MDMA to female rats 
did not affect oocyte meiotic arrest, candidate gene expression in CC or oocytes, or 
promature GDF9 protein levels in COC.  
Behavioural tests were undertaken to ensure a physiologically effective dose of MDMA was 
administered. Rats that received a dose of 5 mg/kg MDMA were markedly more active 
compared to rats that received saline. Locomotor activity, as measured by ambulatory 
counts, is well-known to increase after exposure to MDMA and the effects are dose 
dependent (Callaway et al., 1990; Brennan and Schenk, 2006). The results in this present 
study demonstrate that the dose of MDMA administered to rats in this study was consistent 
with a behaviourally effective dose.  
CX43 protein levels were markedly upregulated in COC from MDMA-treated rats, compared 
to COC from control rats. The differentially phosphorylated forms of CX43 detected in the 
second, but not the first, replicate, suggest that MDMA did not affect the phosphorylation of 
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CX43. To the best of my knowledge, there is only one published study investigating the 
effect of MDMA on CX43 levels. Male rats were administered 20 mg/kg MDMA via ip 
injection and sacrificed at 24 hours post-MDMA administration (Zhuo et al., 2013). The levels 
of CX43 as detected using immunohistochemistry were markedly reduced in heart tissue of 
MDMA-treated, compared to control, rats. 
The results presented herein suggest that MDMA increased the number of GJ channels 
present in the CC and that this is independent of transcription. The increase in CX43 protein 
may occur via several post-transcriptional or post-translational mechanisms including 
increased translation of mRNA stores, alternative splicing of the Cx43 mRNA to variants with 
increased translation efficiency (Pfeifer et al., 2004), or inhibition of CX43 degradation. As 
discussed previously (Chapter 6), the implications of increased GJ communication on COC 
health are largely unknown. Increased nutrient transfer to the oocyte may improve oocyte 
quality due to the increased availability of substrates for maturation and development. 
However excessive nutrient availability to the oocyte can also have negative consequences. 
For example, excessive transfer of glucose and glucose metabolites to the oocyte results in 
increased utilization of alternate metabolic pathways such as the hexosamine biosynthetic, 
pentose phosphate or polyol pathways (Sutton-McDowall et al., 2010). While these 
pathways all have a role in normal oocyte maturation, abnormal upregulation can result in 
deleterious effects such as aberrant O-linked glycosylation, precocious nuclear maturation 
and altered intracellular redox state (Downs et al., 1998; Brownlee, 2001). In addition, 
previous studies have found that under hyperglycaemic conditions, increased reactive 
oxygen species and reduced glutathione concentrations are detected in bovine oocytes 
(Hashimoto et al., 2000). 
For reasons unknown, the GDF9 blots were far less sensitive than those performed for the in 
vitro studies presented in Chapter 9. It is possible that this prevented accurate 
determination of the levels of promature GDF9 in these samples. Indeed, levels of GDF9 in 
COC from MDMA-treated rats were very variable compared to COC from the control rats. 
However, whilst the results presented here do not allow a definitive conclusion on the effect 
of in vivo exposure to MDMA on GDF9 protein levels, it is unlikely that in vivo MDMA 
exposure results in decreased GDF9 promature levels. This observation is supported by the 
197 
 
in vitro studies herein (Chapter 9) where in vitro exposure of rat COC to MDMA for 25 hours 
resulted in increased GDF9 promature protein compared to controls. 
The levels of gene expression in CC and DO from rats that received MDMA were not 
different between treated and control rats for any of the genes tested herein. Furthermore, 
the proportion of oocytes that were in meiotic arrest (i.e. had a visible GV) was not different 
between the treated and control rats. These results contradict those observed following in 
vitro exposure of rat COC to MDMA (Chapter 7 and 8) where GVBD was promoted and levels 
of Cx43, Gfpt1, Cycs, and Pfkp mRNA in rat CC were affected. However, differences may exist 
in the susceptibility of the COC to MDMA between in vitro and in vivo systems. For example, 
the location of the COC in the follicular compartment where it is surrounded by both 
follicular fluid and GC may offer the COC greater protection from MDMA compared to 
isolated COC in culture. Additionally, MDMA is processed in the body into metabolites, such 
as MDA or HHMA that may not affect the parameters tested in this study. Another possibility 
is that any MDMA-mediated effects were attenuated by the time the rats were sacrificed 
approximately 18 hours post-injection. Studies have shown that a dose of 5 mg/kg MDMA 
delivered to adult female rats subcutaneously results in maximum plasma concentrations of 
MDMA (293±50 ng/mL) after 2 hours, while MDA reached maximum concentrations (46±7 
ng/mL) after 3 hours (Fonsart et al., 2009). The half-life of both MDMA and MDA in adult 
female rats when a dose of 1 mg/kg was administered intravenously was 3.1 hours. This 
result suggests that plasma concentrations of both MDMA and MDA would be very low at 18 
hours after administration. However, effects on CX43 protein levels were detected 18 hours 
after MDMA administration in the current study, and 24 hours after MDMA administration 
in a previous study (Zhuo et al., 2013).  
The dose of 5 mg/kg/day used in this current study is approximately equivalent to that 
received in one ecstasy tablet (98 mg or 1.4 mg/kg MDMA in humans; McCann and Ricaurte, 
2001). Ecstasy is typically consumed orally in humans, however in this study MDMA was 
administered via ip injection. A comparison between oral, ip, and subcutaneous routes of 
administration in rats demonstrated that a peak in plasma levels of MDMA occurred 
between 1-3 hours post administration, and these administration routes were comparable 
(Green et al., 2009). Differences in MDMA metabolism between rats and humans may 
complicate comparisons made between studies. For example in humans, MDMA auto-
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inhibits its own metabolism resulting in disproportionately large increases in plasma MDMA 
concentrations following small increases in the dose of MDMA administered (de la Torre et 
al., 2000). However, auto-inhibition of MDMA metabolism is not observed in rats (Green et 
al., 2009). In addition, the major MDMA metabolite produced in humans is 3,4-
dihydroxymethamphetamine (HHMA) while MDA is a minor metabolite. Conversely in rats, 
MDA is the major metabolite produced (Easton and Marsden, 2006) and whilst HHMA is 
detectable in rat urine, it is quickly methylated to 4-hydroxy-3-methoxymethamphetamine 
(HMMA) in blood (Fonsart et al., 2009). Moreover, different enzymes are involved in the 
metabolism of MDMA in humans and rats. For example the enzyme involved in the 
demethylation of MDMA to produce HHMA is CYP2D6 in humans and CYP2D1 in rats (Easton 
and Marsden, 2006). Therefore, while the results presented in this study demonstrate that in 
vivo exposure to MDMA results in increased CX43 levels in rat COC, this may not translate in 
humans.  
In summary, these results establish that administering 5 mg/kg/day MDMA to adolescent 
female rats causes a marked increase in the level of CX43 protein in COC, consistent with 
that of in vitro studies. Whilst the response of GDF9 protein levels to MDMA exposure was 
variable, it is likely not to cause a reduction GDF9 protein levels. Interestingly, despite a 
definitive increase in CX43 protein levels in COC after in vivo MDMA exposure, the 
proportion of oocytes in meiotic arrest, gene expression levels of CC-derived Atr, Cx43, Cycs, 
Gfpt1 and Pfkp mRNA and oocyte-derived Atr, Bmp15, Cx37 and Gdf9 mRNA were 
unchanged. 
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11 DISCUSSION 
One of the major factors for reproductive success is the production of a healthy oocyte by 
the female for fertilisation. Oocyte maturation is tightly coordinated with follicular cell 
processes such as proliferation, metabolism, and steroidogenesis. This coordination is 
achieved, in part, through oocyte-secreted growth factors which modulate the 
aforementioned CC functions. Moreover, transfer of nutrients and small molecules from the 
CC to the oocyte via GJs facilitates cytoplasmic maturation while maintaining meiotic arrest. 
These oocyte growth factor and GJ communication pathways constitute a communication 
loop which is essential for follicular development. The major objective of this thesis was to 
investigate the effects of lifestyle factors on pathways involved in the bi-directional 
communication system of the COC.   
11.1 Method optimisation and validation 
A key component of this research was to establish, optimise and validate technologies that 
would enable the testing of environmental contaminants and lifestyle factors on pathways 
involved in the maintenance of COC communication. Thus, preliminary experiments were 
performed to: 1) establish a standard protocol to measure GJ communication in rat COC in 
vitro; 2) validate the use of calcein-treated CC and DO for multiplex qPCR; and 3) determine 
the health of rat COC over 25 hours in culture.  
A GJ bioassay first described by Thomas et al. (2004) was modified and optimised to test the 
effects of specific compounds on the degree of GJ transfer in rat COC in culture. During in 
vitro culture of COC, the intra-oocyte concentration of cAMP is critical for maintaining GJ 
communication in the COC and meiotic arrest of the oocyte (Wert and Larsen, 1989; Thomas 
et al., 2002). Elevated intra-oocyte cAMP levels within cultured COC may be attained by the 
addition of either cAMP stimulators or PDE inhibitors. An important and unexpected finding 
in this study was that the addition of forskolin, an adenylyl cyclase stimulator, did not 
influence GJ communication in rat COC. However, inhibition of cAMP breakdown by the 
addition of PDE inhibitors, specifically a combination of rolipram and dipyridamole, 
increased GJ communication in rat COC. This suggests a role for PDE7, PDE8, PDE10, and 
PDE11 in maintenance of the nutrient transfer system in this rodent species. A dose-
dependent inhibition of fluorescence transfer to the oocyte occurred when COC were 
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treated with the GJ uncoupler carbenoxolone. Moreover, oocyte fluorescence was markedly 
inhibited when COC were treated with carbenoxolone following up to 22 hours in culture. 
This provides strong evidence that incorporation of calcein in the oocyte occurs 
predominantly via GJ transfer from the CC. Therefore, the GJ bioassay described herein is a 
highly specific and robust indicator of GJ activity within rat COC.  
The desire to directly compare GJ activity with candidate gene expression led to the 
validation of a TaqMan multiplex qPCR methodology using cDNA from calcein-treated COC. 
Baseline fluorescence was not detected in calcein-treated samples by the Corbett Rotor-
Gene 6000 machine, and calcein treatment did not affect global gene expression levels, as 
measured by Rpl19 mRNA. However, calcein treatment did affect expression levels of some 
individual genes. Specifically, oocyte-derived Gdf9 and Cx37, and CC-derived Cycs, Gfpt1, and 
Atr expression levels were all influenced by calcein treatment. Notably, interaction effects 
were measured for the aforementioned CC genes, indicating an effect of calcein on gene 
expression over time. It appeared that gene expression levels in those DO and CC that had 
been incubated for 5 or 13 hours were more sensitive to calcein-mediated changes as 
excluding these samples from the analysis removed most of the treatment or interaction 
effects that were measured. However, a treatment effect remained for oocyte-derived Atr, 
and treatment and interaction effects remained for CC-derived Gfpt1.  
To the best of my knowledge, this study is the first to measure GJ communication and gene 
expression levels in the same COC. These results show that the effect of calcein should be 
tested for each candidate gene, as calcein exposure may up or downregulate levels of some 
genes. Measurement of both GJ communication and gene expression was particularly 
desirable in this study as it allowed the effects of lifestyle and environmental factors on 
these pathways to be determined in individual COC. This is important as follicular 
development is hierarchical resulting in a population of follicles that are functionally distinct 
despite being morphologically identical. Furthermore, the correlation between GJ 
communication and gene expression levels may have potentially large implications for 
determining the genes and pathways that interact with or are affected by GJ activity, 
although no such correlation was observed in this study. In all experiments where the effects 
of lifestyle and environmental factors were being tested, both the control and treated COC 
were exposed to calcein. Therefore, any changes in gene expression levels between the 
201 
 
treated and control groups were a result of the treatment and not a biological effect of 
calcein exposure. However, the effects of lifestyle and environmental factors on gene 
expression in COC that were not treated with calcein will need to be confirmed in future 
experiments. 
In order to test the effects of prolonged exposure of rat COC to various compounds in vitro, 
the effects of culturing rat COC under control conditions, in regards to GJ activity, GVBD, and 
gene and protein expression levels, were characterised (Chapter 5). It was established that 
some of these parameters were regulated by time in culture. GJ communication was 
maintained over 49 hours of culture, and moreover was increased at the time points of 5, 19 
and 25 hours. Concurrently, the proportion of meiotically-arrested oocytes (i.e. those with a 
visible GV) decreased over time. These results demonstrate that the reduction in the 
proportion of meiotically-arrested oocytes, which reached 44 % by 25 hours, was not 
correlated to a decline in GJ communication. Compared to that after 1 hour in culture, CC-
derived CX43 protein levels were markedly reduced at 5 hours, but were increased at 13 and 
25 hours. Interestingly, most of the oocyte genes were stable over time, with the exception 
of Atr mRNA levels, which were reduced after 25 hours in culture. Conversely, expression 
levels of all the CC-derived genes changed over time. Compared to that after 1 hour in 
culture, the expression levels of CC-derived Atr and Gfpt1 mRNA were higher at 13 hours, 
while Cycs mRNA was reduced at 25 hours. Expression levels of both Cx43 and Pfkp were 
markedly reduced from 5 hours onwards. However, given that GJ communication was 
maintained over time as was expression of Cycs, which is involved further down the energy 
production pathway, the findings here reveal that the health of the COC is not necessarily 
compromised following 25 hours in culture. 
Unfortunately, mRNA expression levels of oocyte-derived Cycs and oocyte-derived and CC-
derived Glut1 were below detection limits. Therefore, these were unable to be included in 
the study.  
11.2 In vitro effects of lifestyle factors  
A summary of the in vitro effects of lifestyle factors on COC health is presented in Table 11-1.  
Each of those factors for which a treatment effect on GJ communication was measured (i.e. 
BPA, caffeine, and nicotine) had the greatest effect after 25 hours exposure. Therefore only 
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the 1 and 25 hour samples were tested for gene expression levels. This also allowed 
exclusion of the 5 and 13 hour time points in which gene expression was found to be more 
sensitive to calcein-AM perturbation.  
 
Table 11-1: Summary of the in vitro effects of lifestyle factors on COC function. Arrows indicate that the 
parameter was up- or down-regulated by treatment. For GJ communication and gene expression results, 
overall treatment effects (P<0.05) are indicated by arrows alone, while a treatment x time effect (P<0.05) is 
indicated by an arrow accompanied by the time point at which an effect was noted. For protein expression, 
arrows indicate a trend of up- or down-regulation at a specific time point (>1.2-fold change). Dashes indicate 
that no effect of treatment was observed for that parameter.    
 BPA Caffeine Ethanol Nicotine MDMA THC 
GJ 
communication 
↑ - - ↑ 25 hours - - 
Cx43 mRNA ↑ 25 hours ↓ ↑ 1 hour - ↑ ↑ 
CX43 protein - ↑ 1 hour - 
↓ 1 hour 
↑ 25 hours 
↑ 25 hours - 
Cx37 mRNA - - - ↑ 1 hour - - 
GVBD - - ↓ - ↑ ↑ 
GDF9 protein 
↓ 1 hour 
↑ 25 hours 
↓ 1 hour 
↑ 25 hours 
- - ↑ 25 hours ↑ 25 hours 
Gfpt1 mRNA - - - - ↑ ↑ 
Cycs mRNA - - - - ↓25 hours - 
Pfkp mRNA - - - - 
↑ 1 hour 
↓ 25 hours 
- 
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A notable finding of this study was that in general, CC-derived genes, compared to the 
oocyte-derived genes, were far more sensitive to all the treatments tested herein. The CC 
are known to protect the oocyte from reactive oxygen species (Tatemoto et al., 2000). The 
results from this current study support the evidence that CC have a protective role and 
extend this role to include protection from potentially harmful exogenous factors. 
Furthermore, expression of the CC-derived gene Cx43 was significantly more sensitive to 
exogenous factors than any other gene tested. Indeed, Cx43 levels were altered by all of the 
treatments included in this study, although the effect of nicotine was negligible.  
The concentrations of lifestyle factors chosen for this study were based upon measurements 
in biological fluids. Where available, the concentration of the factor in follicular fluid was 
used as a reference point (i.e. BPA; Ikezuki et al., 2002). In cases where this information was 
not available, the serum concentration was used as a reference point. In general, the 
concentrations used in this study were 10-fold greater than that measured in follicular fluid 
(i.e. BPA) or blood (i.e. caffeine, ethanol, nicotine, MDMA, and THC). The exception to this is 
caffeine, for which the concentration was 10-fold greater than that measured in serum 
(Axelrod and Reichenthal, 1953), but was 150-fold greater than that measured in follicular 
fluid (Al-Saleh et al., 2010). The reason for this is that the concentration of caffeine was 
selected prior to this information being published. Selection of high physiological 
concentrations of lifestyle and environmental factors for the in vitro study reduced the 
probability of false negative results However, due to not selecting concentrations well above 
the physiological range, there was increased difficulty in distinguishing real effects from the 
background variation. Despite this, these results provide convincing evidence that rat COC 
are sensitive to high physiological concentrations of lifestyle and environmental factors.  
A major limitation of this in vitro study was that this model only explores the effects of direct 
exposure of the COC to lifestyle and environmental factors, and does not take into account 
other mechanisms by which oocyte quality is regulated (such as the hypothalamic-pituitary 
axis) or the potential protective effects of the follicular environment. Therefore, follow up 
investigations into the effects of exposure to lifestyle and environmental factors via an in 
vivo route (such as the in vivo MDMA experiments presented in this thesis) are necessary.  
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11.2.1 GJ communication is promoted by BPA, caffeine, and nicotine 
GJ communication and CX43 protein levels decreased over time in culture in the control 
COC. For reasons unknown, this was in contrast to the results in Chapter 5 where oocyte 
fluorescence was higher at 25 hours in culture, compared to 1 hour.  Nonetheless, exposure 
to BPA and nicotine prevented the reduction in GJ communication over time, with higher 
fluorescence levels in the treated oocytes than the control oocytes at 25 hours. A similar 
effect was observed after exposure to caffeine, however this was just under the level of 
significance (P=0.052). Interestingly, GJ communication was not correlated with mRNA levels 
of either Cx43 or Cx37 in individual samples. Furthermore, the pattern of GJ communication 
was not necessarily correlated with changes in CX43 protein levels in the treated COC. This is 
consistent with findings from Wang et al. (2009) where only very weak correlations between 
CX43 protein expression and GJ conductance were observed. 
Post-translational modifications and incorporation into GJ plaques are essential for GJ 
function. In addition, only 2-20 % of CX43 GJs are active within a GJ plaque (Bukauskas et al., 
2000). Therefore, it is perhaps unsurprising that GJ communication does not necessarily 
correlate with mRNA and protein levels of CX43 in this study. Furthermore, it is possible that 
the presence of oocyte-derived GJs composed of CX37, rather than CC-derived GJs 
composed of CX43, are the rate-limiting factor for transfer of nutrients into the oocyte. An 
effort to measure CX37 protein levels was undertaken for this thesis however expression 
levels were so low that it was not feasible to include it in this study.  
Interestingly, Cx43 mRNA levels were increased together with GJ communication after a 25 
hour incubation with BPA. BPA has oestrogenic activity, allowing it to bind to and activate 
the oestrogen receptor albeit with a lower potency than endogenous oestrogens (vom Saal 
et al., 2007). Both Cx43 mRNA and protein levels have been reported to be upregulated in 
response to oestrogens (Wiesen and Midgley, 1994), therefore these results are consistent 
with the oestrogenic properties of BPA. These results suggest that BPA promoted GJ 
communication independently of the number of CC-derived GJs present, because CX43 
protein levels were unaffected. This conclusion is similar to that of a previous study that 
found that BPA inhibited GJ communication in an epithelial cell line independently of mRNA 
or protein levels of CX43 (Lee and Rhee, 2007). Further investigation into the 
phosphorylation states and cellular localisation of CX43 or levels of CX37 protein would 
205 
 
provide further information about how BPA prevents the time-dependent decrease in GJ 
communication. Moreover, determining the level of CX43 protein and GJ communication at 
later times would reveal whether given time, the increased Cx43 mRNA seen at 25 hours 
were translated into CX43 protein and formed functional GJ channels. 
Initial exposure to nicotine reduced CX43 protein levels and increased Cx37 mRNA levels, 
however GJ communication was unaffected. Furthermore, a slight reduction in Cx43 levels 
was observed in the nicotine-treated COC however this did not reach significance. After 25 
hours of exposure to nicotine, GJ communication and CX43 protein levels had increased, 
while Cx37 mRNA levels were similar to the control. These results suggest that nicotine may 
prevent the time-dependent decrease in CX43 protein levels, thereby maintaining GJ 
communication over 25 hours in culture. Given the initial increase in Cx37 mRNA, the levels 
of CX37 protein may also have been increased at 25 hours, however this remains to be 
determined. The finding that CX43 protein levels were differently affected by short and long 
term incubations with nicotine suggests that this effect may be mediated by a metabolite. 
Indeed, cotinine, a stable metabolite of nicotine, has been detected in the follicular fluid of 
smokers (Zenzes and Reed, 1998). However, whether cotinine alters GJ communication of 
CX43 levels is unknown.  
Caffeine initially reduced Cx43 mRNA and CX43 protein levels, however had no effect on GJ 
communication. The effect of caffeine on CX43 protein levels was attenuated by 25 hours 
whereas Cx43 mRNA levels remained low and GJ communication was slightly increased 
(P=0.052). Therefore, despite the increase in GJ communication at 25 hours in caffeine-
treated COC, CX43 protein levels were similar to the control. As with BPA, further 
investigation into phosphorylation states and cellular localisation of CX43 and levels of CX37 
protein may provide insight into how caffeine regulates GJ communication. Indeed, caffeine 
is a PDE inhibitor and therefore may promote GJ communication through increased cAMP 
levels in the COC and promotion of PKA-mediated phosphorylation of CX43  (Mehta et al., 
1992).  
The implication of enhanced GJ communication on COC health is currently unclear. However 
increased availability of energy sources and other nutrients is likely to improve oocyte 
health. This is supported by the finding that increased GJ coupling in human CC cells is 
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correlated to higher pregnancy rates during IVF (Wang et al., 2009). Moreover, maintenance 
of GJ communication during IVM of bovine COC is known to promote blastocyst formation 
(Atef et al., 2005). Additionally, molecules that maintain meiotic arrest in the oocyte such as 
cAMP and cGMP are well documented to be passed through GJs to the oocyte. Human 
oocytes that were pre-incubated with a PDE3 inhibitor (i.e. maintained in meiotic arrest) 
during IVM had higher maturation rates after removal of the inhibitor, compared to controls 
where the inhibitor was absent (Nogueira et al., 2006). No effect of BPA, caffeine, or nicotine 
on GVBD was noted in this study. However the addition of PDE inhibitors may have reduced 
the need for GJ transfer of molecules that maintain meiotic arrest.  
Conversely, increased GJ communication may be indicative of increased energy 
requirements to allow the oocyte to carry out RNA surveillance and DNA damage repair in 
response to environmental stress (Baumann et al., 2007). The findings from this study 
strongly indicate that BPA and nicotine, and to a lesser extent caffeine, promote the transfer 
of small molecules, which may include energy substrates, to the oocyte via GJs. The 
metabolism of glucose via glycolysis occurs in the CC, and subsequently lactate and pyruvate 
are transferred to the oocyte and undergo metabolism by the TCA cycle and oxidative 
phosphorylation to produce ATP. Furthermore, by-products of oxidative phosphorylation 
include reactive oxygen species (Voet and Voet, 2004). Increased glucose concentrations and 
oxidative phosphorylation are associated with the production of reactive oxygen species in 
oocytes (Hashimoto et al., 2000), which may result in a reduction in oocyte quality (Agarwal 
et al., 2003). Moreover, increased transfer of glucose metabolites to the oocyte may result in 
utilisation of alternate metabolic pathways such as the PPP. Hyperglycaemic conditions 
result in the activation of the PPP and subsequent precocious oocyte meiotic maturation 
(Downs et al., 1998). Therefore, increased transfer of PPP substrates to the oocyte may also 
result in precocious nuclear maturation, however this was not observed in this study. 
Further investigation into how upregulation of GJ communication affects the precise 
coordination of oocyte cytoplasmic and nuclear maturation is necessary. Determining 
whether BPA, caffeine, and nicotine promote the formation of reactive oxygen species and 
the activity of the PPP would reveal whether these pathways are activated by increased GJ 
transfer.  
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Although incubation of COC with ethanol, MDMA, or THC did not affect GJ communication, 
each of these treatments did affect Cx43 mRNA levels and/or CX43 protein expression. 
Exposure of COC to ethanol initially raised mRNA levels of Cx43, but this effect was 
attenuated after 25 hours of exposure. MDMA increased expression levels of Cx43 mRNA 
regardless of exposure time, while CX43 protein levels were also increased after a 25 hour 
exposure. THC increased Cx43 mRNA levels after 25 hours. These results demonstrate that 
mRNA and protein levels of CX43 are not good indicators of GJ communication in rat COC.  
11.2.2 GDF9 protein levels are altered by BPA, caffeine, MDMA and THC 
Exposure to BPA or caffeine for 1 hour caused a reduction in promature GDF9 levels. 
However, a 25 hour exposure to BPA or caffeine restored promature GDF9 levels to over and 
above that in the control. Moreover, exposure to MDMA or THC for 25 hours promoted 
promature GDF9 levels. Interestingly, GDF9 protein levels were not correlated to Gdf9 mRNA 
levels, which were unaffected by time or treatments. Detection of the mature form of GDF9 
was inconsistent in this study therefore the major conclusions were drawn from levels of 
promature GDF9. The biological functions of the proregion and promature GDF9 forms are 
currently unknown. However, mice that were immunised against the GDF9 proregion had 
smaller litter sizes suggesting a functional role of the proregion in female reproduction 
(McIntosh et al., 2012). Expression levels of BMP15 were low in rat COC in the current study, 
and therefore the measurement of BMP15 over a wide range of treatments was not feasible. 
However, Gdf9 and Bmp15 mRNA expression levels are known to be tightly co-regulated in 
several species including rat (Crawford and McNatty, 2012). In the rat, Bmp15 mRNA levels 
were 3.65-fold lower than Gdf9 mRNA levels, indicating a reduced requirement for BMP15 in 
rat follicular growth. Indeed, mature BMP15 is not detectable in the rat until just prior to 
ovulation, consistent with the finding that Bmp15 KO mice are fertile (Yan et al., 2001; 
Yoshino et al., 2006). Therefore, although BMP15 protein levels were not measured in this 
study, they are likely to be altered proportionately with GDF9.  
Reduced GDF9 levels are likely to significantly reduce oocyte health. During follicular growth, 
the oocyte tightly controls CC functions including proliferation, metabolism, apoptosis, 
luteinisation, and expansion. It is likely that a reduction in GDF9 levels decreases CC 
proliferation, metabolism, and expansion but increases CC apoptosis and luteinisation. For 
example, downregulation of GDF9 expression using RNA interference demonstrated that CC 
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expansion and expression of genes involved in CC expansion (i.e. Has2 and Ptgs2) were 
significantly inhibited (Gui and Joyce, 2005). Furthermore, polycystic ovarian syndrome, a 
syndrome characterised by anovulation, polycystic ovaries, and hyperandrogenism, is 
associated with reduced Gdf9 expression levels (Teixeira Filho et al., 2002). A complete lack 
of GDF9 (i.e. in Gdf9 KO mice) causes follicular growth to arrest at the primary stage (Yan et 
al., 2001).  
Despite an initial reduction following exposure to BPA and caffeine, GDF9 promature levels 
were higher in the treated COC than the control after 25 hours. This may have been due to 
the action of metabolites of BPA and caffeine which stimulated GDF9 protein levels. 
Alternatively, the oocyte may have produced more GDF9 to stimulate CC metabolism, 
indicating a greater requirement for CC metabolites.  
Increased GDF9 protein levels are likely to have a positive effect on follicle growth and 
maturation. Addition of recombinant GDF9 to is known to promote preantral mouse follicle 
growth in vitro (Hayashi et al., 1999), and to improve oocyte developmental competence 
(Hussein et al., 2006). Furthermore, higher concentrations of GDF9 were correlated with 
higher embryo quality during IVF (Gode et al., 2011). This positive effect of GDF9 on follicular 
development is likely to be mediated through increased CC proliferation and metabolism, 
and decreased CC steroidogenesis and apoptosis (Gilchrist et al., 2008). Indeed, GDF9 
stimulates CC proliferation (Gilchrist et al., 2004b; McNatty et al., 2006), cholesterol 
metabolism (Su et al., 2008), and amino acid uptake (Eppig et al., 2005). However, aberrant 
GDF9 production may stimulate these CC functions inappropriately resulting in follicular 
dysfunction and thus reducing COC health. 
There did not appear to be a correlation between GJ communication, CX43 mRNA, CX43 
protein levels, and GDF9 protein levels. CX43 is thought to positively regulate TGFβ 
signalling, through competitive interactions with SMAD2/3 on microtubules (Dai et al., 
2007). Thus although protein levels of CX43 and GDF9 were not correlated, it is possible that 
GDF9 signalling was correlated to CX43 protein, however this was not investigated.  
11.2.3 GVBD is prevented by ethanol but promoted by MDMA and THC 
Long exposures to ethanol (i.e. >5 hours) resulted in reduced proportions of oocytes 
undergoing GVBD. These results suggest that ethanol prevents oocyte meiotic maturation 
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without inhibiting the transfer of the meiosis-suppressing molecules to the oocyte as GJ 
communication was unaffected. Artificial maintenance of meiotic arrest allows for 
cytoplasmic maturation to complete, and promotes oocyte maturation rates during IVM 
once the inhibitor is removed (Nogueira et al., 2006). Therefore, further investigations into 
whether oocytes are subsequently able to undergo GVBD when ethanol is removed are 
needed. Heavy alcohol consumption is currently known to cause anovulation by inhibiting 
the LH surge. If ethanol completely prevents GVBD in some oocytes, then the results 
presented here suggest that ethanol may act at both the pituitary and the follicle to prevent 
ovulation.  
MDMA and THC both promoted oocyte GVBD when COC were incubated with these 
treatments for >5 hours. Furthermore, no additional oocytes appeared to have undergone 
GVBD at 13 or 25 hours compared to 5 hours, in either the MDMA- or THC-treated groups. 
This suggests that MDMA and THC stimulated GVBD by 4 hours. Interestingly, at 4 hours 
MDMA and THC had promoted GVBD in 75 % and 58 % of COC, compared with the control 
where 17 % had undergone GVBD. This suggests that MDMA has a stronger influence on 
GVBD than THC. Moreover, these results highlight that the effects of contaminants are not 
identical for different COC. For example, 17 % of oocytes retained their GV even in the 
presence of MDMA for 25 hours. Whether these oocytes were meiotically incompetent, or 
whether they were resistant to MDMA is unknown.  
 THC has previously been found to promote GVBD in rat COC in vitro (Reich et al., 1982). The 
results from this study suggest that meiotic maturation in oocytes is more sensitive to THC 
than previously thought as this study used a concentration of THC that was ~30-fold lower 
than that in the Reich study. Precocious resumption of meiotic maturation is thought to 
reduce oocyte quality due to inadequate cytoplasmic maturation. In vivo, the oocyte gains 
meiotic competence around the time of follicular antrum formation (Edson et al., 2009) 
however meiotic arrest must be maintained to allow cytoplasmic maturation such as 
organelle and cytoskeleton reorganization and storage of mRNAs to take place (Marteil et 
al., 2009). Therefore, the current study suggests that MDMA and THC may reduce COC 
health by promoting precocious nuclear maturation.  
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No correlation between the effects of treatments on GVBD and GJ communication was 
noted. The transfer of cAMP and cGMP from the CC to the oocyte through GJs is essential for 
maintenance of oocyte meiotic arrest. However, after the LH surge CX43 is phosphorylated, 
resulting in closure of the GJs and initiation of GVBD (Norris et al., 2008). However, it is 
possible that the addition of PDE inhibitors in the current study reduced the need for CC-
derived cAMP and cGMP for maintenance of meiotic arrest. Both BPA and nicotine are 
reported to cause meiotic abnormalities (Mailhes et al., 2000; Liu et al., 2007; Eichenlaub-
Ritter et al., 2008). BPA suppresses oocyte meiotic maturation in mice (Eichenlaub-Ritter et 
al., 2008), while exposure to nicotine promoted meiotic maturation in vivo, but not in vitro in 
mice (Mailhes et al., 2000). Moreover, caffeine is a PDE inhibitor that prevents meiotic 
resumption in a reversible manner by increasing cAMP levels within the oocyte (Jagiello et 
al., 1972; Kren et al., 2004).  Therefore, measuring the effects of those treatments that 
affected GJ communication (i.e. BPA, caffeine, and nicotine) in the absence of PDE inhibitors 
may have demonstrated a link between GJ communication and meiotic arrest. 
11.2.4 MDMA and THC alter expression of genes involved in glucose metabolism 
Initial exposure to MDMA resulted in increased Gfpt1 and Pfkp mRNA levels. Exposure to 
MDMA for 25 hours resulted in increased Gfpt1, but reduced Cycs and Pfkp mRNA levels.  
These results suggest that metabolism of glucose via the glycolytic and hexosamine 
biosynthetic pathways are promoted after a 1 hour exposure to MDMA. However, after 25 
hours exposure to MDMA, glycolysis and oxidative phosphorylation were reduced and 
hexosamine biosynthesis was increased. Oocytes that are undergoing meiosis (i.e. after 
GVBD and before metaphase II arrest) consume more pyruvate than GV or MII oocytes 
(Downs et al., 2002). Therefore, the increase in Pfkp levels at 1 hour in the MDMA-treated 
group may correlate with the induction of GVBD and thus an increased requirement for 
energy. Although expression levels of Pfkp were increased at 1 hour, GJ communication was 
similar to the controls suggesting that transfer of glucose metabolites to the oocyte 
remained stable. Perhaps by 25 hours, meiosis had progressed such that the need for energy 
substrates (and Pfkp and Cycs expression) had abated. The expression levels of Pfkp did not 
correlate to levels of GDF9 in this study. However, GDF9 has not been implicated in the 
regulation of Pfkp in the mouse, with BMP15 and FGF8 reported to be the main regulators of 
glycolysis (Sugiura et al., 2008).  
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The promotion of Gfpt1 levels at both exposure times by MDMA and THC, suggest that 
glucose metabolism through the hexosamine biosynthetic pathway is upregulated. 
Interestingly, GDF9 protein levels were also promoted by incubation with MDMA and THC 
for 25 hours, correlating to the promotion of Gfpt1 and consistent with the role of GDF9 in 
promoting CC expansion (Elvin et al., 1999). However, CC expansion was not observed in 
either the MDMA or THC-treated COC. This may indicate that glucose was used to produce 
substrates for O-linked glycosylation, rather than hyaluronic acid. Treating porcine and 
bovine COC with glucosamine, which enters the hexosamine biosynthetic pathway 
downstream of GFPT1, inhibited embryo development, and this effect was blocked when O-
linked glycosylation was inhibited (Schelbach et al., 2010). Therefore, determining whether 
MDMA and THC promote O-linked glycosylation or hyaluronic acid synthesis would reveal 
the consequence of upregulation of the hexosamine biosynthetic pathway.  
11.3 In vivo effects of MDMA 
There is currently very little research on the effects of MDMA on female fertility. Given the 
finding that in vitro exposure to MDMA affects several pathways involved in COC function, 
we chose to investigate the effects of in vivo exposure to MDMA on these pathways. In vivo 
exposure to MDMA resulted in upregulation of CX43 protein in rat COC. GJ communication 
in rat COC exposed to MDMA in vivo was not measured, as in vitro exposure to MDMA did 
not affect GJ communication (Chapter 6). However, given the finding that CX43 protein 
levels in COC were enhanced in rats administered MDMA, further investigation into whether 
this affects GJ activity is necessary. Interestingly, the findings from the in vitro experiments, 
i.e. MDMA exposure modulates Cx43, Cycs, Gfpt1 and Pfkp mRNA expression and GDF9 
protein levels in rat COC, were not mirrored in the in vivo experiment. Furthermore, MDMA 
promoted GVBD in vitro, but did not affect meiotic resumption in oocyte in vivo. These 
differences between the in vitro and in vivo effects of MDMA on COC health may be due to 
the delivery of MDMA to the ovary or metabolic processing of MDMA in the circulation. It 
remains to be determined whether MDMA or its major metabolites are detectable in the 
follicular fluid. As discussed in Chapter 10, the major metabolic pathways differ between 
humans and rats. Therefore, future studies may include investigation of the actions of HHMA 
and MDA on COC health. In addition, prospective studies investigating MDMA usage and 
infertility in human populations would provide valuable information regarding the influence 
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of MDMA on female fertility. However, this study provides evidence that MDMA regulates 
the COC communication network in vivo. 
11.4 Future directions 
Clear differences between the effects of in vitro and in vivo exposure to MDMA on COC 
function were observed. These results demonstrate the need for in vivo studies to 
complement in vitro studies. The in vitro studies from this thesis demonstrate that all of the 
treatments investigated (i.e. BPA, caffeine, ethanol, nicotine, MDMA, and THC) affect some 
facet of oocyte function. Therefore, investigation into the effects of in vivo exposure to each 
of these factors would provide further information about their influences on oocyte health. 
Subsequent mating studies would provide further information about the effect of these 
lifestyle factors and environmental contaminants on fertility.  
The finding that GJ communication is not correlated to CX43 protein or Cx43 mRNA levels 
was surprising, although not unprecedented. These findings suggest that other regulatory 
mechanisms affecting post-translational modifications and/or formation of GJ plaques may 
play a critical role in regulating function GJ communication. Further investigations into the 
effects of BPA, caffeine, and nicotine on localisation of CX43 and the phosphorylation states 
may provide more insight into how these treatments affect overall GJ communication.  
In addition, assays investigating oocyte-secreted growth factor actions and glucose 
metabolic functions would provide further information regarding the effects of treatment on 
the activity of these pathways. These studies have shown that Gdf9 mRNA and GDF9 protein 
levels were also not correlated, perhaps due to several post-translational processing steps. It 
is possible that the protein data were confounded by measurement mostly of intracellular 
content rather than the forms secreted into the media. It is noteworthy too that the 
bioactivity of the promature protein, the major form detected here, is unknown. Therefore, 
measurements of secreted protein forms and applying appropriate bioassays to assess the 
bioactivity of GDF9 (e.g. GC proliferation assays) would shed light on how these treatments 
affect oocyte growth factor function.  
The lifestyle factors were tested in isolation in the current study. However, investigation into 
effects of, and interactions between, multiple factors is a more realistic model. For example, 
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correlation between the use of tobacco, alcohol, and cannabis is thought to be around 0.3 
suggesting a relatively high incidence of co-exposure (Lynskey et al., 1998).  
Although these results clearly suggest a role for lifestyle factors in regulating COC function, 
this study only examined antral follicles (i.e. fully grown oocytes). GJs are expressed in the 
follicle from the primordial stage (Kidder and Mhawi, 2002), and are positively regulated by 
FSH levels (Granot and Dekel, 1997). Cx43 mRNA is abolished after the LH surge, and CX43 
protein levels are reduced. Furthermore, GDF9 is expressed from the primary stage onwards 
in rodent follicles (Laitinen et al., 1998). Follicles at different stages of growth may be more 
sensitive to certain contaminants. For example, radiation therapy primarily targets 
primordial, rather than growing follicles (Armstrong, 1986). Therefore, investigation into the 
effects of these lifestyle factors on all stages of follicles will be necessary.  
11.5 Conclusion 
The major objective of this study was to determine whether exposure to BPA, caffeine, 
ethanol, nicotine, MDMA, or THC influences the function of rat COC, and in particular the 
pathways involved in bi-directional communication between the CC and oocyte, that may 
adversely affect health.  
The results presented in this study implicate the bi-directional communication loop and 
glucose metabolic pathways as potential targets for lifestyle factors. Exposure of COC in vitro 
to each of the contaminants included in this study affected at least one of the parameters 
tested. Furthermore, this study has identified that Cx43 mRNA levels are particularly 
sensitive to contaminants however the levels of Cx43 mRNA were not an indicator of 
functional GJ communication in rat COC. The CC appeared to play a protective role, 
preserving the oocyte from damage caused by harmful factors in the COC 
microenvironment. The bi-directional communication loop and glucose metabolic pathways 
appeared to be less sensitive to perturbation by MDMA after in vivo exposure, compared to 
in vitro exposure. Therefore, delivery of lifestyle factors in the blood to the ovary, 
metabolism of these factors, and the containment of the COC within the follicle may be 
important contributors to the effects of contaminants on COC function.  
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It is concluded that GJ communication, GDF9 protein levels, expression levels of genes 
involved in glucose metabolism, and oocyte meiotic arrest are sensitive processes that may 
be influenced by contaminants within the COC microenvironment. 
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APPENDIX 1  CARBENOXOLONE ACTION TIME 
An experiment was performed to determine how long carbenoxolone takes to inhibit dye 
transfer in rat COC. Briefly, COC were isolated as described in Sections 2.1.1 and 2.1.2. All 
steps were performed in the presence of 50 μM dipyridamole and 50 μM rolipram. The 
incubations conditions used were 37 °C, 5 % CO2, and 96 % humidity. The 0 hour control 
group was not exposed to carbenoxolone, and was incubated for 0 hours prior to exposure 
to calcein-AM and further 1 hour incubation as described below. The other groups were 
incubated in the absence of carbenoxolone for varying times, such that the total incubation 
time was equivalent to 240 minutes for all groups, prior to being incubated in 1 mM 
carbenoxolone for 0, 30, 60, 120, 180, or 240 minutes (Table A1-1). Thereafter, the COC 
were incubated with 2 μM calcein-AM and 1 mM carbenoxolone for 10 minutes. The COC 
were transferred into calcein-AM free incubation media containing 1 mM carbenoxolone 
and incubated for a further hour. The oocyte was denuded and oocyte fluorescence 
measured as described previously (Section 2.1.3). 
 
Table A1-1: Incubation conditions for determining time required for maximal inhibition of dye transfer by 1 
mM carbenoxolone. Note that the total pre-calcein incubation time is identical between all groups. 
Group 
Initial incubation 
(min) 
Carbenoxolone incubation 
(min) 
Total pre-calcein incubation 
(min) 
0 240 0 240 
30 210 30 240 
60 180 60 240 
120 120 120 240 
180 60 180 240 
240 0 240 240 
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Maximal inhibition occurred following a 2 hour exposure to carbenoxolone prior to 
incubation with calcein-AM (P<0.0001) (Figure A1-1). An exposure time of 2 hours was 
therefore used to determine the specificity of the GJ bioassay over time (Section 3.3.7). The 
incubation time of 4 hours resulted in significantly increased (P<0.05; Mann-Whitney test) 
fluorescent intensity in the control oocytes (no carbenoxolone), compared to that at 0 hours 
(i.e. note the ~1.5 fold higher value; Figure A1-1).  
 
 
Figure A1-1: Effect of exposure time to 1 mM carbenoxolone on fluorescent dye transfer from adjacent CC to 
oocytes after a 4 hour incubation of rat COC. Values are shown as geometric means ± 95 % confidence 
intervals of fluorescent ratios normalised against the geometric mean of the T0 control group (not shown, 
geometric mean=1.0). The data were generated from 2 replicate experiments with a total of 24-32 readings 
from individual oocytes in each group. The data were analysed by a Kruskal-Wallis test and where significant 
differences were observed, a Dunn’s multiple comparison post hoc test was performed. Groups that do not 
share a letter are significantly different (P<0.05). The mean ± SEM fluorescent reading in the T0 control group 
was 284 ± 31. 
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APPENDIX 2  STOCK SOLUTIONS 
A2.1  GJ Assay Solutions 
Dissection Media 
0.1 % Bovine serum albumin       50 mg 
100 IU/mL Penstrep        500 µL 
15 mM Hepes Buffer       750 µL 
Lebowitz media containing phenol red and L-glutamine   43.7 mL 
Adjust pH to 7.4. Store at 4 °C. 
 
Incubation Media 
0.3 mg/mL polyvinyl alcohol      15 mg 
M199 media containing L-glutamine, 2.2 g/L sodium 
bicarbonate, Earle’s salt (phenol red free)     45 mL 
Adjust pH to 7.4. Store at 4 °C. 
 
Wash Media 
0.1 % Bovine serum albumin      50 mg 
100 IU/mL Penstrep       500 µL 
M199 media containing L-glutamine, 2.2 g/L sodium 
bicarbonate, Earle’s salt (phenol red free)    44.5 mL  
Adjust pH to 7.4. Store at 4 °C.  
 
1 mM calcein-AM solution 
Dissolve a 50 µg aliquot in 50 µL of DMSO. Store at -20 °C. Prior to use in the GJ assay, 
calcein-AM was diluted 1:5 with incubation media to make a 200 μM intermediate dilution. 
This 100x calcein-AM solution was then added to incubation media, containing the 
appropriate treatments, at a final concentration of 2 μM.  
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200x dipyridamole/rolipram working stock  
Dilute 1 mg dipyridamole in 99 μL DMSO 
Dilute 1 mg rolipram in 182 μL DMSO 
Mix these solutions in a ratio of 1:1. Store at -20 °C.  
25x Protease Inhibitor stock 
Resuspend one tablet in 2 mL of dH2O. Aliquot into smaller volumes and store at -20 °C 
 
PBS 
PBS tablets were purchased from Sigma and dissolved in 200 mL dH2O. PBS was autoclaved 
and stored at 4 °C.  
 
100x carbenoxolone stock 
Carbenoxolone was purchased from Sigma, was dissolved in dH2O to a concentration of 100 
mM, and stored at -20 °C. 
 
A2.2 SDS-PAGE stocks 
0.5 M Tris-HCl pH 6.8 
Tris base        6.06 g 
Make up to 100 mL with dH2O. Adjust pH to 6.8. Store at room temperature. 
 
1.5 M Tris-HCl pH 8.8 
Tris base        36.34 g 
Make up to 200 mL with dH2O. Adjust pH to 8.8. Store at room temperature. 
 
10 % (w/v) ammonium persulphate 
Ammonium persulphate      1 g 
Make up to 10 mL with dH2O. Distribute into 1 mL aliquots. Store at -20 °C or at 4 °C for up 
to 1 month.  
 
 
 
219 
 
10 % SDS 
SDS         2 g 
Make up to 20 mL with dH2O, store at room temperature.  
 
30 % bis-acrylamide mix 
The bis-acrylamide mix was purchased from BioRad (Auckland, NZ) and stored at 4 °C.  
 
TEMED 
TEMED was purchased from BioRad and stored at room temperature.  
 
13.5 % separating gel 
dH2O         2.85 mL 
1.5 M Tris-HCl pH 8.8       2.5 mL 
10% SDS        100 μL 
30 % bis-acrylamide mix      4.5 mL 
10 % ammonium persulphate     50 μL 
TEMED        5 μL 
Set up small and large glass plates in a vertical gel holder. Distribute the separating gel mix 
into the plates, layer a small layer of dH2O over the gel, and allow the gel to polymerise.  
 
4 % stacking gel 
dH2O         3.05 mL 
0.5 M Tris-HCl pH 6.8       1.25 mL 
10% SDS        50 μL 
30 % bis-acrylamide mix      650 μL 
10 % ammonium persulphate      25 μL 
TEMED        5 μL 
Remove the layer of water from the separating gel. Distribute the stacking gel over the top 
of the separating gel. Insert a 10 or 15 well comb, and allow the gel to polymerise.   
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5x sample buffer  
0.5 M Tris-HCl pH 6.8       1.0 mL 
Glycerol        0.8 mL 
10 % SDS        4.6 mL 
DTT         80 mg 
1.0 % (w/v) bromophenol blue     0.2 mL 
dH2O         0.8 mL 
β-mercaptoethanol       1.74 mL  
Store at -20 °C.  
 
5x SDS-PAGE Running Buffer 
Glycine        72 g 
Tris base        15 g 
SDS         5 g 
Make up to 1 L with dH2O and adjust pH to 8.3, and store at room temperature.  
 
A2.3  Western blotting solutions 
10x Tris-glycine stock 
Tris base        30.3 g 
Glycine        144 g 
Make up to 1 L with dH2O, store at room temperature.  
 
Transfer buffer 
10x Tris-glycine stock       200 mL 
Methanol        400 mL 
Make up to 2 L with dH2O and store at 4°C.  
 
Ponceau S Stain 
Ponceau S        1.0 g 
Acetic Acid        2.0 mL 
Make up to 200 mL with dH2O. Store at room temperature.  
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1 M Tris pH 7.5 
Tris base        30.29 g 
Make up to 250 mL with dH2O.  
pH to 7.5 
Make up to 250 mL with sterile water and adjust pH to 7.5 Store at room temperature. 
 
TBS 
1 M Tris-HCl pH 7.5       20 mL 
NaCl         8.76 g 
Tween20        1 mL 
Make up to 1 L with dH2O. Store at room temperature.  
 
5 % low-fat milk powder solution 
Low-fat milk powder       2.5 g 
TBS         50 mL 
Make up fresh for each experiment. Store at 4 °C. 
 
A2.4  ECL reagents 
1 M Tris-HCl pH 8.5 
Tris base        30.29 g 
Make up to 250 mL with dH2O and adjust pH to 8.5. Store at room temperature.  
 
90 mM p-coumaric acid 
p-coumaric acid       0.15 g 
Make up to 10 mL with DMSO. Store at -20 °C.  
 
250 mM luminol 
Luminol        0.44 g 
Make up to 10 mL with DMSO. Store at -20 °C.  
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Solution 1 
250 mM luminal       100 μL 
90 mM p-coumaric acid      44 μL 
1 M Tris-HCl pH 8.5       1 mL 
dH2O         8.85 mL 
 
Solution 2 
30 % hydrogen peroxide      6 μL 
1 M Tris-HCl pH 8.5       1 mL 
dH2O         9 mL 
Prepare Solutions 1 and 2 fresh for each experiment. Mix together just prior to performing 
Western development.    
 
A2.5  Stripping solutions 
62.5 mM Tris pH 6.7 
Tris base        1.89 g  
Make up to 250 mL with dH2O. Adjust pH to 6.7. Store at room temperature 
 
Membrane stripping buffer 
62.5 mM Tris pH 6.7       50 mL 
SDS         1 g 
β-mercaptoethanol        350 µL 
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